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 Summary  I
Summary 
Antigen-induced lymphocytic (adaptive) immune responses rely on a complex contact- and 
cytokine-mediated interplay of different cells. Hapten-carrier complexes as antigens have 
been employed to elaborate many characteristic features of this process, e.g. action of antigen-
presenting cells, specificity of T (TCR) and B (BCR) cell antigen receptors, collaboration of T 
and B lymphocytes, function of T cell subpopulations, generation and selection of the primary 
repertoire, immune maturation through somatic hypermutation, class switch recombination 
and isotype regulation, to name the most important ones. One of the best explored antibody 
responses is that of BALB/c mice to the hapten 2-phenyl-oxazolone (phOx) after coupling to 
the thymus-dependent (TD) carrier chicken serum albumin (CSA). The latter response is char-
acterized by the dominant Ox1 idiotype (IdOx1) which is encoded by the canonical VH171/ 
Vκ072 gene combination and contains the typical amino acid sequence aspartic acid-arginine-
glycine (DRG) in the middle of the third complementarity-determining region of the heavy 
chain (HCDR3). The affinity of IdOx1 antibodies is 10-100-times higher than that of non-IdOx1 
antibodies and immune maturation is primarily based on the accumulation of somatic muta-
tions in IdOx1 antibodies. During memory responses, however, there is a repertoire shift to 
non-IdOx1 antibodies encoded by alternative VH and/or VL genes. The propensity of non-IdOx1 
antibodies for somatic mutations is known. 
 
According to the selection theory, many of these characteristics depend on the antigen-specifi-
city of the antigen-binding site (paratope) of the BCR. In principle, two different processes 
participate in the generation of the BCR repertoire during the antigen-independent differentia-
tion in the bone marrow, i.e. on the one hand, the recombination of the genomic variable (V), 
diversity-enhancing (D) and joining (J) genes and, on the other, a non-genetic enhancement of 
this genetic repertoire during V(D)J recombination by the action of three different enzyme 
systems. Exonucleases cut off terminal nucleotides, repair enzymes generate palindromic se-
quences (P nucleotides) and terminal deoxynucleotidyl-transferase (TdT) adds non-template 
nucleotides (N nucleotides) at random. In this way, an enormous non-genetic diversity is cre-
ated at HCDR3 being large enough to allow efficient immune responses even when only a 
single VH and VL gene is available.  
 
The experiments on the humoral anti-phOx response of DH mutant BALB/c mice, described 
in the present communication, were performed to elucidate how HCDR3-related non-genetic 
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and V gene-encoded genetic variability contribute to the thymus-independent type 2 (TI-2) 
and the TD response, primary TD repertoire, IdOx1 dominance, class switch recombination, 
somatic hypermutation and immune maturation during memory TD responses. Two mutant 
BALB/c strains were available which harbored only one single DH gene in their genome in-
stead of 13 DH genes in BALB/c wildtype (WT) mice. The DH gene segment of ΔD-iD mice 
codes for charged amino acids in HCDR3 while that of ΔD-DµFS mice codes for hydrophobic 
amino acids. The phOx-Ficoll-induced TI-2 and the phOx-CSA-induced TD immune response 
of both strains were compared with that of BALB/c WT mice and analyzed at the level of 
single antibody-forming plasma cells and serum anti-phOx antibody formation. The quality of 
the TD response was analyzed with the aid of hybridoma monoclonal antibodies generated 
after early and late primary, secondary and tertiary immunization. 
 
The following results were obtained: 
A  Quantitative aspects of the humoral anti-phOx immune response in DH mutant mice 
1.) The analysis with fluorescence-activated cell sorting (FACS) revealed that the numbers of 
total nucleated cells, lymphocytes as well as T and B cells in the bone marrow of both mu-
tant strains were comparable to BALB/c WT mice. 
2.) However, in the spleens of ΔD-iD and ΔD-DµFS mice, numbers of total mononuclear 
cells as well as both lymphocyte subpopulations were reduced to values of lower than 50 
% of those found in WT mice. 
3.) It is a striking result that the genetic alteration in both strains of mice also affects T cells 
although the genetic alteration is restricted to Ig genes and can thus not directly affect the 
germ line repertoire of TCR. In relation to and in accord with published data, this allows 
concluding that the T cell repertoire is indirectly controlled by B lymphocytes. 
4.) The total immunoglobulin concentrations were reduced for IgM in ΔD-iD but not ΔD-Dµ-
FS mice while the IgG immunoglobulin class was clearly reduced in both strains. 
5.) In contrast to these results, the background numbers of IgM but not IgG anti-phOx anti-
body-secreting cells were significantly enhanced in both DH mutant strains. 
6.) The phOx-Ficoll-induced TI-2 response was comparable for the IgM and delayed for the 
IgG antibody response. 
7.) The IgM production during the primary phOx-CSA-induced TD response was delayed and 
remained at lower maximal levels before falling back to similar low levels as in WT mice. 
IgG titers were severely suppressed during the entire primary response and remained at 
this lower level after secondary immunization. 
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B  VH/VL sequence analysis of monoclonal hybridoma antibodies from the different 
phases of the humoral anti-phOx immune response in DH mutant mice 
Genetic analysis of the phOx-reactive repertoire of ΔD-DμFS mice 
In the early primary response, the IdOx1 gene combination is rarely used and not at all domi-
nant. Antibodies with 5-100-times higher affinities than the normally dominant IdOx1 occur. 
Usage of reading frame 1 (RF1), coding for hydrophobic amino acids, is counter selected dur-
ing the generation of the primary repertoire of ΔD-DμFS mice. The length of the middle por-
tion HCDR3 varied from 1-12 amino acids. This may suggest that it is not of prime impor-
tance for the phOx-specificity. The more D gene nucleotides were eliminated by exonucleases 
during VDJ recombination in the course of generation of the pre-immune repertoire, the short-
er the HCDR3 length will be.  
In contrast to wildtype mice, the late primary anti-phOx antibodies contain an astonishingly 
high number of 56% non-switched IgM antibodies. Since a dominant clonotype did also not 
develop at this time point, this process obviously depends on the available DH gene repertoire 
and can not or only very rarely be generated from the non-natural DH gene of ΔD-DμFS 
mice. An immune maturation is indicated by enhanced mutation rates in IgG antibodies, but 
the mutations do not accumulate in a particular clone. These antibodies preferably used germ 
line-related HCDR3 nucleotides sequences, but `tried to avoid´ RF1.  
Antibodies obtained after secondary immunization showed again that class switch recombina-
tion is impaired in this mouse strain, that the phOx-specific B cell repertoire develops at 
random, that immune maturation occurs in individual, but not all ΔD-DμFS mice and that a 
few individual mice may even generate IdOx1 antibodies. The HCDR3 sequence (CAR-DGG-
AYW) of one these IdOx1 antibodies probably derived from the canonical IdOx1 sequence 
CAR-DRG-AYW. Hence, although ΔD-DμFS mice can generate the VH171/Vκ072 IdOx1 
gene combination, the IdOx1-specific DRG motive in the middle of HCDR3 can either not or 
only extremely rarely be generated.   
An impaired class switch recombination is even observed after tertiary immunization since 
about one third of the established antibodies were of the IgM class. IdOx1 antibodies did also 
not dominate the tertiary TD response. Instead, about one third of IgG antibodies were encod-
ed by the VH/VL gene combination VH158/Vκ115 which has already been observed as a 
major clone in a memory response of BALB/c WT mice. During all phases (1° to 3°) of the 
TD anti-phOx response, ΔD-DµFS mice `try to avoid´ coding of HCDR3 in RF1 causing 
hydrophobic amino acids. Instead, RF2 usage and generation of new nucleotide sequences 
during recombination favor HCDR3 loops which are rich in glycine and tyrosine. 
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Genetic analysis of the phOx-reactive repertoire of ΔD- iD mice with a charged HCDR3 
In the early primary response of ΔD-iD mice, the restriction to a single DH gene segment cod-
ing for charged amino acids changed the pattern of VH/VL combinations and led to the ap-
pearance of some hitherto not observed variable genes. Neither IdOx1 nor other clonotypes do-
minated. In some IgM and IgG antibodies affinities were enhanced by factors of 5-10. The bi-
as against RF1 usage is not as pronounced as in ΔD-DμFS mice. RF2 is not really dominant 
and in most of the antibodies the reading frame could not be assigned. These antibodies have 
shorter D-region lengths. B cells seem to escape the usage of charged HCDR3-loops by shift-
ing the RF and an increased loss of nucleotides at the termini of DH gene, so that 53 % of the 
HCDR3 intervals contained no germ line-encoded DH nucleotides. Hydrophilic HCDR3 
loops are strongly favored. Sequence comparisons showed that the IdOx1 specificity relies not 
only on the DRG motive in the HCDR3 loop, but is also influenced in its 3-dimensional 
structure by other parts of the molecule. 
The genetic repertoire of the late primary response of ΔD-iD mice is quite heterogeneous and 
there is again no dominant VH/VL gene combination. IdOx1 antibodies were not observed. As 
in ΔD-DµFS mice, a high amount of IgM-secreting cells at this time point indicates impaired 
class switch recombination in ΔD-iD mice. These late IgM-secretors showed almost no soma-
tic mutations. Hence, the restriction in ΔD-iD mice to a single DH gene coding for charged 
amino acids in HCDR3 drastically inhibits the early immune maturation. The bias against 
RF1 usage was not as pronounced as in ΔD-DμFS mice. RF2 and RF3 are least frequently 
used and antibodies with germ line non-related HCDR3 sequences are rather common. Non-
assignable reading frames code for shorter D-region lengths. Late primary anti-phOx anti-
bodies of ΔD-iD mice use mainly hydrophilic amino acids in HCDR3.  
In the secondary response, it is again astonishing that an IgM antibody could be isolated al-
ready 3 days after secondary immunization with the TD antigen phOx-CSA. Enhanced muta-
tions and an increased affinity of the IgG antibody indicated that secondary antibodies in ΔD-
iD mice are derived from an immune maturated repertoire. 
In the tertiary response of ΔD-iD mice, a high percentage of naïve, non-mutated and non-ma-
turated IgM antibodies were obtained which thus resemble IgM antibodies from the primary 
response. In contrast to anti-phOx antibodies from earlier stages of TD immune responses, 
tertiary antibodies contained again VH171/Vκ072-encoded IgM and IgG IdOx1 antibodies. 
The IgG IdOx1 antibody contained somatic mutations and was affinity-maturated. However, 
the IdOx1 clonotype was not dominant and there was no other dominant clone. Usage of RF1 
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in HCDR3 was suppressed, but not avoided. RF2 and RF3 were not used and in a rather high 
proportion of antibodies, HCDR3 reading frames could not be assigned. Tertiary antibodies as 
those from earlier phases of the response reveal a selection of hydrophilic HCDR3-loops. The 
obtained sequences confirmed that the original IdOx1 motive DRG is completely associated 
with the VHOx1gene VH171. 
 
Hence, the findings in the anti-phOx response of the 2 DH mutant mouse strains ΔD-DµFS 
and ΔD-iD mice allow the following general conclusions:  
1.) Under the conditions of a single artificial DH gene, the enzymatically created 
extraordinary variability at the third hypervariable region becomes visible. The data 
confirm previous findings that neutral amino acids like tyrosine and glycine are preferred 
in HCDR3. 
2.) Since the T cell-mediated class switch-recombination as well as the expression of domi-
nant B cell clonotypes obviously depends on the available DH genes it can be concluded 
that both processes are not only antigen-driven. This supports the further argument that T 
cells are involved in the selection of particular B cell clones and that this selection de-
pends in a hitherto unknown way on particular HCDR3 sequences. 
3.) A comparison with a large panel of anti-phOx antibodies from BALB/c WT mice (44 VH 
and 40 VL genes) revealed that DH mutant mice made use of 28 more VH and 12 more 
VL genes. 
Further work in ΔD-DµFS and ΔD-iD DH mutant mice, in comparison to BALB/c WT mice, 
must elucidate the precise T cell involvement in regulation of class switch recombination and 
HCDR3-dependent selection of IgG-secreting B cell clones. 
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Zusammenfassung  
Antigen-induzierte lymphozytäre (adaptive) Immunantworten beruhen auf komplexen kon-
takt- und zytokin-vermittelten Wechselwirkungen verschiedener Zellen. Vielfach wurden 
Hapten-Träger-Komplexe als Antigene eingesetzt, die verschiedenen charakteristischen Funk-
tionen der einzelnen Komponenten dieses Prozesses zu entschlüsseln, z. B. die Wirkung der 
antigen-präsentierenden Zellen, Spezifität der T- (TCR) und B (BCR) Zell Antigenrezeptoren, 
die Kooperation von T- und B-Lymphozyten, die Funktion der Subpopulationen der T-Zellen, 
die Entstehung und Selektion des primären Repertoires, die Immunreifung durch somatische 
Hypermutationen, den Klassenwechsel und die Isotypregulation, um die wichtigsten zu nen-
nen. Eine der am besten erforschten Antikörper-Antworten ist die in BALB/c-Mäusen gegen 
das Hapten 2-phenyl-oxazolone (phOx) nach Kopplung an das thymus-abhängige (TD) Trä-
gerprotein Hühnerserum-Albumin (CSA). Die Immunantwort gegen phOx-CSA ist durch den 
dominierenden Ox1 Idiotype (IdOx1) gekennzeichnet, der von der kanonischen VH171/Vκ072 
Genkombination kodiert wird und die typische Aminosäure-Sequenz Asparaginsäure-Arginin-
Glycin (DRG) in der Mitte der dritten hypervariablen Region der schweren Kette (HCDR3) 
enthält. Die Affinität der IdOx1-Antikörper ist 10-100-fach höher als die der Non-IdOx1-Anti-
körper und die Immunreifung beruht in erster Linie auf der Anhäufung von somatischen Mu-
tationen in IdOx1-Antikörpern. Während der Gedächtnisantwort gibt es jedoch eine Repertoire-
verschiebung zu Non-IdOx1-Antikörpern, die durch alternative VH- und/oder VL-Gene kodiert 
sind. Die Neigung von Non-IdOx1-Antikörpern für die somatischen Mutationen ist bekannt. 
 
Nach der Selektionstheorie hängen viele dieser Eigenschaften von der Antigen-Spezifität der 
Antigen-Bindungsstelle (Paratop) des BCR ab. Grundsätzlich sind zwei verschiedene Prozes-
se an der Entstehung des Antiköprper-Repertoires während der antigen-unabhängigen Diffe-
renzierung im Knochenmark beteiligt, nämlich einmal die Rekombination der genomischen 
variablen (V), die Diversität erhöhenden (D) und der verbindenden (J) Gene und zum anderen 
eine nicht-genetische Erweiterung dieses genetischen Repertoires während V(D)J-Rekombi-
nation durch die Wirkung von drei verschiedenen Enzym-Systemen. Exonucleasen schneiden 
terminale Nukleotide ab, Reparatur-Enzyme generieren palindromische Sequenzen (P-Nukle-
otide) und die terminale Deoxynukleotidyl-Transferase (TDT) fügt zufällig nicht-kodierte Nu-
kleotide (N-Nukleotide) hinzu. Auf diese Weise wird in der HCDR3 eine enorme nicht-gene-
tische Diversität geschaffen, die ausreicht, eine effiziente Immunantwort zu ermöglichen, 
selbst wenn nur ein einziges VH- und VL-Gen vorhanden sind. 
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In der vorliegenden Arbeit werden Experimente zur humoralen Anti-phOx-Immunantwort 
von zwei transgenen BALB/c-Mäusestämmen beschrieben, welche jeweils nur ein DH–Gen 
enthalten. Ziel dieser Untersuchungen war es zu bestimmen, welchen Anteil die in HCDR3 
beobachtete nicht-genetische und die auf VH/VL-Genen beruhende genetische Variabilität 
haben: an der thymus-unabhängigen Typ 2 (TI-2) und der thymus-abhängigen Immunantwort, 
dem primären TD-Repertoire, der IdOx1-Dominanz, dem Klassenwechsel, der somatischen 
Hypermutation und der Immunreifung während der TD Gedächtnisantwort. Zwei Mutanten 
des BALB/c–Mäusestammes standen zur Verfügung, die statt der 13 DH-Gene in BALB/c 
Wildtyp-Mäusen nur ein einziges DH-Gen in ihrem Genom tragen. Das DH-Gensegment der 
ΔD-iD Mäuse kodiert für geladene Aminosäuren in der HCDR3, während das DH-Gen der 
ΔD-DµFS Mäuse für hydrophobe Aminosäuren kodiert. Die phOx-Ficoll-induzierte TI-2 und 
die phOx-CSA- induzierte TD-Immunantwort der beiden Stämme wurden auf der Ebene der 
einzelnen antikörper-bildenden Zellen und der Serum-anti-phOx Antikörperbildung analysiert 
und mit denen in BALB/c Wildtyp-Mäusen verglichen. Die Qualität der TD Immunantwort 
wurde mit Hilfe monoklonaler Antikörper, welche aus Hybridomen gewonnen wurden, analy-
siert, die nach früher und später primärer, sekundärer und tertiärer Immunisierung durch Zell-
fusion hergestellt wurden. 
 
Die folgenden Ergebnisse wurden erhalten: 
 
A  Quantitative Aspekte der humoralen Anti-phOx Immunantwort in DH –Mutanten- 
Mäusen  
 
1). Die Analyse mittels Durchflusszytometrie (FACS) ergab, dass die Gesamtzahl der kern-
haltigen Zellen, Lymphozyten sowie T- und B-Zellen, im Knochenmark der beiden Mu-
tantenstämme vergleichbar war mit denen in BALB/c Wildtyp-Mäusen. 
2.) Allerdings war die Gesamtzahl der mononukleären Zellen, ebenso wie der beider Lympho-
zyten-Subpopulationen in der Milz von ΔD-iD und ΔD-DμFS Mäusen auf Werte von we-
niger als 50 % der Wildtyp-Mäuse reduziert. 
3.) Bemerkenswerterweise wirkte sich die genetische Veränderung in beiden Mäusestämmen 
auch auf T-Zellen aus, obwohl die genetische Veränderung auf die Immunglobulin-Gene 
beschränkt ist und deshalb keine direkte Auswirkung auf das TCR-Keimbahn-Repertoire 
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haben kann. Das Ergebnis in Zusammenhang mit den publizierten Daten erlaubt die 
Schlussfolgerung, dass die B-Lymphozyten das T-Zell-Repertoire indirekt kontrollieren. 
4.) Die IgM-Immunglobulin-Konzentrationen waren im Serum von ΔD-iD, nicht aber in ΔD 
DμFS-Mäusen verringert, während die der IgG-Immunglobulin-Klasse deutlich in beiden 
Stämmen reduziert war. 
5.) Im Gegensatz dazu war die Zahl der `background´ IgM-anti-phOx Antikörper-sezernieren-
de Zellen in beiden DH Mutantenstämmen deutlich erhöht, nicht aber der IgG-
sezernierenden Zellen. 
6.) Verglichen mit BALB/c-Wildtypmäusen war die phOx-Ficoll-induzierte TI-2 Antwort 
vergleichbar für IgM, während die für IgG sich verzögert entwickelte. 
7.) Die IgM-Produktion während der primären phOx-CSA- induzierten TD-Antwort verlief 
verzögert und blieb auf niedrigeren Maximalwerten, bevor sie auf ein ähnliches Niveau 
wie bei Wildtyp-Mäusen zurückfiel. IgG-Titer waren während der gesamten primären 
Antwort stark supprimiert und verblieben auf diesem niedrigen Niveau auch nach sekun-
därer Immunisierung. 
 
B  VH/VL Sequenzanalyse von monoklonalen Hybridom-Antikörpern aus den verschie 
denen Phasen der humoralen Anti-phOx Immunantwort in DH Mutante Mäusen  
Genetische Analyse des phOx-reaktiven Repertoires in ΔD-DµFS Mäusen 
In der frühen primären Immunantwort der ΔD-DμFS-Mäuse (RF1 kodiert für hydrophobe 
HCDR3 Aminosäuren) wurde die IdOx1 Genkombination VH171/Vκ072 selten benutzt und 
dominierte in keiner Weise. Antikörper traten auf, die 5–100-fach höhere Affinität als die nor-
malerweise dominierenden IdOx1-Antikörper besaßen. Die Verwendung des RF1 war im pri-
mären Repertoire in ΔD DμFS-Mäusen stark eingeschränkt. Die Länge des mittleren Teils des 
HCDR3 variierte von 1-12 Aminosäuren. Dies könnte darauf hindeuten, dass HCDR3 nicht 
von zentraler Bedeutung für die phOx-Spezifität ist. Je mehr Nukleotide vom DH-Gen durch 
Exonukleasen während der Entwicklung des Prä-Immunrepertoires durch VDJ Rekombina-
tion eliminiert werden, desto mehr verkürzt sich die Länge der HCDR3. 
Im Gegensatz zu Wildtyp-Mäusen enthielten die späten primären Anti-phOx Antikörper einen 
erstaunlich hohen Anteil von 56 % IgM-Antikörpern. Da sich auch zu diesem Zeitpunkt kein 
dominanter Klon entwickelt hatte, folgt, dass eine solche Auswahl offensichtlich von dem zur 
Verfügung stehenden DH-Gen-Repertoire abhängt. Der IdOx1-Klon kann entweder gar nicht 
oder nur sehr selten aus dem artifiziellen DH-Gen der ΔD-DµFS-Mäuse generiert werden. 
Dass eine Immunreifung stattgefunden hatte, wird durch eine erhöhte Anzahl von Mutationen 
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in IgG-Antikörpern angezeigt, aber die Mutationen sind nicht in einem bestimmten Klon 
akkumuliert. Die HCDR3-Nukleotidsequenzen basieren bevorzugt auf dem DH-
Keimbahngen, RF1 ist aber unterrepräsentiert.  
Antikörper, die nach sekundärer Immunisierung erhalten wurden, zeigten, dass die erneute 
Rekombination beim Klassenwechsel in diesen Mäusen beeinträchtigt ist, sich das phOx-spe-
zifische B-Zell-Repertoire zufällig entwickelte, die Immunreifung in einzelnen aber nicht in 
allen ΔD-DµFS Mäuse ablief und einzelne Mäuse sogar IdOx1-Antikörper mit der VH171/Vκ−
072 Gen-Kombination bilden können. Die HCDR3-Sequenz (CAR-DGG-AYW) eines dieser 
IdOx1-Antikörper leitet sich wahrscheinlich von der kanonischen IdOx1-Sequenz CAR-DRG-
AYW ab. Das IdOx1 spezifische DRG-Motiv in der Mitte der HCDR3 kann aber entweder gar 
nicht oder nur äußerst selten gebildet werden.  
Eine Beeinträchtigung des Klassenwechsels war sogar nach tertiärer Immunisierung zu beob-
achten, denn etwa ein Drittel der etablierten Antikörper gehörte zur IgM-Klasse. IdOx1-Anti-
körper dominierten auch nicht in der tertiären TD Immunantwort. Stattdessen wurde über ein 
Drittel der IgG-Antikörper von der VH/VL-Gen Kombination VH158/Vκ115 kodiert, welche 
bereits einmal als ein dominanter Klon während der Gedächtnisantwort in BALB/c Wildtyp-
Mäusen beobachtet worden war. In allen Phasen der primären bis tertiären Anti-phOx TD-Im-
munantwort in ΔD-DμFS-Mäusen war die Kodierung der HCDR3 in RF1, welche hydropho-
be Aminosäuren bedingt, unterrepräsentiert. Stattdessen führten die Verwendung des RF2 und 
die Bildung von keimbahn-unabhängigen Nukleotidsequenzen zu HCDR3-Schleifen, die reich 
an Glycin und Tyrosin sind. 
 
Genetische Analyse des phOx-reaktiven Repertoires der ΔD-iD-Mäuse 
In den frühen primären Antwort der ΔD-iD-Mäuse, deren in RF1 translatiertes DH-Gen für 
geladene HCDR3-Aminosäuren kodiert, war das Muster der VH/VL-Kombinationen geän-
dert, und es wurden bisher nicht beobachtete V-Gene benutzt. Es dominierten aber weder 
IdOx1–Antikörper noch andere Klonotypen. Einige IgM- und IgG-Antikörper hatten 5-10-fach 
höhere Affinitäten als die normalerweise höchst-affinen IdOx1-Antikörper. Die Tendenz gegen 
eine Verwendung des RF1 war nicht so ausgeprägt wie in ΔD-DµFS-Mäusen. Allerdings war 
auch RF2 nicht wirklich dominant, und in den meisten Antikörpern konnte der Leserahmen 
nicht zugeordnet werden. Die D-Regionen dieser Antikörper waren kürzer als es sonst beob-
achtet wird. Die B-Zellen scheinen die Verwendung von geladenen HCDR3-Schleifen einmal 
durch eine Verlagerung des Leserasters und zum anderen durch einen erhöhten Verlust von 
Nukleotiden an beiden Enden des DH-Gens zu vermeiden, so dass etwa 53 % der HCDR3-
 Zusammenfassung  X
Segmente keine keimbahn-kodierten Nukleotide enthalten. Dagegen sind hydrophile HCDR3-
Schleifen stark begünstigt. Sequenzvergleiche zeigten, dass die IdOx1-Spezifität nicht nur 
durch das DRG-Motiv in der HCDR3-Schleife bedingt ist, sondern auch durch die 3-dimen-
sionale Struktur anderer Teile des Moleküls beeinflusst wird. 
Das genetische Repertoire der späteren primären Antwort der ΔD-iD-Mäuse ist sehr hetero-
gen, und es zeigt wieder keine dominierende VH/VL Gen-Kombination. IdOx1-Antikörper 
wurden nicht beobachtet. Wie in ΔD-DμFS-Mäusen zeigte der hohe Anteil an IgM-sezernie-
renden Zellen zu diesem Zeitpunkt, daß der Klassenwechsel auch in ΔD-iD-Mäusen beein-
trächtigt ist. Die fast vollständig fehlenden somatischen Mutationen in diesen späten IgM-An-
tikörpern zeigen, daß die Beschränkung in ΔD-iD-Mäusen auf ein einziges DH-Gen, welches 
für geladene HCDR3-Aminosäuren kodiert, auch die frühe Immunreifung hemmt. Die Nicht-
Verwendung des RF1 war nicht so ausgeprägt wie in ΔD DμFS-Mäusen. RF2 und RF3 wur-
den am wenigsten verwendet, und Antikörper mit keimbahn-unabhängigen HCDR3-Sequen-
zen waren am häufigsten. Letztere Antikörper besaßen wiederum kürzere D-Regionen, und 
die späten primären Anti-phOx-Antikörper der ΔD-iD-Mäuse besaßen hauptsächlich hydro-
phile HCDR3-Aminosäuren.  
In der sekundären Antwort erstaunte es wieder, dass ein IgM-Antikörper bereits 3 Tage nach 
Immunisierung mit dem TD-Antigen phOx-CSA isoliert werden konnte. Vermehrte Mutatio-
nen und eine erhöhte Affinität des IgG-Antikörpers weisen darauf hin, dass sekundäre Anti-
körper in ΔD-iD-Mäusen sich aus einem immungereiften Repertoire entwickeln. 
In der tertiären Antwort der ΔD-iD-Mäuse wurde ebenfalls ein hoher Prozentsatz an naiven, 
unmutierten und ungereiften IgM-Antikörpern erhalten, die damit IgM-Antikörpern der pri-
mären Immunantwort ähneln. Im Gegensatz zu Anti-phOx-Antikörper aus früheren Phasen 
der TD-Immunantwort, waren unter den tertiären Antikörpern wieder VH171/Vκ072-kodierte 
IgM und IgG IdOx1-Antikörper zu finden. Der IgG IdOx1-Antikörper enthielt somatische Muta-
tionen und war immungereift. Allerdings waren IdOx1-Antikörper nicht dominant, und es gab 
auch keine anderen dominanten Klone. Die Verwendung des RF1 in HCDR3 war zwar stark 
vermindert, aber nicht völlig unterdrückt. RF2 und RF3 wurden nicht benutzt, und in einem 
recht hohen Anteil von Antikörpern konnte das verwendete HCDR3-Leseraster nicht zugeord-
net werden. Wie es auch schon in den frühen Phasen der TD-Immunantwort beobachtet wor-
den war, zeigten die tertiären Antikörper eine Tendenz zu hydrophilen HCDR3-Schleifen. Die 
erhaltenen Sequenzen bestätigten, dass das ursprüngliche IdOx1-Motiv DRG vollständig mit 
der VHOx1gene VH171 assoziiert ist. 
 
 Zusammenfassung  XI
Die Beobachtungen zur Anti-phOx-Immunantwort in den beiden DH-transgenen Mäusestäm-
men ΔD-DµFS und ΔD-iD erlauben die folgenden allgemeinen Schlussfolgerungen: 
1.) Unter den Bedingungen eines einzigen künstlichen DH-Genes wurde die außergewöhnli-
che Variabilität in der dritten hypervariablen Region der schweren Immunglobulinkette, 
welche durch die Wirkung von 3 Enzymsystemen bedingt ist, sichtbar. Die Daten bestäti-
gen frühere Ergebnisse, dass neutrale Aminosäuren wie Tyrosin und Glycin in HCDR3 
bevorzugt werden. 
2.) Da sowohl die durch T-Zellen vermittelte erneute Genrekombination des Klassenwechsels 
als auch die Entwicklung eines dominanten B-Zellklons offensichtlich von den verfügba-
ren DH-Genen abhängt, kann man schließen, dass beide Prozesse nicht nur durch eine 
durch das Antigen vermittelten Selektion angetrieben werden. Dies unterstützt das weitere 
Argument, dass T-Zellen an der Auswahl von bestimmten B-Zell-Klonen beteiligt sind 
und dass diese Auswahl in einer bisher unbekannten Art und Weise von bestimmten 
HCDR3-Sequenzen abhängig ist. 
3.) Ein Vergleich mit einer großen Gruppe der Anti-phOx-Antikörpern von BALB/c Wildtyp- 
mäusen (44 VH- und 40 VL-Gene) ergab, dass in den DH–transgenen Mäusen weitere 28 
VH- und 12 VL-Gene benutzt werden. 
Es sind weitere Arbeiten in ΔD-iD und ΔD-DμFS DH-transgenen Mäusen und der Vergleich 
mit BALB/c Wildtypmäusen erforderlich, die genaue Beteiligung der T-Zellen an der Regula-
tion des Klassenwechsels und der HCDR3-abhängigen Selektion der IgG-sezierenden B-Zell-
klone aufzuklären. 
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1 Introduction  1
1 Introduction 
The immune system fulfills two major tasks, namely protection against foreign harmful invad-
ers on the one hand and preservation of the inner integrity of the organism on the other. A va-
riety of mechanisms enables the organism to fight infections by identifying and killing micro-
bial pathogens which range from viruses to parasitic worms. A prerequisite for this action is 
that the immune system has to distinguish them from the organism's normal cells and tissues. 
Hence, the immune system has to and can distinguish `Self´ from `Non-Self´. This ability not 
only allows the elimination of potentially harmful `Non-Self´ molecules and microbes, but al-
so to recognize and destroy abnormal cells that derive from host tissues by malignant transfor-
mation.  
To survive a pathogenic challenge, several mechanisms have evolved that recognize and neu-
tralize pathogens. Even unicellular organisms have rich arsenals of mechanisms for protect-
ion, such as restriction endonucleases [1]. Other basic immune mechanisms evolved in an-
cient eukaryotes and remain in their modern descendants, such as plants, fish, reptiles, insects, 
birds and mammals. These mechanisms include various antimicrobial peptides such as defen-
sins [2], pattern recognition receptors, and the complement system. More sophisticated mech-
anisms, however, developed relatively recently with the evolution of vertebrates [3]. The 
immune systems of vertebrates enclose innate and adaptive immunity and consist of many 
types of proteins, cells, tissues, and organs which interact in an elaborate and dynamic net-
work. 
 
1.1 Innate and adaptive immunity 
The mammalian body is susceptible to infection by many pathogens which, after contacting 
the host, establish a focus of infection. Since the pathogens differ greatly in their surface pro-
teins and mechanisms of pathogenesis, hosts developed two defense systems, namely innate 
and adaptive immune responses. Both responses are able to distinguish Self from Non-Self but 
with different degree of specificity. Also the mechanisms of antigen recognition by both in-
nate and adaptive immunity are very diverse. Cooperation between both types of immune 
responses is required to achieve optimal responses against pathogens. 
Innate immunity represents the first line of host defense through effector mechanisms that act 
immediately on contact with the pathogen at any time. Innate immunity is relatively non-spe-
cific for a particular pathogen. Anatomic barriers like skin and physiologic conditions like 
low pH values of the stomach inhibit the entrance of pathogens and protect against viral and 
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bacterial colonization. Bacteria, viruses, and parasites that overcome this barrier are faced 
immediately with tissue macrophages equipped with surface receptors (e.g. Toll-like receptor) 
that recognize a limited number of molecular patterns common to a wide variety of pathogens 
[4]. This, in turn, leads to an inflammatory response, which causes the accumulation of pha-
gocytic monocytes, neutrophils and macrophages at the site of infection [5]. 
 
Since the mechanisms of innate immune responses do not develop a memory, they are incapa-
ble to improve their ability to resist a subsequent challenge with either the same or a different 
pathogen. These mechanisms prevent the vast majority of infections from becoming establish-
ed or to develop further to a state of disease. However, innate responses often fail to clear the 
infection. In that case, dendritic cells, macrophages and other antigen presenting cells (APC), 
activated in the early innate immune response, help to initiate the development of adaptive 
immune responses [6, 7]. 
 
Adaptive immune responses are carried out by B and T lymphocytes which can, in principle, 
interact with Non-Self as well as Self molecules with membrane-bound antigen-receptors, i.e. 
the B cell antigen-receptor (BCR) and the T cell antigen-receptor (TCR). Antigens are recog-
nized by BCR and TCR in two fundamentally different ways. BCR is a membrane-bound im-
munoglobulin = antibody (see below) which can directly interact with the antigenic molecule. 
The TCR is composed of 2 polypeptide chains, being either α plus β or γ plus δ. This allows 
the classification of two large subpopulations of T cells. While γδ T cells are able to recognize 
antigens directly (like B cells), αβ T cells can only do so when peptide fragments of protein 
antigens are bound to major histocompatibility (MHC) molecules. Protein antigens can be 
taken up and degraded to peptide fragments by antigen-presenting cells (APC) of the innate 
immune system as well as B lymphocytes. Hence, αβ T cells recognize inner peptides of pro-
teins while B cells recognize the surface of antigens. Since lymphocytes express a huge 
repertoire of antigen-receptors, adaptive responses to pathogens are highly specific for partic-
ular molecules of such microbes and this interaction can provide long-lasting memory cell-
mediated protection. Thus, a second attack with the same pathogen induces an adaptive 
response that develops much faster and stronger than the first. 
 
Like innate immunity, adaptive immunity has the ability to distinguish between Self from 
Non-Self and responds, under normal physiological conditions, only to Non-Self molecules. 
However, occasionally, the system fails to make this distinction and reacts destructively 
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against the host's own molecules, giving rise to autoimmune diseases. In addition, many 
foreign molecules entering the body are harmless per se, but can activate pathogenic immune 
reactions under special conditions. Allergic conditions such as hay fever and asthma are 
examples of these deleterious adaptive immune responses against normally harmless foreign 
molecules. 
 
Another distinction concerning adaptive immune responses carried out by B and T lympho-
cytes is that they mediate two broad classes of immune responses, humoral and cell-mediated 
responses, respectively. In the humoral response, antigen-activation of B cells induces their 
differentiation into plasma cells which secrete huge amounts of antibodies which circulate 
with the bloodstream. The protective function of these antibodies can be ascribed to different 
mechanisms. a) The binding of antibodies can inactivate viruses and microbial toxins by 
blocking their ability to bind to receptors on host cells. b) The formation of antigen-antibody 
complexes (immune complexes – IC) can activate secondary effector functions, i.e. activation 
of the complement system or marking invading pathogens for destruction, mainly by making 
it easier for phagocytic cells of the innate immune system to ingest them via cell membrane 
receptors for the constant Fc part of the antibody (Fc receptors = FcR) or complement recep-
tors like those for C3b. c) Moreover, the formation of IC may induce further activation of T 
lymphocytes which supports the differentiation into memory T as well as B cells. 
 
Cell-mediated or cellular immunity is mediated by cytotoxic T lymphocytes (CTL) which are 
able to kill virus-infected and tumor cells [8, 9]. Moreover, B cell responses to protein anti-
gens need the help from T cells. Thus, proteins are so-called thymus-dependent (TD) antigens 
which induce CD4+ T helper (TH) cells. Their interaction with B cells depends on recognition 
of an antigenic peptide presented by MHC class II molecules on the membrane of the B cell. 
Helper T cells can further be subdivided into TH1 cells secreting as major cytokines inter-
leukin 2 (IL-2) and interferon γ (IFN-γ) and TH2 cells secreting cytokines like IL-4, -5, -10 
and -13 [10]. This cytokine network decides, for instance, about class switch recombination 
from primarily activated IgM-producing plasma cells to different IgG subclasses, mutual 
inhibition of TH cell subpopulations and regulatory feedback to antigen-presenting cells. This 
complex cellular interplay is, in addition, regulated by CD8+ suppressor / regulatory T cells 
[11].  
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1.2 Structure of B cell antigen receptor 
The B cell antigen receptor, immunoglobulin or membrane-bound antibody, is a heterodimer-
ic protein composed of two heavy (H) chains which are connected via disulfide bonds and two 
light (L) chains each of which is likewise bound via disulfide bridges to one of the H chains. 
The prototypic Y-shaped structure of the secreted form of an antibody is depicted Fig. 1. 
Thus, the transmembrane domains are omitted. Both chains are composed of one or more con-
stant regions (or domains) that define their class- and subclass-dependent effector functions 
and one variable region that determines antigen specificity and affinity [12]. Immuno-
globulins exist in several isotypic variants, the antibody classes IgM, IgD, IgG, IgA and IgE 
which are characterized by the constant parts of the heavy chains. They are designated μ for 
IgM, δ for IgD, γ for IgG, α for IgA and ε for IgE antibodies. In addition, IgG can be 
subdivided in 4 subclasses, namely IgG1-4 in humans and IgG1, 2a, 2b and 3 in mice. IgA ap-
pears in 2 subclasses, IgA1 and 2. There are 2 types of L chains named κ (kappa) and λ 
(lambda). 
Each of the variable domains of the heavy chain (VH) and the light chain (VL) contain 3 
hypervariable (hv) or complementarity-determining regions (CDR). Since the immunoglobu-
lin domains are folded in a secondary structure with 2 ß-folds, the CDRs of each chain point 
into one direction. Together, they form the antigen-binding site = paratope which recognizes 
and binds the antigenic determinant = epitope. The location of the paratope-forming 3 VL and 
3 VH CDRs are depicted in Fig. 2. The third CDR of the heavy chain (HCDR3) is especially 
important for a specific binding of the antigen. Together with the LCDR3, HCDR3 forms the 
center of the paratope. The immune system is able to create an extraordinary variability at 
HCDR3 (see below). Whereas variable domains allow specific recognition of the antigen, 
constant domains define the effector functions [12]. The C domains are directly germ line 
encoded, whereas V domains are created de novo by means of a complex series of gene 
rearrangement events in developing B cells [13]. 
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Figure 1 
Schematic drawing of a typical antibody molecule 
Each antibody consists of four polypeptides: two heavy and two light chains held together by 
disulfide brigs (S-S). The variable (VL and VH) domain gives the antibody its specificity for 
binding, while the constant domains (CL, CH1, CH2, and CH3) determine the antibody iso-
type. The variable region is further subdivided into hypervariable (hv) or complementarity-
determining regions (CDR) and framework (FR) regions. Within light and heavy chains, there 
are three CDR regions: CDR 1, 2 and 3 and four FR regions: FR1, 2, 3, and 4 which separate 
the hv regions. The 6 CDRs in the N-terminal (NH2) V domain of both H and L chains form 
the antigen binding site, whereas at the C-terminal (COOH) of CH domain is the Fc region 
which mediates different physiological effector functions of antibodies. All antibodies are 
glycosylated at conserved positions in their constant regions. The carbohydrates are indicated 
by (CHO). 
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Figure 2 
Schematic drawing of antigen binding site 
The framework regions (FRs) form beta-sheet structures which hold the complementary-de-
termining regions (CDRs) of L (black dotted ellipsis) and H (orange ellipsis) chains in the 
correct position to form the antigen binding site or paratope. The CDR3s of L and H chains 
make up the center of antigen binding site and they are surrounded by LCDR1 and 2 from one 
site, and from other site by HCDR1 and 2. The paratope makes various contacts with epitope 
(adpted from [29]) 
 
1.3  Immunoglobulin-coding genes 
The adaptive immune system is remarkable for its ability to respond to a seemingly unlimited 
variety and number of antigens, including synthetic antigens which do not occur in nature. 
This characteristic depends on the capacity of lymphocytes to create highly diversified anti-
gen receptor repertoires [13]. The variable regions of the 2 polypeptide chains of B as well as 
T cell antigen receptors are encoded in different ways. One chain of the antigen receptor, i.e. 
the BCR light chain and the TCR α chain, is encoded by variable genes (coding for about 100 
amino acids) and smaller J gene segments (coding for about 10 amino acids) which, after 
recombination, enable joining with the constant genes. The other chain of antigen receptors, 
i.e. BCR heavy chain and the TCR β chain, is likewise encoded by variable genes and J gene 
segments, but between both genetic elements there are small diversity-enhancing D gene 
segments interspersed.  
 
1 Introduction  7
1.3.1 Organization of the immunoglobulin λ and κ gene loci 
Each genetic locus coding for one of the three constant regions, i.e. λ and κ light chains and 
the heavy chain, has its own group of variable genes. This is due to the fact that the different 
genetic loci for Igλ, Igκ and IgH chains are located on different chromosomes. 
The mouse λ locus on chromosome 16 contains only three functional Vλ genes (Vλ1, Vλ2 and 
Vλ3) and two Cλ genes, each with its associated Jλ gene segments [14]. The organization of 
the λ locus also allows for few rounds of Vλ–Jλ rearrangement, in this case between an up-
stream Vλ and a downstream Jλ–Cλ cluster. Vλ elements are flanked by ‘two-turn’ spacers and 
Jλ by `one turn´ spacers (Fig. 3), limiting the likelihood of Vκ–Jλ or Vλ–Jκ rearrangements. 
Because of the few variable genes in this locus, λ-encoded antibodies contribute very little to 
the germ line repertoire. This correlates to the minimal occurrence of only 5 % of antibodies 
with λ L-chains while the rest of 95 % contains κ L-chains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Recombination signal sequences 
(a) DNA nucleotide sequences of recombination signal-sequences. Each recombination signal 
sequence contains a conserved heptamer (7 nucleotides) and a conserved nonamer (9 nucleo-
tides) motif separated by a ‘spacer’ of either 12 (one-turn) or 23 (two-turn) base pairs. 
(b) Location of RSSs in germ-line immunoglobulin DNA. Each V and J chains is jointed with 
one RSS (one-turn or two-turn depends on the isotype) at 3’ and 5’, respectively, whereas the 
DH segment is flanked by one-turn RSS at 3’ as well as one-turn at 5’ for joining to the J gene 
segment and the V gene. 
 
(b)
L Vλ CλJλ
5´ 3´…..λ-chain DNA
Vκ Jκ CκL
5´ 3´…..κ-chain DNA
L JHDHVH
5´ 3´
CH
….. …..Heavy-chain DNA
(a)
CACAGTG  23 bp ACAAAAACC   GGTTTTTGT  12 bp CACTGTG
GAGTCAC  23 bp TGTTTTTGG   CCAAAAACA  12 bp GTGACAC
Two-turn RSS                                      One-turn RSS
Heptamer                               Nonamer Heptamer                               Nonamer
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The mouse Vκ locus is located on chromosome 6 and contains up to 211 expressed Vκ gene 
segments [14]. The Jκ locus contains four functional genes (Jκ1, Jκ2, Jκ4, Jκ5). Jκ3 is a non-
functional pseudo-gene. The mouse κ locus contains only one Cκ element. Joining of one of 
the Vκ genes with one of the Jκ segments is mediated by recombination signal sequences 
(RSS) at the 3’ end of Vκ genes and 5’ end of Jκ (Fig. 3) [15]. As in the λ locus, the RSS con-
tain a highly conserved heptamer sequence separated from a less conserved nonamer se-
quence by 12 or 22/23 base pair intervals termed spacers. Each spacer region serves to sep-
arate the heptamer and nonamer sequences by either one (12 base pairs) or two (22/23 base 
pairs) turns of the DNA helix. Rearrangement of a ‘one-turn’ spacer with a ‘two turn’ spacer 
is strongly favored. In contrast to the λ locus, the Vκ genes are flanked by a ‘one-turn’ spacer 
and Jκ gene segments are flanked by a ‘two-turn’ spacer (Fig. 3). Each of the Vκ gene seg-
ments has the potential to rearrange with any one of the Jκ gene segments. Vκ genes, as well 
as VH and Vλ, can be grouped into families of related sequences that by definition share 
greater than 80 % identity with each other. Expressed Vκ genes in mouse can be grouped into 
eighteen families that contain as few as one and as many as 22 different elements. The mem-
bers of these families are partially clustered in the locus, and a large number of them is invert-
ed in relation to their orientation to the Jκ gene segments. The organization of the κ locus pro-
vides abundant opportunity for multiple rearrangements. Up to three rounds of sequential up-
stream Vκ to downstream Jκ recombination can occur by deletion and inversion.  
 
1.3.2 Genomic organization of the heavy chain locus 
The murine IgH locus spans approximately 3 Mb near the telomeric end of chromosome 12. 
The VH genes lie about 100 kb 5´ of the JH segments, and the distance between two adjacent 
VH genes is 12-15 kb [16]. It has to be stressed that, among the various strains of mice, there 
is considerable variation in the number as well as the sequence of the IgH gene segments. In 
BALB/c mice (one of the best characterized mouse strains), more than 700 genes can be 
grouped into 15 different families arrayed over 2.7 Mb. VH genes that lie closer to the DH 
gene segments have been termed proximal whereas VH genes lying further upstream have 
been termed distal (Fig. 4) [14]. VH and JH gene segments are flanked by `two-turn´ spacers 
(Fig. 3), whereas DH gene segments are flanked by `one-turn´ spacers. The DH gene seg-
ments have the potential to be read in any of six different reading frames, depending on 
whether rearrangement proceeds by deletion or by inversion. Fusions of 2 D gene segments 
(D–D fusions) have also been observed, but they are rare. Importantly, the 3´ terminus of a 
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VH gene contains an embedded cryptic heptamer sequence that is mostly preserved after 
initial V/D/J rearrangement. This sequence can be used to replace a particular VH gene 
sequence. Such a replacement is named receptor editing when happening during the antigen-
independent differentiation in the bone marrow, but receptor revision when is takes place in 
the periphery after stimulation by antigen [17, 18]. 
 
 
 
 
 
 
 
 
 
Figure 4 
Construction of heavy chains 
The heavy chain of an antibody is composed of V and C domains. The BALB/c genome in-
cludes 650 VH genes, 13 DH segments, 4 JH gene segments, and 8 constant genes (μ, δ, γ3, 
γ1, γ2b, γ2a, ε, and α). A functional heavy chain of a mature B cell is encoded by one 
particular VH (blue), one DH (red), one JH (orange) and a constant gene. In this example, VH 
171, DH 5 and JH3 are joined to γ2b constant domain to generate an IgG2b antibody. 
 
The members of the murine VH and DH families tend to be located in clusters of related se-
quences. This contrasts to the situation in humans, where in both the VΗ and the DH loci, 
family members are interspersed within other families. Murine members of the VH5 (7183) 
and VH2 (Q52) families are JH proximal, whereas genes of the VH1 family are most distal 
and account for more than 50 % of the active VH repertoire. Studies of the Ig repertoire sug-
gested that the VH1 family of C57BL/6 mouse consists of ~ 200 closely related members 
[19]. However, the exact number of VH1 genes of BALB/c mouse remained unclear [20-22]. 
 
The BALB/c haploid genome contains 13 active DH and a cluster of four active JH segments, 
which are located about 7 kb 5´ of the CH genes [22], while the C57BL/6 haploid genome 
contains only an estimated 101 functional VH, 9 DH, and 4 JH gene segments. The DH gene 
segments can be grouped into four families: (a) DFL which in BALB/c mice consists of the 
16.1 and 16.2 gene segments and in C57BL/6 only of DFL16.1, (b) DSP consists of nine gene 
segments in BALB/c, but only six in C57BL/6, (c) the singleton DST4 gene segment and (d) 
Germline
genes
Constant genes
μ δ γ3 γ1 γ2b γ2a ε α
Translocation
D
1 Æ 13
J
1 2 3 41 650
VH genes
γ2bJ3D5V171
variable region constant region
B-cell
DNA
e.g. IgG2b
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DQ52. DFL16.1 is most distal from JH (80 kb), whereas DQ52 is adjacent to JH1 (ca. 1 kb) 
[23, 24]. 
 
The mouse CH gene locus consists of the eight constant genes in the following order: 5´-Cμ-
Cδ-Cγ3-Cγ1-Cγ2b-Cγ2a-Cε−Cα- 3´ that cluster in a 200-kb region and code for μ, δ, γ3, γl, γ2b, 
γ2a, ε and α chains. In the mouse CH gene locus there are no stop codon-containing conserved 
pseudogenes [22, 25]. 
 
1.4 Contribution immunoglobulin variable genes to the structure of variable regions  
The VH region is encoded by the three separate DNA segments VH, DH, and JH genes or 
gene segments [26]. Consequently, the complete active VH domain is generated by two soma-
tic recombinations, VH-DH and DH-JH joining. In contrast, VL regions of both types of L-
chains are encoded by only two segments, VL and JL genes. Each newly formed VH and VL 
domain contains 4 intervals with relatively constant sequences which are named framework 
regions (FRs) (Fig. 1). They are separated from each other by three hypervariable intervals 
(complementarity determining regions or CDRs). The FRs encode the anti-parallel strands 
that make up not only the core β-barrel structure of the V but also the C domains. The first 2 
hypervariable regions CDRs 1 and 2 of both, VH and VL regions are encoded by the V genes 
and form the outside borders of the antigen binding site (Fig. 2) [27]. In contrast, the third 
hypervariable regions HCDR3 and LCDR3 are created by VDJ and VL recombination, re-
spectively. Both build the center of the antigen binding site (Fig. 2) [28]. 
 
1.5 Structure of the third hypervariable region of heavy chain (HCDR3) 
After differentiation in the bone marrow, the initial diversity in antibodies is primarily con-
centrated at the joining sites of V, D and J segments thereby creating HCDR3. The extra-
ordinary diversity of CDR3 of VH is created during the recombination process by the action 
of several enzyme systems (Fig. 5). The products of recombination-activating genes 1 and 2 
(RAG-1 and RAG-2 proteins) accomplish the association of RSS of the involved gene seg-
ments and cutting off the loops. However, the hair-pin loops of both double-stranded DNA 
ends are mostly not ligated properly. Before the single DNA strands are connected by ligases, 
other enzymes modify both ends. First, exonucleases cut off nucleotides from the coding 
sequences at the 3´ end of VH, the 5´ and/or 3´ end of DH and or the 5´ end of JH (Fig. 5c). 
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Secondly, the hair-pins may be opened asymmetrically in such a way that sticky ends are 
created which together form a palindromic sequence. Therefore, the subsequently filled in 
nucleotides of the second strand are termed P nucleotides (Fig. 5a). Third, during the recombi-
nation process, so-called non-germ line encoded nucleotide sequences (N nucleotides) are in-
serted by the enzyme terminal deoxynucleotidyl transferase (TdT) at the DH-JH and the VH-
DH border (Fig. 5b). Furthermore, the BALB/c DH locus encloses 13 diversity DH segments, 
which can be used, at least theoretically, in 6 different reading frames (RFs). As an overall 
result, only the middle part of the HCDR3 sequence is encoded by variable parts of a given 
DH gene while parts at the border are generated through random nucleotide sequences insert-
ed during the recombination process [12]. The inserted nucleotides provide the opportunity to 
create totally random HCDR3 sequences, indicating that HCDR3 is not restricted to the 
genomic nucleotide repertoires of the DH gene segments. The recombination process at 
HCDR3 is so multifaceted that it is not possible to deduce the original DH germ line gene 
segment in a rather high percentage of antibodies [29]. 
 
In several murine immune responses, the vast majority of antibodies use DH reading frame 1 
(RF1) which favors tyrosine and glycine residues [30]. It has been argued, that the preference 
for RF1 usage can be explained by the fact that RF1 of mice DH gene segments encodes 
neutral amino acids, while RF2 and RF3 are counter selected on the basis of stop codons 
and/or hydrophobic encoded nucleotides [31, 32]. Hence, such antibodies are eliminated by 
secondary regulatory mechanisms. This is indicated by the finding, that many auto-reactive 
antibodies are distinguished from non-pathogenic antibodies only by HCDR3 through insert-
ion of P/N nucleotides or usage of alternative DH reading frames [33]. Hence, the restriction 
of HCDR3 plays a critical role in controlling autoimmune diseases [34]. Thus, under normal 
conditions, the central amino acids of HCDR3 are usually derived from the nucleotides en-
coded by RF1 of DH gene segments. Moreover, a preferentially usage of some DH gene 
segments restricts the HCDR3 repertoire [35]. In fact, HCDR3 of fetal antibodies are shorter 
than in antibodies produced in later life [36]. This is due to low or no expression of TdT (lack 
of N nucleotides) and usage of short DH gene segments. 
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Figure 5 
Imprecisions during DH-JH recombination 
V(D)J recombination is mediated by the 2 RAG enzymes which cleave out the recombination 
signal sequences (RSS). However, during the recombination of DH-JH and its subsequent 
joining with a particular VH gene, the genomic sequences of the involved genetic elements 
are modified by three different mechanisms. 
a) The resulting DNA hairpins may be opened asymmetrically in such a way that sticky ends 
are generated which may contain DNA palindromic sequences. Such P-nucleotides (green) 
are encoded by the complementary strand. 
b) Nucleotides are added by terminal deoxytransferase (TdT) at random before complemen-
tary pairing occurs. Since these nucleotides are not encoded in the germ line they are termed 
N-nucleotides (blue) or N region insertions. 
c) During this process, exonucleases cut off nucleotides (red) at the ends of the involved gene 
segments. 
All three variability-enhancing mechanisms also occur during the recombination processes of 
joining between VH-DH and VL-JL.  
 
Several reports have demonstrated that the HCDR3 is especially important and decisive for 
the determination of antigen-specificity of antibodies. Transgenic mice carrying a single func-
tional VH gene but a full DH diversity repertoire are able to generate efficient immune re-
sponses to a variety of antigens. Antibodies generated in these mice, share the same VH and 
VL gene and differ only at HCDR3 [37]. Furthermore, mice lacking TdT (TdT°) [38] show 
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drastically reduced BCR and TCR repertoires similar to that found in fetuses, where the TdT 
is not or minimally expressed [29, 39]. Interestingly, the responses to TD and TI antigens are 
very similar in TdT° and control WT mice. Moreover, several studies have demonstrated that 
CDR3s of the TCR are crucial for antigen-recognition by T cells [37, 40]. Thus, it was 
concluded that HCDR3 determines antigen-specificity, while CDR1 and 2 play a role in the 
cross-reactivity [37]. 
 
1.6 B cell development 
Mammalian B lymphocytes are derived from the primary lymphoid organs fetal liver and 
bone marrow, while B cells in birds are generated in the bursa of Fabricius. B cell 
development is a linear progression of defined stages characterized by assembly of the BCR 
from different genetic elements. This differentiation in the bone marrow is an intrinsic ability 
of the system and occurs independently of external antigens [41]. The assembly of the BCR 
begins in the H chain locus in pro-B cells. At first, one of the 13 DH segments (in BALB/c 
mice) is recombined with one of the available 4 JH gene segments with the aid of RAG1 and 
RAG2 proteins. In the early pre-B cells, a VH gene is joined to previously established DHJH 
segment, completing the rearrangement of the IgH locus by production of heavy chain of the 
µ isotype. The further successful association of the μ chain at pre-B cell stage with a surrogate 
light chain (SLC) correlates with the downregulation of transcription of RAG1 and RAG2 
genes. SLC is a heterodimer composed of two peptides λ5 and VpreB. λ5 and VpreB show 
homology to lambda constant and variable regions, respectively. SLC combine with µ chain 
to form pre-B cell receptor complex (pre-BCR). In the late pre-B cell, reactivation of RAG1 
and RAG2 allows L chain rearrangement. Typically, Vκ–Jκ recombination precedes Vλ–Jλ 
joining. Successful association of an in-frame L chain with the endogenous μ chain forms 
membrane bound molecules (mIgM), establishing immature B cells [42]. If the expressed IgM 
is not properly assembled or is auto-reactive, the interaction with self-antigens may induce 
either receptor editing by a secondary gene rearrangement to produce non-auto-reactive BCR, 
or the cells die by apoptosis in order to avoid autoimmunity [43]. If the cells pass this check 
point, an alternative splicing is induced which leads to co-expression of IgD at the surface. 
These mature B cells, which have survived negative selection in the bone marrow, leave the 
bone marrow via the blood stream and colonize the secondary lymphoid organs. In the 
periphery, they can receive positive selection signals necessary for further differentiation and 
maturation [44]. Depending on the nature of the antigen, mature naïve B follow different 
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destinations. Cells failing a renewed check of self-reactivity may undergo receptor revision 
changing the specificity of their BCR, convert to anergic (non-responsive), or may be deleted 
by apoptosis. B cells reacted with thymus-independent (TI) Ag will differentiate into plasma 
cells producing mostly IgM isotype. Anti-thymus-dependent (TD) Ag B cells receive addi-
tional stimulations from TH cells necessary for hypermutation and class switch. Anti-TD 
antigen-specific B cells can differentiate into Ab secreting plasma and memory B cells. 
 
1.7 Antibody response 
The specific interaction between antigens and BCR on particular B cells is the basis for the 
clonal selection theory. The reactive B cells are activated to proliferation and differentiation 
into plasma cells that synthesize and secrete antibodies with identical specificity as the origin-
al BCR. Some antigens are capable of inducing a rapid antibody response that does not re-
quire T-cell help. There are of two types of the thymus-independent (TI) antigens. TI-1 anti-
gens (e.g. bacterial lipopolysaccharide) can specifically be recognized by the B cell receptor 
(BCR) and, in a more non-specific way, by toll-like receptors (TLRs). Recognition by this 
second receptor induces proliferation and differentiation of the B cells. Another group of TI 
antigens is typically composed of repetitive carbohydrate (e.g. pneumococcal polysaccharide) 
or protein epitopes present at high density on the surface of a microorganism. These TI-2 anti-
gens can extensively cross-link the antigen receptors and co-receptors on the B-cell surface. 
The rapid TI humoral responses are largely brought about by B-1 and marginal zone (MZ) B 
cells which produce predominantly IgM antibodies [45]. While TI-1 antigens do not induce 
generation of immunological memory, it is generally assumed that responses to TI-2 antigens 
include a long-term memory effect [46].  
 
In contrast, thymus-dependent (TD) antigens require T helper (TH) cells to stimulate antibody 
production. TD antigens must first be bound and internalized by antigen-presenting cells 
(APC) where they are enzymatically fragmented (processed). Peptide fragments are then pre-
sented by MHC class II molecules to antigen-specific T cells in order to activate them. Thus, 
interaction of TH and B cells depends on recognition of the MHC class II-bound peptide by 
the TCR and simultaneous interaction of the MHC class-II on the B cells with CD4 on the T 
cell, i.e. TH-B cell interaction is MHC class II-restricted. The successful interaction of both 
cell types leads to antibody production and secretion by plasma cells. The first antibodies 
made after TD antigen priming are of the IgM class. With continued TH B-cell stimulation 
activated B cells undergo isotype switching, somatic hypermutation, and affinity maturation 
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within the germinal centers of secondary lymphoid organs, resulting in secretion of IgG 
antibodies with increased affinity/avidity for the inducing antigens. In addition, stimulation 
with TD antigens generates long lived plasma cells migrating to the bone marrow and induces 
B/T memory cells. While long lived plasma cells are capable to secrete specific antibodies for 
several months without antigen [47], memory B/T cells are fundamental for secondary and 
further immune responses providing efficient protection for many years [45, 48]. 
 
1.8 Internal processing of antigen-induced immune responses  
The immune system does not only respond to the stimulation by external antigens, but devel-
ops a “balance between the processing of foreign antigens and well-balanced self-reactivity” 
[49]. This is achieved by idiotypic interactions: When antigen-reactive antibodies (idiotypes 
or Ab1) from one animal (rabbit, mouse) were used to immunize another animal, this pro-
duced Abs reacting with individual specificities of the injected idiotypes (anti-idiotypes or 
Ab2). Ab2 could stimulate anti-anti-idiotypes (Ab3) in a third animal, and Ab3 could stimu-
late anti-anti-anti-idiotypes (Ab4) in a fourth animal. This idiotypic cascade also proceeds 
within a particular immune system and the adaptive immune system functions as an idiotypic-
ally connected network [50]. Antibodies at each step of the idiotypic cascade represent a poly-
clonal collection and each clone expresses multiple idiotypic epitopes (idiotopes). Hence, 
every clone of a particular collection, e.g. Ab1, has a counterpart among Ab2s. Nevertheless 
is the collection of Ab3s not identical with that of Ab1s and, likewise, Ab4s are not identical 
with Ab2s. In a minority of investigations only, low amounts of antigen-reactive Ab1’ anti-
bodies were found among Ab3s after immunization with Ab2. Hence, the induction of anti-
idiotypes does not only depend on mutual recognition, but is also dictated by regulatory pro-
perties within the idiotypic network. This regulation depends largely on helper and regulatory 
T cells (Treg) recognizing BCR as well as TCR idiotopes. The induction of autologous anti-
idiotypic (aId) immune responses demonstrates that the immune system develops no tolerance 
to the idiotopes of its own antigen-receptors. Therefore, the pre-immune repertoire as well as 
that of antigen-activated B and T cells is regulated by idiotypic interactions [50-52]. For in-
stance, in the thymus-independent type 2 response to α (1>3) dextran, Treg restrict the re-
sponse to two major idiotypes and inhibit a class switch-recombination to IgG [53]. The in-
volved Treg cells are not antigen-, but Id-specific and recognize the HCDR3 region of the ma-
jor J558 Id in an I-Ed-restricted manner [53]. Since these Id-specific Treg do not arise in germ-
free mice even when transferred to a normal environment at an age of 8 weeks it can be con-
cluded that they were neonatally induced by contact with microbial antigens and persisted for 
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a long period of time. Hence, idiotypic regulation is evidently of particular importance during 
early ontogeny and it has been hypothesized that maternal antibodies play a major role by in-
ducing an immunological imprinting which directs the future development of the immune 
system until adulthood. 
 
1.9 Characteristic features of the anti-phOx immune response in BALB/c mice 
The molecular events during the onset and the maturation of immune responses have mostly 
been studied with model antigens composed of hapten carrier complexes. Thymus-dependent 
immune responses to several hapten-coupled proteins are characterized by dominant 
idiotypes. It is only this circumstance that allowed tracking of the fate of particular primarily 
activated clones during secondary and tertiary responses. Hence, these systems were funda-
mental for detection of somatic hypermutation during TD responses as the underlying mecha-
nism of immune maturation. One of the best studied systems is the TD response of BALB/c 
mice to the hapten 2-phenyl-oxazolone (phOx) after coupling to chicken serum albumin 
(CSA) as a carrier [54, 55].  
 
The analysis of VH/VL sequences of a large number of hybridoma-derived antibodies 
allowed the construction of genealogical trees of antibodies activated during sequential steps 
from primary to memory responses [54, 56]. Analogous confirming data have been obtained 
in several other experimental systems including responses to other haptens like p-nitrophenyl-
acetyl (NP) [57] and phenylarsonate (Ars) [58, 59], and protein antigens [60, 61].  
 
The primary TD anti-phOx response in BALB/c mice is characterized by a dominant clone, 
the Ox1 idiotype or IdOx1. On day 7 after primary immunization, about 75 % of all antibodies 
are of this idiotype which, however, is lost within 3 weeks by somatic mutations. Ox1-idio-
typic antibodies are of highest affinity while the binding strength of non-IdOx1 is 10-100-times 
lower. Immune maturation is primarily based on accumulation of somatic mutations occurring 
in IdOx1, but the propensity of non-IdOx1 antibodies for somatic mutations is also known. 
Hence, the phOx-specific antibody production is probably the best known immune response at 
the molecular level.  
 
IdOx1 antibodies are encoded by the VH/VL gene combination VH171/Vκ072 (nomenclature 
of the VBASE2 data base; old nomenclature VHOx1/VκOx1) [56]. However, syngeneic 
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monoclonal Ox1 (IdOx1) idiotype-specific antibodies have demonstrated that the idiotypic 
specificity entirely depends on the HCDR3 sequence Asp-Arg-Gly (DRG) [62]. This inter-
action is obviously extremely sensitive to conformational alterations of the idiotype and of 
high specificity, as documented by the observation that about half of 19 anti-IdOx1 antibodies 
lost their reactivity already with class switching from IgM to IgG and none of the anti-IdOx1 
reacted with anti-phOx antibodies which carried a glycine or histidine instead of arginine as the 
middle amino acid of the D region [62]. During immune maturation in the late primary and the 
secondary response, antibodies exhibiting a DRG D-segment are first lost before they may 
reappear during the very late stages of tertiary and quaternary memory responses in the context 
of highly mutated VH and VL genes [62]. This observation was interpreted to indicate that the 
activation of antigen-reactive antibodies thereupon induces idiotypic responses which sup-
press major antigen-reactive clones, but stimulate minor clones. Concurrently, mutated clones 
would survive and could participate in later stages of immune maturation and memory 
responses. These mutations probably alter the overall structure of the paratope and in 
particular HCDR3 so that IdOx1-specific suppression is not active. Hence, idiotypic network 
reactions were viewed as the driving force of immune maturation. An involvement idiotypic 
regulation in clonal progression during immune maturation has also been deduced from the 
observation that IdOx1 clones are suppressed during secondary anti-phOx responses, while 
non-IdOx1 antibodies encoded by alternative VH/VL genes appear at an increased rate. This 
allowed the assumption that `idiotypic interactions and, in particular, idiotypic suppression 
could be a way of dampening a dominating monoclonal response to favor the shift´ [55]. Other 
reports, however, did not find evidence for this possibility [63-65]. If clonal progression during 
immune responses is actually regulated by idiotypic regulation, this can only take place with 
the help of idiotypically connected T cells [52] which restrict the activation of anti-IdOx1 
antibodies to HCDR3-specific ones. Since the IdOx1-specific DRG-sequence is only expressed 
in those anti-phOx antibodies which are encoded by the VH171/Vκ072 gene combination 
[46], it is conceivable that the IdOx1 dominance is T cell-mediated. It is generally assumed that 
IdOx1 antibodies dominate the early response because of their superior affinity and that further 
clonal progression is also brought about by preferential activation of memory B cells which 
exhibit BCR with stepwise increasing affinities. However, this view is not quite valid since 
the pre-immune repertoire of BALB/c mice contains phOx-reactive non-IdOx1 clones of higher 
affinity (Lange et al., in preparation). 
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1.10 Mice carrying single DH gene segments 
The above data indicated a strict correlation between dominance of the IdOx1 with the canoni-
cal gene combination VH171/VL072, the expression of a DRG amino acid sequence in 
HCDR3 and the ability of the syngeneic host to produce DRG-specific anti-idiotypic anti-
bodies. Hence, these relationships depend on the available D gene repertoire in the BALB/c 
strain. Hoping to shed light on these relationships, we analyzed the anti-phOx primary and 
memory immune responses in two BALB/c mutant strains each of which harbor only one of 
two different DH gene-segments in their genome. These strains were generated in the follow-
ing way. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 
Generation of mice carrying a single DH gene segment 
The murine IgH locus contains variable genes (blue), diversity-enhancing (D gene segments - 
black), joining (J gene segments - orange) and constant genes (white). (a) The D locus of 
BALB/c wildtype mice is made up of 13 DH genes. (b) In ΔD-DFL mice, only the DFL16.1 
D gene segment remained while the other 12 of the DH gene segments are deleted by gene 
targeting with the aid of the Cre-loxP system. In ΔD-DµFS mice (c), the central amino acids 
of DFL16.1 in ΔD-DFL mice are replaced by hydrophobic and in ΔD-iD mice (d) by charged 
amino acids. For ΔD-DµFS mice (c) and ΔD-iD mice (d), the nucleotides of the respective 
single DH gene segments and the deduced amino acid sequences, translated in reading frame 
1 (RF1) are also shown. 
 
Cre-loxP gene targeting was used in a BALB/c embryonic stem cell line to create mice in 
which the DH locus was simplified to only one gene, DFL16.1, the most JH-distal DH gene 
segment. The other 12 DH gene segments were deleted. Thus, the ΔD-DFL mice have only 
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the most VH-proximal naturally DH gene DFL16.1 in the DH locus, instead of 13 DH gene 
segments in WT animal [66] (Fig. 6). 
The ΔD-DFL mice were used to create two other mutant strains, ΔD-iD and ΔD-DµFS mice, 
both of which also have only 1 DH gene segment each coding for HCDR3 amino acid sequen-
ces with very different properties. 
 
 (a) 
 ΔD-DµFS T TTT ATT ACT ACG GTA GTT AGC TAC  
       F   I   T   T   V   V   S   Y     RF1 (Hydrophobic) 
    F   Y   Y   Y   G   S   *   L       RF2 (Neutral) 
       L   L   L   R   *   L   A             RF3 (Hydrophobic) 
 
 (b) 
 ΔD-iD TT TAT CGT AAT CAT AGT AGA AGC TAC 
         Y   R   N   H   S   R   S   Y  RF1 (Charged) 
        F   I   V   I   I   V   E   A   RF2 (Hydrophobic) 
      L   S   *   S   *   *   K   L     RF3 (Hydrophobic) 
 
Figure 7 
Reading frames of mutant DH genes in ΔD-iD and ΔD-DµFS mice 
First line denotes the genomic nucleotide sequences (in blue), the followed three lines stand 
for the amino acid sequences in three reading frames (RF) (in black). Asterisks symbolize a 
stop codon. (a) and (b) represent the mutant DH gene of ΔD-DµFS and ΔD-iD mice, respect-
tively. 
 
 
In ΔD-iD mice, the central portion of DFL16.1 was replaced with the complete inverted cod-
ing sequence of DSP2.2 [67], [68]. In this way, central RF1 codons for tyrosine and glycine 
were replaced with those for arginine, histidine and asparagines. Thus, RF1 is coding for 
charged amino acids, while i-RF1 generates the original tyrosine enriched sequence of 
DSP2.2. The coding sequences for tyrosine and serine at the 5′ and 3′ termini of the DFL16.1 
DH gene segment were retained to preserve microhomology between the VDJ boundaries. 
RF2 produces hydrophobic stretches of HCDR3 and leads probably to new-Dµ protein 
expression. RF3 and i-RF3 (inverted RF3) contain termination codons (Fig. 7 b).  
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ΔD-DµFS mice were also derived from ΔD-DFL mutant mice. Hence, they harbor a modified 
DFL16.1 gene in the DH locus while the other 12 DH gene segments were deleted. The 
reading frame of DFL16 was shifted by insertion of two thymidine nucleotides (Fig. 7 a). 
While RF1 is thus coding for hydrophobic amino acids of old RF2, RF2 and RF3 comprise a 
stop codon and recreate the old RF1 and RF3, respectively.  
 
1.11 Aim of the work 
In the present communication, we analyzed the humoral immune response to the hapten phOx 
in the 2 mutant mouse strains ΔD-iD and ΔD- DµFS in the hope to answer the following 
questions: 
1.) Is the VH/VL gene repertoire of anti-phOx antibodies identical to that of WT mice 
when the genome harbors only 1 DH-region gene instead of 13? 
2.) Is the VH/VL gene repertoire identical, but the DH gene-dependent HCDR3 repertoire 
of the anti-phOx response restricted when it is generated from a single DH gene 
segment?  
3.) Is the VDJ-recombination with only 1 available DH gene segment flexible enough to 
create the canonical IdOx1 VH/VL gene combination together with the typical DRG D-
region sequence? Are there differences in this respect between the two mutant strains? 
4.) Is the IdOx1 still dominating the anti-phOx response, i.e. does the IdOx1 dominance 
depend on the VH171/Vκ072 gene combination only or is it really dictated by the 
DRG D-region sequence? 
5.) How does the immune maturation in the 2 mutant strains develop from primary to 
memory responses, i.e. does immune maturation still depend on accumulation of 
somatic mutations in one or more particular primarily activated clonotypes? 
6.) Is the immune maturation in these mutant mouse strains strong enough to develop 
clones of highest affinity? 
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2 Materials and methods 
2.1 Materials 
2.1.1 Buffer and media  
Phosphate-buffered saline, PBS 
137 mM sodium chloride (NaCl) 
2.7 mM potassium chloride (KCl) 
4.3 mM disodium hydrogen phosphate (Na2HPO4) 
1.4 mM potassium dihydrogen phosphate (KH2PO4) 
Adjust the pH to 7.4 with hydrochloric acid (HCl) 
 
Carbonate bicarbonate buffer (0.5 M, pH 9.6) 
Sodium hydrogen carbonate (NaHCO3) 2.93g 
0.5 M disodium carbonate (Na2CO3) 1.59g 
ddH2O to     1 liter 
 
Standard medium for cell culture 
RPMI 1640   a bottle of powder for 10 liters  
GlutaMAX  2 mM 
Streptomycin  100 U/ml 
Penicillin  0.1 mM 
2ß-mercaptoethanol 0.1 mM 
FCS   10 % final concentration 
NaHCO3  20 g 
ddH2O   add 10 l 
Adjust the pH to 7.4 with HCl. Sterilize by filtration (0.2 µm filter)  
 
HT-Medium 
Standard medium (see above) fortified with: 
Hypoxanthin (50 mM) 
Thymidin (0.2 mM) 
10 % J774A.1-supernatant  
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Freezing medium 
Standard medium  
+ 10 % (v/v) Dimethylsulfoxyd (DMSO) 
+ 10 % (v/v) FCS (20 % final concentration) 
Filter through 0.2 µm filter. 
Aliquot in 15 ml conical tubes and store in –20 °C freezer for long term periods 
 
6X Loading Dye Solution  
10mM Tris-HCl (pH 7.6)  
0.03 % bromophenol blue  
0.03 % xylene cyanol FF  
60 % glycerol 
60 mM EDTA 
 
DEPC-treated water 
0.1 ml DEPC  
100 ml dd H2O  
Autoclave for 15 min to remove any trace of DEPC  
 
10xPCR buffer 
200 mM Tris-HCl 
500 mM KCl 
pH 8.4 
 
EB 
10 mM Tris.Cl 
pH 8 
 
10x TBE Buffer (Tris-Borate-EDTA)  
108 mg Tris base  
55 mg Boric acid  
9.3 mg Na4EDTA  
Add ddH2O to 1 liter 
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The pH is 8.3 and requires no adjustment. 
2.1.2 Chemicals and instruments  (all companies in Germany) 
ABTS      Roche Diagnostics, Mannheim 
Agarose      Serva, Heidelberg 
Amphotericin B    Merck Biosciences, Darmstadt  
Buffer for ABTS    Roche Diagnostics, Mannheim 
Casein Natrium    Roth, Karlsruhe 
Dimethylsulfoxid (DMSO)    Sigma, Taufkirchen 
DNA Ladder Plus    Fermentas, St. Leon-Rot 
Ethanol      Roth, Karlsruhe 
Ethidium bromide    Roth, Karlsruhe 
Fetal calf serum (FCS)   Invitrogen, Karlsruhe 
GlutaMAX     Invitrogen, Karlsruhe  
HAT      Sigma, Taufkirchen 
Histopaque     Sigma, Taufkirchen 
HT      Sigma, Taufkirchen 
Imject Alum     Perbio Science, Bonn 
Isopropanol      Roth, Karlsruhe 
Minocyclin     Sigma, Taufkirchen 
Oligonucleotide; HPSF purified   MWG, Ebersberg 
Penicillin      Sigma, Taufkirchen 
Polyethylenglycol PEG1500   Roche Diagnostics, Mannheim  
RPMI 1640     Biochrom, Berlin 
Streptomycin      Sigma, Taufkirchen 
Taq polymerase    Fermentas, Leon-Rot 
Tiamulin     Sigma, Taufkirchen 
Trypan Blue, 0.4 %     Promega, Mannheim 
 
6-well culture plates     Sarstedt, Nümbrecht 
24-well culture plates    Sarstedt, Nümbrecht 
cDNA Synthesis     Fermentase, Leon-Rot 
Electrophoresis chamber    Serva, Heidelberg 
ELISA reader     Bio rad, München 
Forceps     Roth, Karlsruhe 
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Fusion culture plates     Greiner, Frickenhausen 
Gel casting trays     Serva, Heidelberg 
Loading buffer    Fementas, Leon-Rot 
MaxiSorp plates     Nunc, Wiesbaden, 
Multiscreen HTS plates   Milliport, Billerica, USA 
PCR clean-up gel extraction    Macherey-Nagel, Düren 
Petri dishes     Sarstedt, Nümbrecht 
Power supply      Serva, Heidelberg 
RNA Extraction Kit    Quiagen, Hiden 
Sample combs     Serva, Heidelberg 
Scissors     Roth, Karlsruhe 
Sterile 0.2 ml microfuge tubes  Sarstedt, Nümbrecht 
Sterile centrifuge tubes    Sarstedt, Nümbrecht 
Thermal Cycler    Serva, Heidelberg 
Total IgG Kit      Roche, Karlsruhe 
Transilluminator     Bio rad, München 
UV spectrophotometer tubes   Eppendorf, Hamburg 
 
2.1.3 Antibodies 
APC anti-mouse CD19   NatuTec, Frankfurt 
FITC anti-mouse CD3e   NatuTec, Frankfurt  
Goat anti-mouse IgG    Dianova, Hamburg 
Goat anti-mouse IgG/M/A   Dianova, Hamburg 
Goat anti-mouse IgM    BIOZOL Diagnostica, Eching 
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2.2 Methods 
2.2.1 Mice 
ΔD-iD and ΔD-DµFS mice, carrying a targeted deletion of 12 DH gene segments and 
intervening sequences [66], [68], were obtained from PD. Dr. M. Zemlin (Marburg) and 
maintained in the animal facility of the CAU under clean conventional conditions. After 
arrival, the mice were kept at last two weeks in the animal house to adapt to the new 
environmental conditions before starting with the experiments. 
 
2.2.2 Preparation of hapten carrier complex (phOx-CSA) 
The hapten-carrier-complex (phOx-CSA) was prepared as described by Mäkelä et al [69]. 
CSA (fraction V; 0.5 ml) was stirred with 37.5 mg of phOx in 20 ml of 5 % NaHCO3 for 24 h 
at 4 °C. 
After incubation, the mixture was centrifuged for 30 min at 35.000 g and then excessively 
dialyzed against 0.15 M NaCl. The amount of non-dialyzable phOx was estimated from the 
optical density assuming that phOx coupled to the lysine residues of the protein has the same 
optical density (OD352 = 32.000) as phOx coupled to epsilon-aminocaproic acid. 
The conjugate contained 8.5 molecules of phOx per molecule of CSA. The final solution was 
sterile filtered, aliquoted in 200 µl and stored by –20 °C until usage. For generation of a 
strong immune response, the antigen was mixed with Imject Alum (Pierce; Rockford, USA) 
as an adjuvant at a 1:1 ratio for 30 min. Imject Alum is an aqueous solution of aluminum 
hydroxide (40 mg/ml) and magnesium hydroxide (40 mg/ml) plus inactive stabilizers.  
 
2.2.3 Immunization 
ΔD-iD and ΔD-DµFS mice were injected intraperitoneally (i.p.) with 80 µg of alum-adsorbed 
phOx-CSA. For analysis of the early and late primary response, mice were sacrificed on day 7 
and 14, respectively. Spleens were teased apart and the spleen cells were fused by convention-
al PEG-mediated hybridization with the immunoglobulin-negative myeloma cell line Ag8.653 
[70]. 
For analysis of the secondary response, mice were boosted 8 weeks later by i.p. injection of 
the same amount of Ag and spleen cells were fused on day three. Mice were rested until the 
antibody titers of the secondary immune response had declined after about two months. Then, 
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the tertiary i.p. immunization was performed and at day three, mice were sacrificed and spleen 
cells were fused with Ag8.653 myeloma cells. The antibody titers were tested regularly after 
every immunization and compared with that of wild type animals. 
 
2.2.4 Collection of blood samples 
The mouse was isolated in a small cage or container and warmed under an infrared lamp for 
10-15 min. This treatment increased the blood flow to the tail, but should not hurt the mouse. 
The tail was swabbed with antiseptic and nicked with a sterile scalpel on the underside across 
one of the lower veins that should be visible. Several drops of blood could be collected and 
the mouse was returned back to its cage. 
The blood was incubated at 37 °C for 1 h and shaken several times to dislodge the clot. After 
the tube was transferred to 4 °C for 2 h or overnight and spun at 10.000 x g for 10 min at 4 
°C, the cell pellet was discarded and the supernatant was spun a second time for 10 min. The 
serum was transferred to a new tube, preserved by adding 0.02 % sodium azide or 0.001 % to 
0.01 % thimerosal and frozen at –20 °C. 
 
2.2.5 Cell culture 
Myeloma and hybridoma cell lines were cultured in RPMI 1640 medium supplemented with 
foetal calf serum (FCS) to a final concentration of 10 % and 11 x 10-5 M β-Mercaptoethanol. 
FCS is used normally, because it contains very low concentrations of IgG molecules that may 
interfere in some assays or purifications. In addition, the medium was supplemented with 
antibiotics; penicillin at 100 U/ml and streptomycin at 100 µg/ml. The cells were cultivated in 
a CO2-incubator at a concentration of 7.5 % CO2, 37 °C and water-saturated atmosphere. 
 
2.2.6 Counting of cells  
Cell viability was assessed by trypan blue exclusion using a Neubauer haemocytometer. An 
aliquot of 0.2 ml cell suspension was prepared and mixed with 0.3 ml medium and 0.5 ml (0.4 
%) trypan blue. Ten µl of the mixture was transferred to the counting chamber of the 
haemocytometer. After 1-2 min (but not longer as viable cells may die and begin to take up 
the dye) the number of cells could be counted within "counting squares". The calculated 
percentage of unstained cells represented the percentage of viable cells. 
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2.2.7 Thawing of cells 
It was important to arrange all reagents before starting thawing of cells. 10 ml of medium 
were dispensed into a sterile 15 ml tube and warmed at 37 °C in a water bath. The freezing 
vial was removed from the liquid nitrogen and placed on ice until thawing in a water bath by 
gentle agitating. The O-ring and cap should be kept out of the water to prevent contamination. 
The vial was removed from the warmed water as soon as the contents were thawed. 
After thawing, the entire vial had to be sprayed with 70 % EtOH (or antiseptic) and the cell 
suspension was poured out from the vial to the 10 ml of pre-warmed medium. After centri-
fugation for 5 min at 1.100 x g, the supernatant was aspirated with a Pasteur pipette and the 
cell pellet was dispersed by gentle tapping and flicking of the tube to prevent cell clumping 
when medium was added and resuspended in 5 ml fresh medium. The cell suspension was 
then transferred to a Petri dish (TC-quality) and placed in the CO2-incubator. 
 
2.2.8 Freezing of Cells. 
Generally, cells were frozen slowly and thawed quickly for maximal survival. For freezing, 
cells had to be in log phase of growth and centrifuged at 1.100 x g for 7 min. The old medium 
was aspirated as completely as possible with a sterile Pasteur pipette and the cells were 
resuspended at a concentration of 0,5 - 2 x 106 cells/ml in freezing medium and aliquots of 1 
ml were put into freezing vials (1.8 ml cryovials). These vials were placed in a -20 °C freezer 
for 1 h and then transferred to –80 °C. After several days, the tubes could be removed from 
the freezer and transferred to liquid nitrogen. 
 
2.2.9 Cell fusion  
Before fusion, myeloma cells should be cultured for a certain period of time in the logarithmic 
phase and maintained at a density of about 1 x 106 cells/ml. The mouse was sacrificed and the 
abdominal area swabbed with alcohol. After opening the abdomen with sterile forceps and 
scissors, the spleen was removed and placed into a sterile Petri dish containing 10 ml of 
serum-free RPMI 1640 medium. Splenocytes were passed through sterile Falcon 0.40 µm cell 
filter using syringe needle and sterile forceps. The suspension was transferred to a 15 ml tube 
and centrifuged for 5 min. Then, the supernatant was discarded, the pellet of splenocytes was 
washed twice in serum free medium, resuspended in 10 ml medium and the viable lympho-
cytes were counted in a haemocytometer. 
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Concurrently with the splenocytes, Ag8.653 myeloma cells were washed twice with serum-
free medium, centrifuged for 5 min at 1.100 x g, resuspended in 10 ml medium and counted. 
The spleen and myeloma cells were mixed in a 50 ml tube at a ratio of 2:1-5:1 and centrifuged 
for 5 min at 1.100 x g. The supernatant fluid was aspirated as completely as possible with a 
Pasteur pipette and the pellet was gently disrupted by tapping the bottom of the tube. One ml 
of warmed 50 % PEG 1500 (w/v) was added dropwise and slowly to the pellet over a period 
one min while tapping the side of the tube to achieve thorough mixing. Then, the PEG/cell 
mixture was gradually diluted under continuous and gentle swirling of the tube: 5 ml serum-
free medium for 5 min and thereafter 25 ml serum free medium for 5 min.  
After centrifugation for 5 min at 1.100 g, the supernatant was removed and the fused cells 
gently resuspended and mixed with 400 ml volume of standard RPMI 1640 medium supple-
mented with 10 % FCS, HAT selection medium, 10 % J774A.1 supernatant, 2.5 ml Ciprobay 
and 5 µg/ml Amphotericin B. The cell suspension was distributed in fusion plates (1.5 
ml/well) and incubated for the next 10 days at 37 °C and 8-10 % CO2. 
The fusion plates were examined visually 24-48 h after fusion for any abnormalities (e.g. 
bacterial contaminations) and during the next days for growing of cell clusters. At day 10, 0.5 
ml aliquots were taken from every well and tested for phOx-reactive antibodies by ELISA. 
 
2.2.10 Determination of hybridomas secreting phOx-specific antibodies 
96-well microtiter plates (Nunc; Wiesbaden, Germany) were coated with phOx-BSA using 
multichannel pipette (50 µl/well; 10µg protein/ml sodium carbonate buffer; 0.05 M, pH 9.6) 
and blocked with casein (1 % casein in PBS, 200µl/well). Antibody-containing cell culture 
supernatant fluids (50 µl/well) were added and incubated for 1 h. After careful washing, HRP-
labeled goat anti-mouse antiserum was added as a secondary antibody and incubated for 1 h. 
All incubations were performed at 37 °C for 1h. Washing was performed with PBS/T using an 
automatic washer. ABTS was used as substrate (50 µl/well), and the absorbance was meas-
ured at a 405 nm wavelength. Extinction values exceeding those of the negative controls with 
PBS, instead of phOx-BSA, by a factor of 5 were considered positive. Clones of positive 
wells picked up and transferred separately to 24 well plates. One week later, the clones of 24 
well plates were tested again for reactivity with phOx-BSA, but non-reactivity with BSA. 
Antibodies fulfilling this criterion were considered as phOx-specific. 
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2.2.11 Isolation of total RNA 
Total RNA was extracted with the aid of Qiagen´s RNEasy mini kits according to 
manufacturer’s instructions (Qiagen, Hilden, Germany). 1x107 myeloma cells were used to 
cover the maximum binding capacity of this column (100 µg RNA). After centrifugation of 
the cells at 1.100 g for 7 min, the cell pellet was disrupted by addition of 600 µl lysis buffer 
(RLT) and homogenized by vortexing for 1 min. One volume (600 µl) of 70 % ethanol was 
added and mixed thoroughly by pipetting. 700 µl of the solution was transferred to an  
RNEasy mini column and centrifuged for 15 sec at 10.000 g. The RNA was bound to the 
column material and the flow-through was discarded. For cleaning of the column-bound 
RNA, 700 µl wash buffer (RW1) was spun through the column for 15 sec at 10.000 g. Then, 
the collection tube was changed to a clean 1.5 ml Eppendorf tube and 500 µl of a second wash 
buffer (RPE) was spun through the tube again for 15 sec at 10.000 g. Then, 500 µl of RPE 
buffer was added to the tube and spun for 2 min at 10.000 g to ensure that the column was 
dry. As an additionally precaution against contamination, the collection tube was changed 
again and the column was spun for 1-2 min at maximum speed (13.000 g). To elute the RNA 
from the tube, 70 µl of RNase-free H2O was added directly to the filter in the column and 
spun for 1 min at 10.000 g. The RNA concentration was determined spectrophotometrically at 
260 nm and extracted RNA was frozen at –20 ºC. 
 
2.2.12 Synthesis of complementary DNA 
The cDNA library was constructed using a “RevertAid First Strand cDNA Synthesis” kit 
according to the manufacturer’s protocol (Fermentas, St. Leon-Rot, Germany). 8 µl  of total 
RNA was added in a 50 µl sterile tube on ice, mixed gently with 1 µl oligo(dt)18 primers (0.5 
µg/µl) and 3 µl of DEPC-treated water and spun down for 5 sec in a microcentrifuge. The 
mixture was incubated at 70 °C for 5 min and the tube placed on ice. Then, the following 
components were added: 4 µl of 5 x reaction buffer, 1 µl of Ribolock TM (ribonuclease 
inhibitor, 20 U/µl) and 2 µl of 10 mM dNTP mix, mixed gently and incubated at 37 °C for 5 
min. Now, 1 µl of RevertAidTM M-Mulv (reverse transcriptase, 200 U/µl) was added and the 
mixture was incubated at 42 °C for 60 min. Finally, the reaction was stopped by heating at 70 
°C for 10 min. The new synthesized cDNA could be used directly in PCR reaction or frozen 
at –20 °C. 
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2.2.13 Polymerase chain reaction (PCR) 
The PCR reaction was performed in volumes of 50 µl and the following components were set 
up in 200 µl sterile tube: 
5 µl  10x PCR reaction buffer 
5 µl  DMSO 
1 µl  dNTP (10 mM) 
1.5 µl  MgCl2 (50 mM) 
1 µl   3´ primer (10 µM) (Tab. 1) 
1 µl   5´ primer (10 µM) (Tab. 2) 
0.4 µl  Taq polymerase (5 U/µl) 
2 µl   cDNA (from first-strand reaction) 
33 µl  autoclaved, distilled water 
 
The sample was mixed by pipetting up and down and loaded in a thermocycler at 94 °C. The 
thermocycle included 1 cycle at 94 °C for 2 min of initial denaturation, and 35 cycles at 94 °C 
for 1 min, at 72 °C for 1.5 min, and at 54 °C for 1.5 min, followed by a final extension at 72 
°C for 10 min. The amplified DNA was then chilled at 4 °C. The PCR products were 
separated by electrophoresis in a 1 % agarose gel, stained with ethidium bromide and the 
desired fragments were cut out and purified. 
 
Table 1 
Primers 3´Æ5´ 
Name of primers    Sequences     TM[°C] 
KLM13   gta aaa cga cgg cca gtg gaa gct tac tgg atg gtg  72.9  
CHIgG M13   gta aaa cga cgg cca gtg gaa gct tay ctc cac aca  72.3  
CM 15     gct ctc gca gga gac        53.3  
KL – primer of constant L chain. CHIgG – primer of constant H chain of IgG.  
CM 15 – primer of constant H chain of IgM.  
TM [°C] = 2 (nA +nT) + 4 (nG + nC), annealing temperature. 
Y = C, T 
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Table 2 
Primers 5´Æ3´ 
Name of primers    Sequences     TM[°C] 
VLFR1M13rev gga aac agc tat gac cac aga crt cma gat ray cca 70.6  
VLFR2M13rev gga aac agc tat gac cac ara mat tkt gct gac yca 69.5  
VLFR3M13rev gga aac agc tat gac cac aga try tkt gat gac cca 70.0  
VLFR4M13rev gga aac agc tat gac cac asr aaw tst tct cwy mca 68.9  
VLFR5M13rev gga aac agc tat gac cac arr crt tst gat gwc aca 70.0  
VLFR6M13rev gga aac agc tat gac cac aga tat tgt gat rac kca 68.3  
VLFR7M13rev gga aac agc tat gac cac arr yat tgt gat gac cca 70.0  
VH1M13rev gga aac agc tat gac cag taa gac gtc mag ctt cag 71.2  
VH2M13rev gga aac agc tat gac caa att gac gtc car syg cag 71.7  
VH3M13rev gga aac agc tat gac caa att gac gtc cag ytg swg 71.2  
VH4M13rev gga aac agc tat gac cac agc tga ags ast cag gac 72.9  
VH5M13rev gga aac agc tat gac cam wgs kgg tgg agt ctg ggg 75.2  
VH6M13rev gga aac agc tat gac caa rss tgg tgg aat ctg gag 72.3  
VH7M13rev gga aac agc tat gac caa rgs tgr tsg agt ctg gag 72.9  
VH8M13rev gga aac agc tat gac cac agc tgc agc agt cwg tg 73.0  
VH9M13rev gga aac agc tat gac cam asy tgs wgg wgw 68.1  
VH10M13rev gga aac agc tat gac cac agm tsc agc agy ctg g  73.1  
UmIgVH   tga ggt gca gct gga gga gtc 68.39 
UmIgVK       gac att ctg atg acc cag tct g 62.74 
VH – primers of variable H chains. VL – primers of variable L chains. UmIg – universal Ig 
primers. TM [°C] = 2 (nA +nT) + 4 (nG + nC), annealing temperature. 
N = A, C, G, T  B = G, T, C  M = A, C  S = G, C 
V = G, A, C   H = A, T, C  R = A, G  Y = C, T 
D = G, A, T   W = A, T  K = G, T 
 
2.2.14 Agarose gel electrophoresis of DNA 
Agarose gel electrophoresis is a method used in biochemistry and molecular biology for sep-
aration of DNA or RNA molecules according to size. This is achieved by moving negatively 
charged nucleic acid molecules through an agarose matrix with an electric field (electropho-
resis). Shorter molecules move faster and migrate further than longer ones. 
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To pour a gel, agarose powder was mixed with electrophoresis buffer (TBE) to a final concen-
tration of 1 %, and then heated in a microwave oven until completely melted (10 min, 400 
W). After cooling the solution to about 60 °C, it was poured into a casting tray containing 2 
combs, one at the middle of the gel and the other at one side, about 5 mm from the end of the 
gel and allowed to solidify at room temperature or in a refrigerator. 
After the gel was solidified, the combs were removed using care not to rip the bottom of the 
wells. The gel in its plastic tray was inserted horizontally into the electrophoresis chamber and 
just covered with buffer. Samples containing DNA were mixed with loading buffer and then 
pipetted into the sample wells (30 µl), the lid and power leads were placed on the apparatus 
and a current was applied (100 V, 400 mA). DNA migrated towards the positive electrode, 
which is usually colored red. 
After 35 min, the gel was stained by soaking in a dilute solution of ethidium bromide for 15 
min. To visualize amplified DNA, the gel was placed on an ultraviolet transilluminator. Now, 
the desired DNA bands could be cut out of the gel and dissolved to retrieve the purified DNA 
fragments. 
 
2.2.15 Isolation of DNA from agarose  
QIAquick PCR purification kit (Qiagen, Hilden, Germany) was used to isolate and extract 
DNA fragments from the gels. The amplified DNA fragments were separated in horizontal 
agarose gels and visualized under UV light. The respective DNA fragments of about 450 pb 
were cut from the gel and placed into a microcentrifuge tube. 
All buffers needed for the DNA isolation were included in the kit. In the first step, 3 volumes 
of binding buffer (QG) were added to 1 volume of gel slice and solubilized in a water bath or 
thermomixer at 50 ºC. After complete solubilization, 1 gel volume of isopropanol was added 
and the solution was immediately applied onto a mini spin column. During centrifugation (1 
min, 10.000 g), the DNA was bound onto the column material. The flow-through was 
discarded and 500 µl of washing buffer (QC) was added to wash away all traces of agarose. 
The column was centrifuged for 1 min and the flow-through was discarded. In a third 
centrifugation step, 750 µl of washing buffer (PE) was added and spun through. Then the 
column was spun for a second time to ensure complete removal of the buffer. At that time, the 
spin column was placed into a clean and sterile microcentrifuge tube. To elute the purified 
DNA, 50 µl of sterile water or elution buffer (EB) was added and the column was centrifuged 
for 1 min at 10.000 x g. The concentration of the extracted DNA could be determined by UV 
spectrophotometer. 
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2.2.16 Determination nucleic acid concentration 
Nucleic acid concentrations were determined in an UV spectrophotometer by measurement of 
the extinction (E) at 260 and 280 nm using UV tubes, where an E260 = 1 corresponds to a 
concentration of 40 ng/µl RNA or 50 ng/µl double-stranded DNA [71]. The cleanness was 
controlled by means of the quotients E260/E280, which should lie between 1.8 and 2.0 [71]. 
 
2.2.17 DNA sequencing 
The DNA sequencing was performed using the dye-terminator Sanger sequencing method and 
Roche FLX sequencer provided by different companies (Agova; Berlin, Germany, Qiagen; 
Hilden, Germany). In addition, variable sequences of some antibodies were determined at the 
Institute of Clinical Molecular Biology of Kiel University. 
 
2.2.18 Determination of serum anti-phOx antibody titers 
96-well microtiter plates (Nunc; Wiesbaden, Germany) were coated with phOx-BSA with the 
aid of multichannel pipettes (50 µl/well; 10µg protein/ml sodium carbonate buffer; 0.05 M, 
pH 9.6) and blocked with casein (1 % casein in PBS, 200µl/well). The sera were diluted 
serially in PBS/T and 50 µl/well were added. Horseradish peroxidase (HRP)-conjugated goat 
anti-mouse IgG and IgM Abs were diluted 4000-fold in PBS/T and 50 µl/well were added. All 
incubations were performed at 37 °C for 1 h. After every incubation step, three washes with 
PBS/T were performed using an automatic washer. ABTS was used as substrate (50 µl/well), 
and the absorbance was measured at a 405 nm wavelength. 
 
2.2.19 Determination of relative affinity of phOx specific Abs 
Determination of relative affinity of phOx specific IgG and IgM antibodies was done in two 
steps. In the first step, the dilution factor corresponding the 80 % of maximal binding of every 
supernatant was determined. In the next step, the concentration of 80 % value was used in an 
inhibition assay. Antibodies that did not reach maximal binding plateau were excluded from 
further investigation. 
96-well flat-bottomed microtiter plates (Nunc; Wiesbaden, Germany) were coated with phOx-
BSA and then 25 µl of doubled concentration of the 80 % value of every supernatant and 25 
µl of serially diluted phOx-caproic acid were incubated for 1 h at RT. After washing, 50 µl of 
horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG and IgM Abs were added to 
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the wells and the plates were incubated for 1h at RT and then washed three times in PBS/T. 
ABTS (50 µl/well) was used as a HRP-substrate and incubated in the dark at RT for 10 min. 
The absorbance of the wells was read at 405 nm. PhOx-caproic acid concentration giving 50 
% binding inhibition was considered as relative affinity of the investigated anti-phOx 
antibody. An affinity factor was generated as the quotient of the relative affinity of the 
prototype Ox1-idiotypic antibody NQ2/16.2 divided by that of a particular antibody. Hence, 
antibodies with an affinity factor of >l exhibited a higher while those with an affinity factor of 
<l a lower affinity than NQ2/16.2. 
 
2.2.20 Idiotypic determination of phOx specific antibodies 
Since the monoclonal anti-idiotypic antibody (Ab2) 8-21/W18 recognizes an Ox1 idiotype-
(IdOx1)-specific idiotope of anti-phOx specific antibodies, this antibody was used to character-
ize anti-phOx antibodies generated in ΔD-DµFS and ΔD-iD mice. 
Microtiter plates were coated with phOx-BSA and residual surface of the wells were blocked 
with 1 % casein in PBS. After addition of 25 µl of anti-phOx antibody-containing supernatant 
fluid and 25 µl of serially diluted 8-21/W18 supernatant (1/1 – 1/4800), the plates were 
incubated for 1 h at RT. After washing, 50 µl of horseradish peroxidase (HRP)-conjugated 
goat anti-mouse IgG and IgM Abs were added to the wells and the plates were incubated for 1 
h at RT and then washed three times with PBS/T. ABTS (50 µl/well) was added as a HRP-
substrate and incubated in the dark at RT for 10 min. The absorbance of the wells was 
measured at 405 nm. IdOx1 anti-phOx antibodies showed a descending curve in an 8-21/W18-
depended manner, while Id-Ox1 negative Abs were not affected by addition of the anti-Id 8-
21/W18 and showed a straight line in the plot (absorbance against Ab2 concentration). 
 
2.2.21 Flow cytometric measurement 
A single cell suspension was prepared from freshly isolated spleen and bone marrow using 
scalpel, forceps and cell strainer (0.22 µl). The cell suspension was centrifuged 5 min (4,000 x 
g) at 4 °C and the pellet was resuspended in 3 ml of complete RPMI 1640 medium. Red blood 
cells were removed by density gradient of Histopaque (Sigma-Aldrich Chemie; Munich, 
Germany) centrifugation. Three ml of Histopaque was filled into a 15 ml conical tube and 3 
ml of the cell suspension was carefully layered on top. After centrifugation at 400 x g for 
exactly 30 min at RT, the upper layer was discarded and the cells lying on top of the opaque 
interface were quantitatively collected with a Pasteur pipette and transferred into a new 15 ml 
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centrifuge tube. The cells were washed two times with PBS, and then resuspended in 3 ml 
PBS, 5 % FCS (staining buffer) and a small sample (50 µl) was used to perform a cell count 
and viability analysis by Trypan Blue. 
The cell suspension was adjusted to concentrations of 1-10 x 105 cells/sample (0.5 ml) in U 
bottom plastic centrifuge tube (Sarstedt; Nümbrecht, Germany). After centrifugation, the 
purified cells were suspended in 50 µl of staining buffer and pre-incubated with 1 µl (0.5 µg) 
of anti-CD16/CD32 (anti-FC) for 5-10 min at RT to block unspecific staining by reaction with 
Fc-receptors (FcR) of the cells. For the staining, 1.25 µl (0.25 µg) of Allophycocyanin (APC) 
anti-CD3e and 2 µl (1 µg) of fluorescein isothiocyanate (FITC) anti-CD19 were added pro 
sample. The negative controls were performed only with staining buffer without any antibod-
ies. The samples were mixed by gently vortexing or tapping and incubated for 60 min in the 
dark at 4 °C. After incubation, 3 ml of staining buffer was added, mixed, and centrifuged at 
400 x g for 5 min. After the cell pellet was resuspended in 500 μl of PBS, 2 % FCS on ice, the 
cell sample could be analyzed in the flow cytometer. 
 
2.2.22 Flow cytometric staining of dead cells with 7-Amino-actinomycin D 
7-Amino-actinomycin D (7-AAD) intercalates into double-stranded nucleic acids. Since it is 
excluded by viable cells but can penetrate cell membranes of dying or dead cells it is suitable 
for determination of dead cells in flow cytometric assays. 
The cells were stained as outlined above in the protocol for dual color staining with APC and 
FITC monoclonal antibodies. After the last washing step, the cells were resuspended as usual 
in 500 μl of PBS containing 2 % FCS. Then, viability of the cell sample was assessed by 
addition of 1-2 µl of 7-AAD solution per tube. The samples were kept in this solution as usual 
at 4 °C and protected from light until analysis in the flow cytometer. 
 
2.2.23 Flow cytometric analysis 
Cell fluorescence was analyzed with a FACScan apparatus (BD Biosciences; San Jose, USA) 
using an excitation laser wavelength of 488 nm. Cell populations of interest were gated and 
analyzed using CellQuest 3.3 software. Gates were set to eliminate debris. 
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2.2.24 The enzyme-linked immunospot assay (Elispot) 
The Elispot assay provides an effective method of measuring single plasma cells secreting 
antigen-specific antibodies. Each well of MultiScreen plates (Millipore; Billerica, USA) was 
pre-wetted with 15 µl of 35 % ethanol for 1 min and then rinsed with 150 µl sterile PBS three 
times before the ethanol evaporates. One plate was coated with 100 µl (10 µg/ml) phOx-BSA 
in carbonate buffer (0.05 M, pH 9.6). In parallel, a second plate was coated with BSA alone 
under the same condition as phOx-BSA. Then, the plates were incubated over night at 4 °C. 
After two washing steps with 150 µl bidest. H2O per well, the membrane was blocked with 
150 µl per well of culture medium (RPMI 1640, 10 % FCS, penicillin, streptomycin, 
glutamine) for at least 2 h at 37 °C. 100 µl (ca. 5 x 105 cells) of purified mononuclear cell 
suspension isolated from spleen and BM (as described for flow cytometry using a Histopaque 
density gradient) was added per well. 
The cells were incubated for 18 h at 37 °C in 5 % CO2 incubator and then removed by wash-
ing the plate 6 times with PBS/0.01 % Tween 20. 100 µl of secondary antibodies (HRP-conju-
gated anti-IgG or anti-IgM, diluted 1/40,000 in PBS) was added per well and incubated for 1 
hr at 37 °C in an atmosphere containing 5 % CO2 and 95 % humidity. After this incubation 
period, the secondary antibodies were decanted and the plate was washed 3 times with PBS-
0.01 % Tween 20, followed by 3 washes with PBS. 100 µl/well of 3-Amino-9-Ethylcarbazol 
(AEC) was added and incubated until dark spots emerge. Spot development was stopped after 
10 min under running water and left to dry. After complete drying, the spots were counted 
under a dissecting microscope. The number of phOx-specific antibody-secreting plasma cells 
was calculated by subtracting the number of spots of BSA- from phOx-BSA-coated wells. 
 
2.2.25 Statistical analysis 
Statistical analysis was performed with one-way analysis of variance (ANOVA) followed by 
Dunnet’s multiple comparison post test, using GraphPad Prism for Windows (version 4.02, 
GraphPad Software Inc., San Diego, CA, USA). Values of P < 0.05 were considered signific-
ant. 
 
2.2.26 Hydropathicity of the HCDR3 
The hydropathicity of the HCDR3 interval was determined with normalized Kyte-Doolitle hy-
dropathicity index [72, 73]. The average hydropathicity was calculated by adding the hydro-
pathicity value for each amino acid in the HCDR3 divining by the number of amino acid. 
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3 Results 
Investigations of 3 genetically engineered mouse strains have demonstrated that B cell devel-
opment and immune responses strongly depend on the number of available DH gene segments 
and the sequence of particular remaining single DH genes. ΔD-DFL mice containing only the 
natural occurring DFL16.1 gene segment in the DH locus showed, in comparison to WT mice, 
a rather normal B cell development and an almost unaltered response to the TD antigen NP-
CGG [66]. Although the number of immature IgM+IgD- B cells in the bone marrow was de-
creased, numbers of mature IgM+IgD+ B cells in BM and spleen as well as B1a, B1b and B2 
in the peritoneal cavity were as in WT mice. Length and amino acid compositions of DFL-
16.1-encoded HCDR3 of BM B cells resembled those of WT mice, but differed in non-
DFL16.1-related D regions. In ΔD-iD mice with an inverted DH gene segment encoding for 
the charged amino acids asparagine, histidine and arginines (instead of the normally predomi-
nating tyrosine and glycine), marginal zone (MZ) B cells were increased, but the numbers of 
mature B cells in BM and spleen as well as B1 cells in the peritoneum were reduced to half 
and immune responses to thymus-dependent (TD) as well as thymus-independent (TI) anti-
gens were substantially reduced [68]. A similar strong impact on B cell development and TI-2 
antigen-induced IgM immune responses was observed in ΔD-DμFS mice containing a frame-
shifted DFL16.1 gene in the DH locus [74, 75]. In these mice, kept under specific pathogen-
free conditions, immunoglobulin serum concentrations of IgM, all IgG subclasses and IgA 
and the development of primary and secondary immune responses to TD antigen NP-CGG 
were identical to those of WT mice. The latter 2 strains, ΔD-iD and ΔD-DμFS mice, are under 
investigation here. 
 
3.1  Composition of B and T cell compartments in mutant mouse strains 
For a first broad characterization of the immune systems of our mutant mice and a comparison 
to published data [66, 68, 74, 75], we examined the compartment of B cells in BM and spleen. 
Moreover, we determined the size of the T cell compartment and compared it with that of 
WTe mice for two reasons: 1.) Since we surmised that the selection of HCDR3 amino acid 
composition might be connected with T cell regulation (see 1.9), the reduced B cell com-
partment may also cause a reduction of the total number of T cells. 2.) The development of B 
and T cells are not independent of each other but mutually regulatory as demonstrated in seve-
ral investigations: a) B cells and antibodies participate in the selection of the T cell repertoire 
[76] and this immunoglobulin-dependent T cell selection operates only during the first 3 
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weeks of life [77]. b) Spleens of B cell deficient mice show a three- to fivefold reduction in T 
cell numbers [78]. c) Studies of B cell deficient mice demonstrate that B cells are not only 
important for antibodies production, but also required for efficient T cell responses [79, 80]. 
 
Total mononuclear cells were isolated from BM and spleen of WT, homozygous ΔD-DμFS 
and homozygous ΔD-iD mice. After purification by Histopaque gradient centrifugation, cells 
were analyzed by fluorescence-activated cell sorting (FACS).  
The average number of splenic mononuclear cells of ΔD-DμFS and ΔD-iD mice was about 
2.5 and 2 fold lower than in WT mice. A similar reduction was also seen for lymphocyte 
counts. Lymphocytes in the spleen of ΔD-DμFS mice were 2.6 times lower and those of ΔD-
iD mice were 2.4 times lower as in WT mice. In contrast, in the bone marrow, numbers of 
total mononuclear cells as well as lymphocytes of both mutant strains and WT mice were 
rather identical (Tab. 3). 
The flow cytometric analysis of total T and B cell numbers in the spleen were determined 
with goat-anti-mouse CD3 and CD19, respectively, as shown in Fig. 8 and summarized in 
Tab. 3. In the spleen of ΔD-DμFS mice, the total number of 8.1 x 105 T and 20.6 x 105 B cells 
was approximately two and fourfold lower than in WT mice (29.2 x 105 and 74.4 x 105, re-
spectively). The splenic T and B cells of ΔD-iD mice were reduced to a similar extent (Tab. 
3). When relating the proportion of T and B cells to total numbers of mononuclear cells, the 
following picture merged. Compared to WT mice with 14.7 %, the contribution of T cells of 
ΔD-DμFS (10.3 %) and ΔD-iD (13.2 %) among mononuclear cells remained almost un-
changed. However, the percentages of B cell were relatively decreased, i.e. 26.3 % in ΔD-
DμFS and 25.4 % in ΔD-iD mice compared to 37.5 % in WT mice. 
Flow cytometric analysis of bone marrow cells demonstrated a much more heterogeneous 
picture of cells (Fig. 9), but numbers of B and T lymphocytes were rather similar in both 
mutant mouse strains as well as in WT mice (Tab. 3). 
Hence, compared to WT mice, both mutant mouse strains have significantly reduced amounts 
of total mononuclear cells as well as T and B lymphocytes in the spleen. However, the pro-
portion of T cells among mononuclear cells was rather unchanged while B cell counts were 
significantly reduced. We therefore compared the concentrations of total IgM and IgG in mut-
ant and BALB/c WT mice. Total IgM concentration of ΔD-DμFS mice (~144 µg/ml) was 
comparable with that of WT (~153 µg/ml), while ΔD-iD mice showed a slightly decreased 
IgM level of about 99 µg/ml (Fig. 10). Thus, amounts of IgM immunoglobulin were in the 
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same range in all 3 strains. IgG concentrations, however, were significantly reduced in both 
mutant strains (Fig. 10). 
 
Table 3 
FACS analysis of spleen and bone marrow cells of BALB/c wild-type and ΔD-iD and ΔD-
DμFS mutant mice 
 
 Total mononuclear cell x E+05 
Lymphocytes 
x E+05 T cell x E+05 B Cell x E+05 
Spleen 
WT 197.6 + 24.5 118.2 + 15 29.2 + 8.3 (14.7 %) 74.2 + 17.6 (37.5 %)
ΔD-DµFS 78.2 + 17.6 45.2 + 7.8 8.1 + 3.2 (10.3 %) 20.6 + 6.3 (26.3 %)
ΔD-iD 99 + 12.8 48.5 + 8.1 13.1 + 6.4 (13.2 %) 25.2 + 10.2 (25.4 %)
Bone marrow 
WT 8.02 + 1.46 0.42 + 0.105 0.037 + 0.012 (0.46 %) 0.33 + 0.12 (4.1 %)
ΔD-DµFS 8.22 + 1.12 0.53 + 0.11 0.046 + 0.011 (0.55 %) 0.44 + 0.08 (5.3 %)
ΔD-iD 7.16 + 1.43 0.48 + 0.12 0.033 + 0.013 (0.46 %) 0.40 + 0.09 (5.5 %)
 
Legend 
Spleen and bone marrow mononuclear cells were isolated by Histopaque gradient centrifuga-
tion. Cell numbers + standard error of the mean of five separately analyzed cell preparations 
are given for 1 spleen or refer to the bone marrow of two femurs of five 10-wk-old ΔD-iD, 
ΔD-DμFS or wild-type BALB/c mice. The numbers and percentages of B (CD19+) and T 
(CD3+) cells are related to the amount of total mononuclear cells. Lymphocytes are calculated 
from gate P1 in Fig. 6 and 7.  
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Figure 8 
Flow cytometric analysis of splenic lymphocytes of homozygous ΔD-iD mice  
Cells within the lymphocyte gate of spleen cells (upper left panel) were differentiated on the 
basis of CD19 and CD3 expression. The top right histogram shows the dot plot analysis of 
splenic B lymphocytes stained with FITC-labeled anti-CD19 versus T cells stained with APC-
labeled anti-CD3. The lower two panels of gated splenic lymphocytes show the intensity of 
staining with both specific antibodies. P1, P2 and P3 represent the total number of lympho-
cytes, B and T cells, respectively. The data show representative staining of five separately 
analyzed spleen cell preparations. Cell viability (> 98 % data not shown) was estimated by 
staining with fluorescent marker 7-Aminoactinomycin D. The analysis of splenocytes of 
wildtype as well as homozygous ΔD-DμFS mice gave similar results (data not shown). The 
average total numbers of different cells type in the spleen are depicted in Tab. 1. 
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Figure 9 
Flow cytometric analysis of bone marrow lymphocytes of homozygous ΔD-iD mice 
Cells within the lymphocyte gate in the bone marrow (upper left panel) were differentiated on 
the basis of CD19 and CD3 expression. The top right histogram shows the dot plot analysis of 
BM B cells stained with FITC-labeled anti-CD19 versus T cells stained with APC-labeled 
anti-CD3. The lower two panels of gated BM lymphocytes show the intensity of staining with 
both specific antibodies. P1, P2 and P3 represent the total number of lymphocytes, B and T 
cells, respectively. The data show representative staining of five separately analyzed BM cell 
preparations. Staining with fluorescent marker 7-Aminoactinomycin D showed a cell viability 
of > 98 % (data not shown). The analysis of bone marrow cells of wildtype as well as homo-
zygous ΔD-DμFS mutant mice gave similar results (data not shown). The average total num-
bers of different cells type in the spleen are depicted in Tab. 3. 
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Figure 10 
Total IgM and IgG concentrations in normal sera 
Immunoglobulin concentrations of 10-weeks old ΔD-DµFS (red lozenge), ΔD-iD (blue tri-
angle) and WT (black circle) mice were determined with isotype-specific secondary antisera. 
P1 < 0.0003, P2 < 0.0004. 
 
 
3.2 Comparison of phOx-specific background plasma cells and serum antibody con-
centrations  
Hence, the question arose as to whether the observed global changes in the T and B cell com-
partments may influence the starting position for a specific immune response. Since WT 
BALB/c mice contain considerable concentrations of phOx-reactive antibodies in the serum 
[81], we first compared the background anti-phOx-secreting plasma cells and serum antibod-
ies in mutant mice with that of WT mice. Plasma cells secreting phOx-specific IgM or IgG 
were determined with the Eli-spot assay. In this test, cells are incubated in culture wells on 
antigen-coated membranes so that secreted antibody can bind to the antigen-coated surface. 
After washing off the cells, bound antibody is detected with enzyme-labeled secondary anti-
body. Plasma cells are indicated by coloured spots as shown in Fig. 11. Surprisingly, com-
pared to WT control mice, numbers of phOx-reactive IgM-secreting plasma cells were signifi-
cantly enhanced in spleens as well as in the bone marrow of both mutant strains (Fig. 12). 
However, plasma cells secreting phOx-reactive IgG antibodies were missing in both trans-
genic strains as well as in WT mice (Fig. 12). 
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Figure 11  
Determination of anti-phOx secreting splenic plasma cells with the ELI-spot assay 
At an age of 10 weeks, BALB/c mice received a primary immunization with the TD antigen 
phOx-CSA. On day 7, mononuclear spleen cells were isolated by Histopaque gradient centri-
fugation. For determination of IgM and IgG anti-phOx secreting plasma cells, graded concen-
trations of mononuclear cells were incubated for 18 hr in phOx-BSA- or BSA-coated wells. 
Bound antibodies were detected with secondary antiserum to IgG (B) or IgM (C). In the nega-
tive control (A), wells were reacted with all reagents, but mononuclear cells were omitted. 
Splenocytes and bone marrow cells of ΔD-iD and ΔD-DμFS mice provided a similar pattern 
(data not shown). The average numbers of phOx-specific IgG- and IgM-secreting plasma cells 
were calculated as the difference between ELI-spots on phOx-BSA- and BSA-coated wells. 
ELI-spot numbers of BSA-reactive IgG as well as IgM were usually 10-15 % of phOx-BSA-
reactive spots. 
 
 
3.3 Comparison of the humoral anti-phOx immune response in D-mutant and wildtype 
BALB/c mice 
We then compared the primary immune responses of all 3 mouse strains. 
First, mice were stimulated with the type 2 thymus-independent form of the antigen, i.e. im-
munization was performed with the hapten phOx coupled to Ficoll in a ration of about 60:1. 
Despite the enhanced numbers of IgM-anti-phOx-secreting background plasma cells (Fig. 12), 
primary IgM (Fig. 13A) as well as IgG (Fig. 13B) response to this TI-2 antigen of all three 
mouse strains were rather similar and there was no significant difference. 
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Figure 12 
Anti-phOx antibody-secreting plasma cells in spleen (A) and bone marrow (B) of non- 
immunized mutant and wildtype BALB/c mice 
For determination of IgM and IgG anti-phOx antibody-forming plasma cells (AFC), graded 
concentrations of Histopaque-isolated mononuclear cells were incubated for 18 hr in phOx-
BSA- or BSA-coated wells and bound antibodies were detected with secondary antiserum to 
IgG or IgM. The number of phOx-specific antibody-secreting plasma cells was calculated as 
the difference of spots in phOx-BSA- and BSA-coated wells. The error bars indicate the 
standard error of the mean of five separate determinations. 
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Figure 13 
Primary anti-phOx humoral response after immunization with the TI-2 antigen phOx- 
Ficoll 
IgM (A) and IgG (B) anti-phOx antibodies in the sera of 10-weeks old ΔD-DµFS (red curve), 
ΔD-iD (blue curve) and WT mice (black curve) were determined at the given times points 
(weeks) after primary immunization with phOx-Ficoll at day 0. Background anti-phOx titers 
were evaluated in normal pre-immune sera. 
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Second, the TD response was induced with phOx-coupled CSA (phOx-CSA) and measured at 
the single cell level [antibody-forming cell response (AFC); Fig. 14] and by determination of 
serum antibody concentrations (Fig. 15). In WT BALB/c mice (Fig. 14), the primary IgM 
AFC-response on day 7 was hardly distinguishable from the level of background plasma cells 
shown in Fig. 12. In contrast, mice of both mutant strains ΔD-DμFS and ΔD-iD showed a 
substantial increase of IgM AFC (Fig. 14A) which was at least twofold higher than that of 
WT mice. These IgM-secreting plasma cells seem to be recruited from the bone marrow since 
anti-phOx-secreting plasma cells in this organ are reduced 7 days after immunization (Fig. 
14B). Interestingly, the average number of phOx-specific IgG-secreting cells of WT mice 
(276 pro spleen) was approximately fourfold higher than that of ΔD-DμFS (64, p < 0.0001) 
and ΔD-iD mice (74, p < 0.0001) (Fig. 14A). This result seems to indicate an impaired class 
switch recombination in both mutant mouse strains. 
In bone marrow, phOx-specific IgG-secreting cells were neither detectable in WT nor in 
transgenic mice (Fig. 14B).  
 
The phOx-CSA-induced TD response was also measured by determining the humoral anti-
body concentrations after immunization. Despite the enhanced numbers of IgM anti-phOx-
secreting plasma cells (Fig. 14), ΔD-DμFS as well as ΔD-iD mutant mice developed reduced 
primary IgM TD responses and secondary IgM responses were barely visible in all three 
strains (Fig. 15A). The primary IgG response of both mutant strains developed with slower 
kinetics and maximal titers reached 2 weeks after immunization were about 5 times lower 
than in WT mice. In all three strains, the primary maximal titers remained for several weeks. 
When a secondary immunization with phOx-CSA was performed 14 weeks after primary 
stimulation, the difference between mutant and WT mice remained. Two weeks after second-
ary immunization, the mean anti-phOx IgG titer of WT (302000 [250000-350000]) was ap-
proximately sevenfold higher than ΔD-DμFS (45800 [36000-60000]) and ΔD-iD mice (40200 
[28000-45000]) (Fig. 15). 
These data may allow the conclusion that in transgenic mice lower numbers of memory B 
cells are generated in the primary response and that this drawback can not be compensated for 
during the secondary response.  
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Figure 14 
Primary Anti-phOx-secreting plasma cells in spleen (A) and bone marrow (B) of mutant 
and wild-type BALB/c mice 
Seven day after primary i.p. immunization with the TD antigen phOx-CSA, spleen and bone 
marrow cells were isolated by Histopaque gradient centrifugation and phOx-reactive anti-
body-forming plasma cells (AFC) were determined with the ELI-spot assay. For further de-
scription see legend to Fig. 12. The error bars indicate the standard error of the mean of five 
separate determinations. 
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Figure 15 
Primary and secondary anti-phOx humoral immune response of wildtype and mutant 
mice to the TD antigen phOx-CSA 
IgM (A) and IgG (B) anti-phOx antibodies in the sera of 10-weeks old ΔD-DµFS (red curve), 
ΔD-iD (blue curve) and WT mice (black curve) were determined after primary immunization 
at day 0 and secondary immunization 14 weeks later with phOx-CSA. Back ground anti-phOx 
titers were evaluated in pre-immune sera. 
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3.4 Analysis of variable genes of anti-phOx antibodies generated in ΔD-DμFS and ΔD-
iD mice 
In the order to study the influence of DH gene segments on VH/VL gene usage, somatic 
mutation and affinity maturation, the TD immune response to the hapten-carrier complex 
phOx-CSA in ΔD-DμFS and ΔD-iD mice, each of which carry a single modified DH gene 
segment, was studied at single cell level. To this end, mice of both strains were first immun-
ized by i.p. injection of 80 µg of phOx-CSA adsorbed to AL(OH)3 and hybridomas were gen-
erated by  fusion of immune spleen cells with the Ig non-secretor myeloma cell line Ag8.653. 
The primary immune response was analyzed at an early stage on day 7 and a late stage on day 
14. 
Furthermore, since the alteration in the DH locus obviously impaired the antibody production 
in the memory response (see 3.3), a set of hybridomas were also prepared after secondary and 
tertiary immunizations. Secondary immunization was performed 8 weeks after primary 
immunization also by i.p. injection of the same amount of antigen and the fusion was done 
three days later. The tertiary immunization followed two months later and cell hybridization 
was again performed on day 3. 
 
 
 
 
 
 
 
 
 
Figure 16 
Amplification of variable region-coding sequences of anti-phOx antibodies 
Here, the amplification of the variable region-coding sequences of heavy and light chains of 
antibodies iD°7-1, iD°7-2, iD°7-6 and iD°7-14 is shown. Amplification was performed with 
one of 10 VH and 7 VL variable primers in combination with respective constant primers. 
(A) Amplification of heavy chain. (B) Amplification of light chain. The molecular size of the 
amplified DNA fragment can be estimated at approximately 450 base pair (bp). DNA frag-
ments of interest are sliced out of the gel purified and used for sequencing (blue rectangle). 
M - DNA marker. 
 
Primers VH     1    2   3   4    5    6   7    8    9   10    M    1   2    3    4    5
Primers VH   6    7    8    9   10   M    1    2    3    4    5    6   7   8    9  10
Primers VL 1   2  3   4   5   6 7  M 1  2   3   4  5  6   7
Primers
500
200
500
200
1 2 3 4 5 6 7 8 9 10  M 1 
9 10  M   1  2  3  4  5 6 7  8  9  10
iD1°7-14 iD1°7-6
VL 1   2   3   4   5  6  7 M 1  2   3   4  5  6   7
iD1°7-14 iD1°7-6
iD1°7-1
iD1°7-1 iD1°7-2
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Anti-phOx antibody-secreting hybridomas could be established from all stages of the primary 
to the tertiary immune response. RT-PCR was performed to amplify heavy and light chains of 
every positive clone (Fig. 16). Ten different primers were included for amplification of VH 
and seven different primers for amplification of VL. The size of amplified segments lies 
between 430 and 460 bp (Fig.16). Despite amplification of all the clones, some of them could 
not be sequenced successfully, i.e. incomplete or bad quality of the nucleotide sequence. In 
those cases, repetition of the sequencing reaction was also ineffective. 
 
3.5 Genetic analysis of phOx-reactive antibodies generated from ΔD-DμFS mice 
For an assessment of the genetic repertoire of both DH-mutant BALB/c variants it is essential 
to remember that it is to be compared with that of the anti-phOx repertoire of BALB/c WT 
animals. Therefore, the different characteristic molecular features of this response are repeat-
ed: 
1.) The primary response is characterized by expression of a dominant clone with the canon-
ical gene combination VH171/VL072. This Ox1-named idiotype (IdOx1) makes up 75 % of 
the IgG antibodies on day 7. 
2.) The specific idiotope of IdOx1 is related with the characteristic sequence aspartic acid-argi-
nine-glycine (DRG) in the third hypervariable region of the heavy chain (HCDR3). 
3.) The reactivity of IdOx1 antibodies with syngeneic IdOx1-specific monoclonal anti-idiotypic 
antibodies is lost within 3 weeks by somatic mutations.  
3.) IdOx1 antibodies are of highest affinity while non-IdOx1 have a 10-100-times lower one. 
4.) Immune maturation is primarily based on the accumulation of somatic mutations occurring 
in IdOx1 antibodies. 
5.) Non-IdOx1 antibodies encoded by alternative VH/VL genes appear during secondary and 
tertiary immune responses.  
6.) The propensity of non-IdOx1 antibodies for somatic mutations is known. 
Hence, the primary genetic repertoire and the clonal development during memory responses 
in both mutant strains will be compared with these findings. 
 
3.5.1 Genetic analysis of the phOx-reactive repertoire of ΔD-DμFS mice 
First, V region-coding sequences of anti-phOx antibodies will be described which were gene-
rated from TD responses of ΔD-DμFS mice. These mice can only make use of a single DH 
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gene coding for hydrophobic amino acids in HCDR3. The complete amino acid sequences of 
V regions are showed in Fig.  1 in the appendix. 
 
3.5.1.1 Analysis of primary anti-phOx antibodies 
Primary repertoire 
From the early primary day 7 TD response, 36 antibodies could be produced from two inde-
pendent fusions (Tab. 4). The nomenclature of the antibodies is as follows: FS stands for ΔD-
DμFS mice and 1°7 indicates that the antibodies were generated after primary immunization 
and fusion on day 7. In both fusions, about half of the antibodies were of the IgM and IgG 
class, respectively. 
The repertoire of the 18 IgM antibodies was extremely heterogeneous and every gene combi-
nation was unique. Hence, there was no dominant clone = idiotype. The IdOx1 was not realized 
among IgM antibodies. Two IgM antibodies (FS1°7-09, FS1°7-10) expressed the VHOx1 
gene VH171, but in combination with alternative light chains, namely Vκ078 and Vκ121, re-
spectively. Antibody FS1°7-03 is encoded by the VκOx1 gene Vκ072 in association with al-
ternative heavy chain gene VH627. 
The repertoire of 17 IgG antibodies was as heterogeneous as that of IgM antibodies and again 
every gene combination was unique. However, antibody FS1°7-24 used the canonical IdOx1 
combination (VH171/Vκ072). The 2 antibodies FS1°7-27 and FS1°7-34 used the VκOx1 
gene Vκ072 but in combination with a VH163 gene and an unknown VH gene, respectively. 
In addition, one IgA antibody was obtained. 
• In conclusion, the TD antigen-activated repertoire of ΔD-DμFS mice does not contain 
the IdOx1 gene combination as a major component, neither among IgM nor among IgG 
antibodies.  
 
Affinity of primary antibodies 
Since the primary immune response reflects the first encounter of naive B cells with antigen, 
the dominance of IdOx1 antibodies in the primary anti-phOx response of BALB/c WT mice 
was ascribed to their superior affinity for the hapten. Indeed, non-IdOx1 antibodies of the IgM 
class were generally of much lower affinity. To elucidate the influence of a restriction to a 
single DH gene, coding for hydrophobic amino acids, on the affinity of the primarily stimu-
lated antibodies, we measured the relative affinities of our antibodies in comparison to the 
IgM IdOx1 H11.5 (μ,κ) and IgG IdOx1 NQ2.16.2 (γ,κ) (Tab. 4). It is interesting to see that only 
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3 IgM were of very low affinity (FS1°7-01, -05 and -13), 3 exhibited slightly reduced affini-
ties and 3 had similar affinities as the IdOx1 control antibody H11.5 (μ,κ). Surprisingly, anti-
bodies FS1°7-09 and -14 had significantly enhanced affinities.  
 
Table 4 
VH/VL gene combinations of phOx-CSA-induced primary day 7 anti-phOx antibodies 
of ΔD-DμFS mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a –  The annotation of antibodies indicates their generation from ΔD- DμFS mice (FS), after 
MAba VH chain genes VL chain genes rel.
FS1°7 Isb Famc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J Aff.g
01h µ 1 2 673 8/2 1 9B 1 121 0/0 2 0,01
02h µ 1 1 671 4/4 1 10 1 139 0/1 1 0,4
03h µ 1 2 627 12/3 1 4/5 1 072k 1/0 4 0,4
04h µ 1 2 627 3/0 2 10 1 139 0/0 1 0,6
05h µ 1 1 532 4/1 2 4/5 1 078 0/0 2 0,03
06h µ 1 2 506 13/3 2 9B 1 121 1/0 1 0,8
07h µ 1 3 396 0/0 2 19/28 1 201 2/0 4 -
08h µ 1 3 386 5/1 3 9A 1 112 2/0 2 0,1
09h µ 2 1 171k 1/0 3 4/5 1 078 -/- 4 4,5
10h µ 2 1 171k 0/0 1 9B 1 121 0/0 2 0,6
11h µ 3 1 138 0/0 1 4/5 1 163 0/0 5 0,3
12i µ 3 1 138 1/1 2 19/28 1 157 0/0 2 -
13h µ 3 1 128 1/2 1 - - - -/- - 0,04
14h µ 3 1 120 0/1 3 21 1 066 2/2 1 5,2
15h µ 6 1 114 2/0 3 9B 1 106 1/0 2 -
16h µ 9 1 155 1/0 4 1 1 122 0/0 1 2,2
17i µ - - - -/- - 4/5 1 154 0/0 2 -
18h µ - - - -/- - 9B 1 121 0/0 2 -
19h γ 1 2 690 5/1 2 21 1 210 0/0 1 2,0
20h γ 1 2 690 5/5 1 24/25 1 123 0/0 2 1,8
21h γ 1 2 643 8/5 2 21 1 210 0/0 1 0,5
22h γ 1 1 532 3/0 2 4/5 1 077 1/1 2 0,5
23h γ 1 2 307 -/- 1 4/5 1 078 0/0 1 0,1
24h γ 2 1 171k 1/0 3 4/5 1 072k 0/0 5 0,5
25h γ 3 1 128 0/2 1 - - - -/- - 0,1
26h γ 3 1 128 3/1 1 4/5 1 143 10/1 5 2,7
27i γ 5 1 163 1/1 3 4/5 1 072k 2/0 2 13,6
28h γ 5 1 163 1/2 4 23 1 168 1/1 4 14,1 
29h γ 5 1 139 2/0 2 2 1 099 0/0 2 5,7
30i γ 6 1 114 1/0 3 1 1 115 0/0 2 1,8
31h γ 7 1 158 1/0 4 21 1 210 2/1 2 0,08
32h γ 14 1 125 4/0 3 10 1 108 0/0 1 -
33h γ 14 1 125 1/0 3 12/13 1 172 4/4 4 2,0
34h γ - - - -/- - 4/5 1 072k 1/0 4 -
35h γ - - - -/- - 1 1 179 -/- 1 115
36h α 14 1 125 3/0 3 12/13 1 172 2/0 2 -
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    primary immunization (1°) on day 7 (7) and is followed by a sequential number. 
b –  Isotype of the monoclonal antibody. 
c –  Indication of VH or VL gene family in the VBASE2 integrative database. 
d –  In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
    genomic and rearranged evidence, for class 2 genes only genomic evidence and for 
    class 3 genes only rearranged evidence. 
e –  VH and VL gene numbers according to the integrative database VBASE2. 
f –  Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
g –  The relative affinities were measured in a hapten inhibition test in comparison to IdOx1 
     IgM and IgG anti-phOx antibodies, respectively. 
h, i –  Indication of different fusions. 
k –  IdOx1 genes VH171 and Vκ072 are marked in bold.  
- –  Sequence not determined. 
Grey background shows the IdOx1 gene combination VH171/Vκ072. 
 
A similar picture emerged in IgG antibodies. Some of them had lower and some had rather 
similar affinities as the IgG IdOx1 control antibody NQ2/16.2. Strikingly, 4 non-IdOx1 antibod-
ies exhibited clearly enhanced affinities and one of them (FS1°7-35) had an even 100-times 
higher affinity.  
Conclusion: 
• Thus, the pre-immune repertoire contains clonotypes exhibiting clearly higher affinities 
than the normally dominant IdOx1.  
 
Mutations in early primary antibodies 
Somatic mutation is targeted to the rearranged immunoglobulin V-gene itself and their intron-
ic flanking sequences. In cells harbouring hypermutated V-genes, the constant (C) and un-
rearranged V genes are usually not modified. After intraperitoneal injection of a TD antigen, 
activated B cells migrate into the primary follicles of peripheral lymphoid organs where they 
undergo intense proliferation and form germinal canters, which appear towards the end of the 
first week after challenge and provide the location for both hypermutation and antigen selec-
tion. 
We compared the V region sequences with those of the next related known V genes and 
counted the numbers of silent and productive mutations (Tab. 4). This comparison did not 
reveal any alteration from mutation rates seen in WT mice. The majority of light chain se-
quences of IgM anti-phOx antibodies was not mutated or contained less than 2 mutations per 
chain. In contrast, few VL genes of IgG antibodies showed clearly mutated Vκ genes, i.e. 
FS1°7-26 and -33 with 11 and 8 mutations, respectively.  
When comparing mutations in VH, it is striking to see that all IgM encoded by VH1 family 
genes contain rather high mutation rates except antibody FS1°7-07 with no mutations. Aston-
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ishingly, VH1 family-encoded IgM showed no or very few mutations in VL. This disparity is 
not seen in the other IgM antibodies, but again in VH1 family-encoded IgG antibodies FS1°7-
19 to -22. Since the entire number of VH1 family genes is not known it can be assumed that 
the observed differences do not represent real mutations, but indicate hitherto unknown genes 
of this family. 
It is widely accepted that VH genes show higher mutation rates than VL genes [64, 82-84]. 
One example of this kind seems to be IgG antibody FS1°7-32 with 4 productive mutations in 
VH, but no mutations in VL. However, the opposite situation is found in antibody FS1°7-33 
with only 1 productive mutation in VH, but 4 productive plus 4 silent mutations in VL. This 
situation has already been observed in a previous investigation [46]. 
Conclusions: 
• The mutation rates of early primary phOx-CSA-induced antibodies in ΔD-DμFS mice 
differed not significantly from those of BALB/c WT mice. Thus, the alteration in the 
DH locus did not influence the mutation rate at this stage of immune response.  
 
HCDR3 nucleotide sequences of early primary antibodies 
The comparison of D-region nucleotide sequences of the early primary anti-phOx antibodies 
of ΔD-DμFS mice with the genomic DH gene sequence is depicted in Tab. 5. As proposed by 
Kaartinen and Mäkelä [30], we assumed that an identity of at least 6 successive nucleotides 
with the genomic sequence, interrupted by no more than 1 mismatched nucleotide, proves that 
the genomic DH gene is verified in a particular antibody. If so, HCDR3 sequences of 7/13 
IgM and 11/18 IgG could be traced back to the genomic D gene. However, one IgM and 3 
IgG had identical sequences of 4 nucleotides (marked in blue in Tab. 5). It is difficult to de-
cide if this sequence is derived from the genome or generated during the recombination pro-
cess. 
As stated above, the vast majority of antibodies, including those with phOx-specificity, use 
DH reading frame 1 (RF1) which favors tyrosine and glycine residues [30] while RF2 and 
RF3 are counter selected on the basis of stop codons and/or hydrophobic encoded nucleotides. 
However, the analysis of CDR3 sequences of the early primary anti-phOx antibodies from 
ΔD-DμFS mice showed quite a different picture. Only 3/13 IgM and 4/18 IgG antibodies used 
RF1 in HCDR3, 4/13 IgM and 7/18 IgG used RF2 and in 6/13 IgM and 7/18 IgG the reading 
frame could not be assigned. 
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Table 5 
Nucleotide sequences of HCDR3 of phOx-CSA-induced primary day 7 anti-phOx antibodies generated from ΔD-DµFS 
FS1°7     ----VHa----  -----------------------------DHb--------------------   ----JHc----  RFd  
DH gene       T TTT ATT ACT ACG GTA GTT AGC TAC    1  
05  μ  TGT GCA AGA TGG GGC TCT ATT ACT AAG GTA GTT AGT GTC TAC TGG 1  
06 μ  TGT GCA AGT    G TGT ATT ACT ACG GTA GA  GAC TGC TGG 2  
10  μ  TGT GCA GGA   G TCC ATA ATT ACT ACG GTA GTT ACG GGT GGT ACT TC  GAT GTC TG 2  
12  μ  TGT GCA CTC          TTT ACT ACG GTA GTT AGC TAC GTA CTT TTT GAC TAC TGG 1 
14  μ  TGT GCA AGA        G TTT ACT ACG AAG ACG GGT TT GCT TAC TGG 2 
15 μ  TGT GCG GGC                      GTA GTT AGG TTT GCT TAC TGG 1 
16  μ  TGT GCA AGA    G ATT ATT ACT ACG AGG GTA TG GAC TAC TGG 2 
03  μ  TGT GCA AGG        G GGT ACT TC  GAT GTC TGG nf 
04  μ  TGT GCA AGA  GCG AAC TTT   GAC TAC TGG nf  
07  μ  TGT GCA ATA  CGA   GAC TAC TGG nf 
08  μ  TGT GCA AGG  GCT ACG GCC ATG GGG GCC TGG TTT GCT TAC TGG nf 
09 μ  TGT GCC AGA  CTG ACC CAG ACG TTT  GCT TAC TGG nf 
13  μ  TGT GCA AGG  CGG TAC TTC   GAT GTC TGG nf 
11  γ  TGT GCA AGA          TTT ACT ACG GTA GTT TGC TAC TGG TAC TTC GAT GTC TGG 1 
19  γ  TGT GCA AGT    G TAG CTA ACT ACC GTA GTA ATA AAC GAG GGG AA AAC TAC TGG 2 
20 γ TGT GCA GTT          ATT ACT ACG GTA GCC CCC  GAT GTC TGG 1 
21   γ  TGT GCA AGA                      AGA GTT AGC TAC GGA AAC TAC TTT GAC TAC TGG 1  
22  γ  TGT GCA AAT            T ACT ACG GTA CCT CCT TT GAC TAC TGG 2 
23  γ  TGT GCA AGG    G CCT ATT ACT ACG GC  GAT GTC TGG 2  
27   γ  TGT GCA AGC        C ATT ACT ACG GTA CCC CTT TT GCT TAC TGG 2 
30  γ  TGT GCC AGG        C CGG GTT ACG GTA GTC CCT GGT TT GCT TAC TGG 2 
31   γ  TGT GCA AGA              CCT ACG GTA GTT AGC TTC TAT GCT ATG GAC TAC TGG 1 
33 γ  TGT GCT CTT        T ATT ACT ACG GTA GTG GGA CCT GGT TT TCT TAC TGG 2  
36  γ  TGT ACT AGC T ACC GGC AGG CCT ACG GTA GTT CCT GGT TT GCT TAC TGG 2 
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01   γ  TGT GCA AGA  GGG TAC TTC   GAT GTC TGG nf 
24   γ  TGT GCC AGA GAT CCC GGG   GCT TAC TGG nf 
25  γ  TGT GCA AGG CGG TAC TTC   GAT GTC TGG nf 
26  γ  TGT GCA AGA GGA CTC TTA GTT TAC TGG TAC TTC GAT GTC TGG nf 
28   γ  TGT GCA AGA CAT AAC AAC TAT GCT ATG  GAC TAC TGG nf 
29  γ  TGT GCA AGA TCG CCC GGA   GAC TAC TGG nf 
32   γ  TGT GTC CCG GTG GCC TGG TTT   GCT TAC TGG nf 
 
Legend 
a  – VH-encoded base of HCDR3. 
b  – DH nucleotides of the HCDR3-loop. 
c  – JH-encoded base of HCDR3. 
d  – Reading frame of DH gene. 
inv – inverted. 
nf  – not found. 
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline sequence in ΔD-DµFS mice. 
Nucleotides marked in red are generated by N and P region insertions. 
Nucleotides marked in blue (4 or 5 successive nucleotides) correspond probably to DH germline sequence in ΔD-DµFS mice. 
DH germ line coding sequence of ΔD-DµFS is outlined in first line in green colour. 
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Conclusions: 
• It seems that RF1 which codes for hydrophobic amino acids is counter selected during 
the generation of the primary repertoire ΔD-DμFS mice, harbouring only 1 non-natural 
= artificial gene in the DH locus.  
 
HCDR3 amino acids in early primary antibodies in ΔD-DμFS mice 
The lengths of the HCDR3-loops of the early primary anti-phOx antibodies from ΔD-DμFS 
mice are shown in Tab. 6. The HCDR3 lengths vary in a wide range from only 1 to 12 amino 
acids. It seems that the average length correlates with the used reading frame, i.e. antibodies 
in which the D region is encoded by RF1 or RF2, i.e. with `green amino acids´, have longer 
HCDR3 loops than those antibodies in which the reading frame could not assigned, i.e. they 
only contain `red amino acids´. HCDR3 loops of `green´ IgM and IgG antibodies have an av-
erage length of 7.85 and 8.09 amino acids, respectively. In IgM and IgG antibodies containing 
only `red´ amino acids, the D region loops have on average 3.83 and 4.1 amino acids, respec-
tively. 
Antibody FS1°7-24 which is encoded by the canonical IdOx1 gene combination VH171/Vκ072 
has a D loop with amino acids DPG which is rather similar to the DRG of IdOx1 antibodies. 
Therefore, we tested these primary antibodies with our prototypic IdOx1-specific monoclonal 
antibody 8-21/W18. It turned out that none of these primary antibodies were IdOx1 positive. 
Hence, the substitution of the middle R with P destroys the idiotope recognized by syngeneic 
IdOx1-specific antibodies, although the following base of the loop contains alanine and tyro-
sine (AY) which are also expressed in IdOx1 antibodies. This confirms a previous observation 
that an exchange of R with P destroys the IdOx1 quality (Lange et al., 2008). 
In conclusion: 
• The extreme variability of HCDR3 length suggests that the D region is not of prime im-
portance for the phOx-specificity of ΔD-DμFS mice primary antibodies.  
• The more D gene nucleotides are eliminated by exonucleases during VDJ recombination 
in the course of generation of the pre-immune repertoire, the shorter the HCDR3 length 
will be. 
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Table 6 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced primary day 7 anti-
phOx antibodies generated from ΔD-DµFS mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a  –  VH-encoded base of HCDR3. 
b  –  Predicted amino acid sequence of the HCDR3 loop. 
c  –  JH-encoded base of HCDR3. 
d  –  Reading frame of DH gene.  
e  –  The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop  
   [72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-DµFS mice. 
Amino acids marked in red are generated by N and P region insertions. 
nf  –  not found 
FS1°7 Basea CDRH3-loopb Basec RFd He
05 μ CAR WGSITKVVS VYW 1   0.38
06 μ CAS VYYYGR DCW 2 -0.08
10 μ CAG VHNYYGSYGWYF DVW 2 -0.04
12 μ CAL FTTVVSYVLF DYW 1   0.78
14 μ CAR VYYEDGF AYW 2 -0.28
15 μ CAG VVRF AYW 1 0.75
16 μ CAR DYYYEGM DYW 2 -0.28
03 μ CAR GYF DVW nf 0.28
04 μ CAR ANF DYW nf 0.28
07 μ CAI R DYW nf -1.3
08  μ CAR ATAMGAWF AYW nf 0.5
09 μ CAR LTQTF AYW nf 0.27
13 μ CAR RYF DVW nf -0.15
11 γ CAR FTTVVCYWYF DVW 1 0.55
19 γ CAS VANYRSNKRGE NYW 2 -0.42
20 γ CAV ITTVAP DVW 1 0.59
21 γ CAR RVSYGNYF DYW 1 -0.026
22 γ CAN YYGTSF DYW 2 0.07
23 γ CAR AYYYG DVW 2 -0.002
27 γ CAS HYYGTPF AYW 2 -0.1 
31 γ CAR PTVVSFYAM DYW 1 0.56
30 γ CAR PGYGSPWF AYW 2 0.03
33 γ CAL YYYGSGTWF SYW 2 0.004
36 γ CTS YRQAYGSSWF AYW 2 -0.12
01 γ CAR GYF DVW nf 0.28
24 γ CAR DPG AYW nf -0.44
25  γ CAR RYF DVW nf -0.15
26 γ CAR GLLVYWYF DVW nf 0.6
28 γ CAR HNNYAM DYW nf -0.26
29 γ CAR SPG DYW nf -0.14
32 γ CVP VAWF AYW nf 0.83
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3.5.1.2 Analysis of late primary anti-phOx antibodies  
Clonal development in the late primary response 
Next, we prepared anti-phOx antibody-secreting hybridomas 14 days after primary immuniza-
tion with the TD antigen phOx-CSA. From the established 16 clones, 9 (56 %) secreted IgM 
and 7 (44 %) secreted IgG antibodies (Tab. 7). This is in clear contrast to the control response 
in BALB/c WT mice where the vast majority of the anti-phOx forming cells at this stage of 
immune response produce IgG antibodies. Furthermore, while in WT mice there is a clear 
preference for IdOx1 antibodies as a dominant clonotype, ΔD-DμFS mice did not develop any 
dominant clone. The VHOx1 gene VH171 is only expressed in antibody FS1°14-11 and the 
VκOx1 gene Vκ072 was not used at all. Thus, no clone was encoded by the IdOx1 canonical 
gene combination VH171/Vκ072. 
Conclusions: 
• The development of the dominant IdOx1 clonotype obviously depends on the available 
DH gene repertoire and can not or only very rarely (see previous section) be generated 
from the non-natural DH gene of ΔD-DμFS mice. 
 
Mutations in late primary antibodies 
The mutation rates of these late primary anti-phOx antibodies were higher than those of the 
early primary antibodies (Tab. 4). This is especially the case if one only looks at those 
antibodies which are encoded by VH and VL class 1 genes and disregards uncertain mutations 
in antibodies encoded by class 2 genes. (Classification of variable genes as class 1 rests on 
genomic as well as rearranged evidence while for class 2 genes, there is only genomic 
evidence and so far such genes have not been observed in known antibodies.) However, the 
numbers of mutations in VH differ greatly and range from 0 in antibody FS1°14-06 and -07 to 
11 mutations in antibody FS1°14-08. Collectively, IgG antibodies seem to contain more 
mutations than IgM antibodies. Moreover, the observed mutation rates in these late primary 
anti-phOx antibodies of ΔD-DμFS mice are comparable with those of BALB/c WT mice. The 
VH/VL ratio of mutations is in accord with the above mentioned rule that VH contain more 
mutations than VL. A ratio of productive to silent mutations greater than 1 (Tab. 7) indicates 
an antigenic selection of the produced clones. 
Conclusions: 
• Late primary anti-phOx antibodies in ΔD-DμFS mice contain an astonishingly high 
number of non-switched IgM antibodies. 
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• An immune maturation is indicated by enhanced mutations rates, but the mutations do 
not accumulate in a particular clone. 
 
Table 7 
VH/VL gene combinations of phOx-CSA-induced primary day 14 anti-phOx antibodies 
in ΔD-DµFS mice  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a – The annotation of antibodies indicates their generation from ΔD-DμFS mice (FS), after 
primary immunization (1°) on day 14 (14) and is followed by a sequential number. 
 All clones are generated from the same fusion. 
b – Isotype of the monoclonal antibody. 
c – Indication of VH or VL gene family in the VBASE2 integrative database. 
d – In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
genomic and rearranged evidence, for class 2 genes only genomic evidence and for 
class 3 genes only rearranged evidence. 
e – VH and VL gene numbers according to the integrative database VBASE2. 
f – Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
k – IdOx1 genes VH171 and Vκ072 are marked in bold.  
- – Sequence not determined. 
 
 
MAba VH chain genes VL chain genes rel.
FS1°14 IsbFamc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J   Aff.g
01 μ 1 2 569 2/0 2 4/5 1 077 0/0 2 -
02 μ 1 1 532 1/0 3 2 1 097 1/0 4 -
03 μ 1 2 495 5/0 3 4/5 1 166 0/0 1 -
04 μ 1 2 286 1/0 1 4/5 1 166 0/0 2 -
05 μ 1 2 073 4/1 3 10 1 129 3/0 2 -
06 μ 5 1 147 0/0 2 23 1 179 0/0 4 -
07 μ 9 1 155 0/0 3 4/5 1 082 0/0 4 -
08 μ 9 1 118 6/5 4 2 1 097 0/0 1 -
09 μ - − - -/- - 4/5 1 166 0/0 2 -
10 γ 1 1 480 3/0 3 1 1 115 2/1 5 -
11 γ 2 1 171k 5/4 3 4/5 1 142 5/1 4 -
12 γ 5 1 192 1/2 2 - 1 - -/- - -
13 γ 5 1 139 1/1 3 9A 1 103 1/0 4 -
14 γ 7 1 168 6/1 3 1 1 115 4/0 2 -
15 γ 7 1 158 5/2 3 - 1 - -/- - -
16 γ 14 1 125 3/0 3 12/13 1 172 2/0 2 -
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Table 8 
Nucleotide sequences of HCDR3 of phOx-CSA-induced primary on day fourteen anti-phOx antibodies generated from ΔD-DµFS 
FS1°14  ----VHa----  --------------------DHb------------------------ ----JHc----  RFd 
DH gene                       T TTT ATT ACT ACG GTA GTT AGC TAC    1  
01 μ TGT GCA AGA                 T CCT ATT ACT ACG GTA GGG CCT TT  GAC TAC TGG 2 
02 μ TGT GCA AGA                     G GTT ACT ACG GTA GCT CCT GGT TT  GCT TAC TGG 2  
04 μ TGT GCA AGA                     T CAG ACT ACG GTA GTT ACG ACT GGT ACT TC GAT GTC TGG 2 
06 μ TGT GCA AGA C ATC CGG TAG TTA GCA TGT ACT ACT TT  GAC TAC TGG 2  
03 μ TGT GCA AGA TGG GAG  GCT TAC TGG nf  
05 μ TGT GCA AGA GAC GGG GGT  GCT TAC TGG nf  
07 μ TGT GCA AGA AAG GGG GCT ACC GTC ACT TTT AGG GTG TTT  GCT TAC TGG nf 
08 μ TGT GCC AGA TTT ATG GTA GTT TGG GGT TCT ATG  GAC TAC TGG nf 
10 γ TGT GCA AGA          TCT GAT TTT ATT ACT CAC GCC TGG TTT GCT TAC TGG 1 
12 γ TGT GCA AGA                  CTG AGT ACT ACG GCG GAC TAC TGG 1 
14 γ TGT TCA AGA                G GCC ATT ACT ACG GCT CCT GGT TT GCT TAC TGG 2 
15 γ TGT GCA AGA                G GGG ATT ACT ACG GTT GTT GGT TT  GCT TAC TGG 2 
16 γ TGT GCT AGC              TTT TTT ATT ACT ACG GTA GTT AGG  GCT TAC TGG 1 
11 γ TGT GCC AGA GAT TTC GGT AAG GAC TGG nf 
13 γ TGT GCA AAA GAC TAC GGT GTC GGG TGG nf 
 
Legend 
a    –  VH-encoded base of HCDR3.     b   – DH-nucleotides of the HCDR3-loop.     
c    –  JH-encoded base of HCDR3.     d   – Reading frame of DH gene.      
inv – inverted.        nf – not found.        
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline sequence in ΔD-DµFS mice. 
Nucleotides marked in red are generated by N and P region insertions. 
Nucleotides marked in blue (4 or 5 successive nucleotides) correspond probably to DH germline sequence in ΔD-DµFS mice. 
DH germ line coding sequence of ΔD-DµFS is outlined in first line in green colour. 
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Table 9 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced primary on day 
fourteen anti-phOx antibodies generated from ΔD-DµFS mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a  –  VH-encoded base of HCDR3. 
b  –  Predicted amino acid sequence of the HCDR3 loop. 
c  –  JH-encoded base of HCDR3. 
d  –  Reading frame of DH gene.  
e  –  The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop  
   [72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-DµFS mice. 
Amino acids marked in red are generated by N and P region insertions. 
nf  – not found 
 
HCDR3 nucleotide sequences of late primary antibodies 
The nucleotide sequences of the late primary antibodies are depicted in Tab. 8. Ten of these 
16 antibodies (62 %) contained 6 or more successive nucleotides derived from the germ line 
DH gene segment with more or less modifications at both boundaries of VDJ joining sites. 
The other 6 antibodies (37 %) showed no homology with the germ line DH segment. 
As already observed in early primary antibodies of ΔD-DμFS mice, RF1 usage was reduced 
in late primary antibodies in favor of RF2 (37 %) or a situation that the reading frame could 
not be determined. With antibodies FS1°14-07 and -8 as exceptions, HCDR3 loops were 
longer in antibodies with germ line-related than in those with non-related DH nucleotide 
sequences. 
FS1°14 Basea CDRH3-loopb Basec RFd He
01 μ CAR SYYYGRAF DYW 2 -0.04
02 μ CAR GYYGSSWF AYW 2 0.04
04 μ CAR SDYGSYDWYF DVW 2 -0.2
06 μ CAR HPVVSMYYF DYW 2 0.35
03 μ CAR WE AYW nf -0.57
05 μ CAR DGG AYW nf -0.31
07 μ CAR KGATVTFRVF AYW nf 0.37
08 μ CAR FMVVWGSM DYW nf 0.71
10 γ CAR SDFITHAWF AYW 1 0.27
12 γ CAR LSTTA DYW 1 0.39
14 γ CSR GHYYGSWF AYW 2 -0.07
15 γ CAR GDYYGCWF AYW 2 0.06
16 γ CAS FFITTVVR AYW 1 0.71
11 γ CAR DFG KDW nf 0.04
13 γ CAK DYG VGW nf -0.41
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Conclusions: 
• Late primary anti-phOx antibodies of ΔD-DμFS mice preferably use germ line-related 
HCDR3 nucleotides sequences, but `try to avoid´ reading frame 1.  
 
HCDR3 amino acids in late primary antibodies in ΔD-DμFS mice 
The deduced amino acid sequences from the HCDR3 nucleotide sequences prove the above 
conclusions (Tab. 9). With the exceptions of antibodies FS1°14-07 and -08, antibodies with 
germ line-related HCDR3 sequences have clearly longer D region loops than antibodies with 
non-related sequences. Among the antibodies with germ line-related HCDR3 sequences, only 
3 (FS1°14-10, 12 and 16) used the DH RF1 coding for hydrophobic amino acids. This is indi-
cated by a positive hydrophobicity index (Tab. 9). Only RF2 in HCDR3 encoded the normally 
preferred amino acids glycine and tyrosine. Since 6 clones (37 %) used a germ line non-
related reading frame in HCDR3 intervals, antibodies with DH RF1 represent only 19 % 
instead of 90 % in WT. 
Analysis of hydropathic score of the HCDR3 demonstrated that the germ line DH non-related 
clones used hydrophobic as well as hydrophilic amino acids and some of this clones (FS1°14-
5, FS1°14-11, FS1°14-13) presented a similar HCDR3-loop (DXG) found in WT mice. How-
ever, clones using RF1 in DH showed a hydrophobic HCDR3, while that using RF2 presented 
mostly a hydrophilic HCDR3. 
In conclusion: 
• As concluded from the early primary anti-phOx antibodies of ΔD-DμFS mice, the varia-
bility of HCDR3 length suggests that the D region is not of prime importance for the 
phOx-specificity.  
• In general, the more DH gene nucleotides are eliminated by exonucleases during VDJ 
recombination in the course of generation of the pre-immune repertoire, the shorter the 
HCDR3 length will be. 
 
3.5.1.3 Analysis of secondary anti-phOx antibodies 
Clonal composition of the secondary response 
Eight weeks after primary immunization, a group of ΔD-DμFS mice were immunized a sec-
ond time with the TD antigen phOx-CSA and phOx-reactive antibody-secreting hybridomas 
were prepared 3 days later by cell fusion. From 2 such fusions, 12 anti-phOx specific hybrid-
omas were established (Tab. 10). From the first fusion of one mouse, only 4 IgM anti-phOx 
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antibodies were obtained and from the other mouse only 8 IgG-secreting clones. Compared to 
BALB/c WT mice, isolation of IgM antibodies in the first fusion is a rather strange event, par-
ticularly since they were obtained already on day 3 after immunization. The collection of anti-
bodies obtained in the second fusion also present curious features. In wildtype mice, the 
secondary response is characterized by a clonal shift away from the primary dominant IdOx1 to 
other clonotypes. In these secondary antibodies from ΔD-DμFS mice, 3 antibodies (FS2°-05 
to -07) were encoded by the IdOx1 gene combination VH171/Vκ072. Hence, they dominated 
the secondary response of this mouse with 37 %. In addition, antibody FS2°-08 was also en-
coded by VH171, but in combination with VL gene Vκ137.  
Conclusions: 
• The very different outcome in these 2 fusions indicates that the repertoire of B cells in 
ΔD-DμFS mice which can be activated by phOx-CSA develops at random. Therefore, 
the normally dominant IdOx1 may even be generated in very few mice. 
• Because of the probably non-sufficient amount of secondary antibodies, a clear reper-
toire switch as in BALB/c WT mice can not be concluded. 
 
Mutations in secondary antibodies 
The IgM antibodies were almost non-mutated and the 7 productive and 5 silent mutations in 
antibody FS2°-01 are problematic since the coding gene VH623 is `only´ a class 2 gene. Since 
the complete repertoire of the VH1 family is not known, the VH gene used FS2°-01 may be-
long to the group of hitherto unknown VH1 family genes. Thus, we can regard the associated 
cells as naive and not as memory B cells. 
As mutation rates of secondary IgG antibodies are higher than in late primary antibodies, it 
can be concluded that these antibodies have undergone immune maturation through somatic 
hypermutation. Indeed, VL-coding gene Vκ072 of antibodies FS2°-06 and -07 contain the 
well known classical affinity-enhancing early mutations H>N in position 33 and Y> F in po-
sition 35 [55]. In addition, the VH171 gene of antibody FS2°-07 contains the known mutation 
S>T in position 31 [55]. Hence, the 4 antibodies encoded by VH171 are immune maturated 
and this correlates well with their considerably enhanced affinities (Tab. 10). 
Conclusion: 
• Immune maturation can occur in individual, but not all ΔD-DμFS mice. 
 
HCDR3 nucleotide sequences of secondary antibodies 
Two of the IgM antibodies could be sequenced in VH. Both of them used germ line-related 
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 nucleotide sequences in HCDR3, 1 in RF1 and the other in RF2 (Tab. 11). HCDR3 sequen-
ces of 3 IgG antibodies are also germ line-related. Two of them are translated in RF2 and the 
in RF3. Interestingly, the other 4 IgG antibodies which are encoded by one or both IdOx1 vari-
able genes have rather short HCDR3 loops (Tab. 11). 
Conclusion: 
• In ΔD-DμFS antibodies encoded by one or both genes of the canonical IdOx1 combina-
tion, the HCDR3 loop could obviously not be generated from germ line-related nucleo-
tide sequences. 
 
Table 10 
VH/VL gene combinations of phOx-CSA-induced secondary anti-phOx antibodies in 
ΔD-DµFS mice 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a  –  The annotation of antibodies indicates their generation from ΔD-DμFS mice (FS), after  
      secondary immunization (2°) and is followed by a sequential number. 
b  –  Isotype of the monoclonal antibody. 
c  –  Indication of VH or VL gene family in the VBASE2 integrative database. 
d  –  In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
      genomic and rearranged evidence, for class 2 genes only genomic evidence and for 
      class 3 genes only rearranged evidence. 
e  –  VH and VL gene numbers according to the integrative database VBASE2. 
f  –  Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
g  –  The relative affinities were measured in a hapten inhibition test in comparison to IdOx1 
      IgM and IgG anti-phOx antibodies, respectively. 
h, i  –  Indication of different fusions. 
k  –  IdOx1 genes VH171 and Vκ072 are marked in bold.  
-  –  Sequence not determined. 
Grey background shows the IdOx1 gene combination VH171/Vκ072. 
 
MAba VH chain genes                VL chain genes rel.
FS2° Isb Famc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J Aff.g
01h μ 1 2 623 7/5 3 1 1 115 0/0 2 -
02h μ 1 2 591 0/0 3 - - - -/- - -
03h μ - - - -/- - 1 1 097 0/0 1 -
04h μ - - - -/- - 9B 1 121 0/0 2 -
05i γ 2 1 171k 3/0 4 4/5 1 072k 1/0 5 16,4
06i γ 2 1 171k 6/0 3 4/5 1 072k 5/0 5 127,7
07i γ 2 1 171k 5/2 3 4/5 1 072k 4/2 5 65,7
08i γ 2 1 171k 6/0 4 10 1 137 3/3 2 19,1
09i γ 2 1 162 10/6 3 1 1 115 3/3 1 -
10i γ 7 1 158 9/5 3 1 1 115 2/1 2 2,0
11i γ 15 1 125 3/1 2 10 1 137 4/0 1 10,4
12i γ - - - -/- - 19/281 202 1/0 2 -
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Table 11 
Nucleotide sequences of HCDR3 of phOx-CSA-induced secondary anti-phOx antibodies generated from ΔD-FµFS 
FS2° ----VHa----   -------------------------DHb----------------------   ----JHc----  RFd 
DH gene                   T TTT ATT ACT ACG GTA GTT AGC TAC   1 
01     μ TGT GCA AGA    GGG TGG AGT ATT ACT ACG GTA GTT AGC TAC GCT TAC TGG 1  
02  μ TGT GCA AGA  G AGA GGT CTT TTT ACT ACG GTA GGG AGT GGC TGG TT TGC TTA TGG 2  
09  γ TGT GCC AGA CA TGA ATT TTT ATT ACT ACG GAG TTA CCT ACG C  GCT TAC TGG  3 
10  γ TGT GCA CGA          G GGC ATT ACT ACG GTA CTT GGT TT GCT TAC TGG  2 
11  γ TGT GTT AGA              T ATT ACT ACG GTA GGC CT  GAC TAC TGG  2  
05  γ TGT GCC AGA GAC TCC GGG  GAC TAC TGG nf 
06  γ TGT GCC AGA GAT GGG GGG  GCT TAC TGG  nf 
07  γ TGT GCC AGA              G ATT ACG GA ATT TAC TGG nf 
08  γ TGT GCC AGA GAT GGG GGG  GAC TAC TGG nf 
 
Legend 
a  –  VH-encoded base of HCDR3. 
b  –  DH nucleotides of the HCDR3-loop. 
c  –  JH-encoded base of HCDR3. 
d  –  Reading frame of DH gene. 
inv  –  inverted. 
nf  –  not found. 
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline sequence in ΔD-DµFS mice. 
Nucleotides marked in red are generated by N and P region insertions. 
Nucleotides marked in blue (4 or 5 successive nucleotides) correspond probably to DH germline sequence in ΔD-DµFS mice. 
DH germ line coding sequence of ΔD-DµFS is outlined in first line in green colour. 
 
 
3 Results  67
Table 12 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced secondary anti-phOx 
antibodies generated from ΔD-DµFS mice 
 
 
 
 
 
 
 
 
Legend 
a  –  VH-encoded base of HCDR3. 
b  –  Predicted amino acid sequence of the HCDR3 loop. 
c  –  JH-encoded base of HCDR3. 
d  –  Reading frame of DH gene.  
e  –  The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop 
         [72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-DµFS mice. 
Amino acids marked in red are generated by N and P region insertions. 
nf  –  not found 
 
HCDR3 amino acids in secondary antibodies in ΔD-DμFS mice 
A conspicuous character of the secondary response is the reduced usage of DH RF1-encoded 
hydrophobic amino acids in the HCDR3 loop. Antibodies FS2°-2, -10 and -11 used tyrosine-
rich germ line-related DH sequences and only antibody FS2°-01 used hydrophobic amino 
acids encoded by the DH RF1 (Tab. 12). Thus, the single clone using DH RF1 represents only 
11 % of our secondary Abs. 
Thus, tyrosine- and glycine-rich HCDR3s were seen in all clones except antibodies FS2°-01 
and FS2°-09. The prevalence of these 2 amino acids shifted the average hydrophobicity of the 
HCDR3s strongly into the hydrophilic range (average hydrophobicity less than -0.3) (Tab. 
10). In contrast, hydrophobicity of HCDR3 in antibodies FS2°-01 and FS2°-09 had average 
hydropathicity scores in the normalized Kyte-Doolittle scale of 0.17 and 0.42, respectively.  
Moreover, the usage of VHOx1 in antibodies FS2°-05 to -08 was accompanied by the expres-
sion of germ line-non-related Ox1 motive (DXG), pointing out the minimal role of DH genes 
in the constraining of amino acid composition of the HCDR3. However, the DRG sequence 
FS2° Basea CDRH3-loopb Basec RFd He
01 μ CAR GWSITTVVSY AYW 1 0.42 
02 μ CAR ERSFYYGREWLV CLW 2 -0.1 
09  γ CAR HEFLLLRSYLR AYW 3 0,17
10  γ CAR  GHYYGTWF AYW 2 -0,06
11 γ CVR  YYYGRP DYW 2 -0,41
05 γ CAR   DSG DYW nf -0,36
06  γ CAR DGG AYW nf -0,31
07  γ CAR DYG IYW nf -0,41 
08  γ CAR   DGG DYW nf -0,36
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determining the IdOx1 idiotope was not found. Hence, these antibodies did not react with our 
IdOx1-specific prototypic monoclonal anti-idiotype 8-21/W18. 
Conclusions: 
• In principle, ΔD-DμFS mice can generate the genetic VH/VL combination of IdOx1 anti-
bodies. 
• However, the idiotypic motive DRG in which the middle arginine is essential for recog-
nition by syngeneic anti-idiotypes can either not or only extremely rarely be generated.    
 
3.5.1.4 Analysis of tertiary anti-phOx antibodies 
Clonal composition of the tertiary response 
Two months after secondary immunization mice received a tertiary immunization and on day 
3 thereafter, hybridomas secreting phOx-specific antibodies were prepared by cell fusion with 
the non-secretor myeloma cell line Ag8.653. From one fusion, 35 hybridoma lines could be 
established (Tab. 13). Strikingly and in accord with secondary fusions (see above), even after 
tertiary immunization, 12/35 clones (34 %) secreted antibodies of the IgM class. This is in 
sharp contrast to BALB/c WT mice in which only IgG antibodies can be established at this 
stage of a memory response [46]. 
Among IgM antibodies, FS3°-04 was encoded by the VHOx1 gene VH171 and antibodies 
FS3°-07 used the VκOx1 gene Vκ072. However, the classical full VHOx1/VκOx1 combina-
tion was not found (Tab. 13). IgG antibodies FS3°-18 and -19 were encoded by the VHOx1 
gene VH171, but only FS3°-18 utilized the VκOx1 gene Vκ072. This gene was also used in 2 
other IgG antibodies, in FS3°-15 in combination with the VH2 family gene VH175 and in 
FS3°-23 in combination with the VH5 family gene VH139. Interestingly, 7 IgG clones (FS°3-
24 to -30, representing 30 % of IgG antibodies) were encoded by the VH/VL gene combina-
tion VH158/Vκ115. Thus, this combination can be regarded as a dominating clone in the ter-
tiary response of ΔD-DµFS mice. 
Conclusions: 
• In contrast to BALB/c WT mice with a full DH gene repertoire, the IdOx1 does not pre-
vail the tertiary TD response of ΔD-DµFS mice which can only make use of one artifi-
cial DH gene coding for hydrophobic amino acids. 
• Instead, the VH158/Vκ115 genetic combination may develop into a dominating clone. 
Interestingly, this gene combination was also a major clone when wildtype mice were 
3 Results  69
immunized first with the TI-2 antigen phOx-Ficoll, 3 months later with the TD antigen 
phOx-CSA and a second TD immunization 2 months later [46].   
 
Table 13 
VH/VL gene combinations of phOx-CSA-induced tertiary anti-phOx antibodies in ΔD-
DµFS mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MAba VH chain genes VL chain genes
FS3° Isb Famc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J
01 μ 1 2 627 2/0 2 24/25 1 096 0/0 5
02 μ 1 2 495 2/0 2 - - - -/- -
03 μ 1 2 286 1/0 3 9A 1 112 1/0 2
04 μ 2 1 171k 0/1 2 10 1 137 3/0 2
05 μ 5 1 178 2/0 1 21 1 210 0/0 1
06 μ 5 1 176 0/0 3 8 1 195 0/0 2
07 μ 5 1 139 1/0 2 4/5 1 072k 4/0 5
08 μ 5 1 139 2/0 2 1 1 231 5/3 4
09 μ 6 1 494 8/3 3 2 1 099 0/0 5
10 μ 7 1 158 10/1 3 1 1 115 1/3 2
11 μ - − - -/- - 10 1 137 3/0 2
12 μ - - - -/- - 1 1 115 0/1 1
13 γ 1 2 627 1/0 2 9A 1 103 6/0 2
14 γ 1 2 627 1/0 2 12/13 1 174 0/0 5
16 γ 1 2 073 3/2 2 4/5 1 078 2/1 5
17 γ 1 2 073 6/0 2 - - - -/- -
15 γ 2 1 175 3/1 3 4/5 1 072k 6/0 5
18 γ 2 1 171k 7/4 3 4/5 1 072k 1/0 5
19 γ 2 1 171k 8/3 3 10 1 137 3/3 2
20 γ 3 1 138 7/0 1 24/25 1 123 2/0 1
21 γ 5 1 139 3/1 3 4/5 1 072k 5/2 5
22 γ 6 1 114 3/2 2 9A 1 108 3/2 2
23 γ 6 1 114 2/1 2 9A 1 108 2/1 2
36 γ 7 1 663 4/1 3 1 1 115 3/1 4
24 γ 7 1 158 8/1 3 1 1 115 0/0 2
25 γ 7 1 158 9/1 3 1 1 115 1/1 2
26 γ 7 1 158 5/5 3 1 1 115 4/1 4
27 γ 7 1 158 10/2 3 1 1 115 0/0 2
28 γ 7 1 158 10/2 3 1 1 115 0/0 2
29 γ 7 1 158 11/2 3 1 1 115 0/0 2
30 γ 7 1 158 4/1 3 1 1 115 1/1 4
31 γ 14 1 125 8/1 2 10 1 129 2/2 1
32 γ 14 1 125 8/1 2 10 1 129 2/1 1
33 γ 14 1 125 3/0 2 12/13 1 172 0/1 4
34 γ - - - -/- - 4/5 1 078 2/0 1
35 γ - - - -/- - 10 1 137 3/3 2
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Legend 
a  –  The annotation of antibodies indicates their generation from ΔD-DμFS mice (FS), after 
tertiary immunization (3°) and is followed by a sequential number. All clones are 
generated from the same fusion. 
b  –  Isotype of the monoclonal antibody. 
c  –  Indication of VH or VL gene family in the VBASE2 integrative database. 
d  –  In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
genomic and rearranged evidence, for class 2 genes only genomic evidence and for 
class 3 genes only rearranged evidence. 
e  –  VH and VL gene numbers according to the integrative database VBASE2. 
f  –  Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
g  –  The relative affinities were measured in a hapten inhibition test in comparison to IdOx1 
   IgM and IgG anti-phOx antibodies, respectively.  
k  –  IdOx1 genes VH171 and Vκ072 are marked in bold.  
-  –  Sequence not determined. 
Grey background shows the IdOx1 gene combination VH171/Vκ072. 
 
 
Mutations in tertiary antibodies 
Mutations further accumulated in tertiary IgG antibodies as compared to secondary antibodies 
while IgM antibodies remained rather non-mutated. Only IgM FS3°-09 and -10 contained 
considerable numbers of mutations. This might indicate that both antibodies had undergone 
immune maturation. However, if this were the case it has to be asked why they did not tra-
verse class switch recombination.   
Among IgG antibodies, the 2 VH171 genes in antibodies FS3°-18 and -19 exhibited rather 
high numbers of mutations, but the typical S>T mutation in position 31 is not seen. However, 
antibody FS3°-19 showed a silent mutation in this position. Highest mutation rates in IgG 
antibodies occur in antibodies encoded by the VH158/Vκ115 gene combination (Tab. 13). In 
4 positions (52, 56, 61 and 76), the VH158 gene in all of these antibodies had a variable 
number of silent and productive mutations in common with previously established anti-phOx 
antibodies [46]. Those antibodies were obtained in mice which had been immunized first with 
the TI-2 antigen phOx-Ficoll followed by a primary and then a secondary immunization with 
phOx-CSA. This further proves that tertiary ΔD-DµFS antibodies with the VH158/Vκ115 
gene combination had undergone immune maturation. 
Conclusions: 
• The tertiary anti-phOx antibodies from ΔD-DµFS mice underscore that the single artifi-
cial DH gene in these mice does not allow the IdOx1 to become a dominant clone. 
• However, ΔD-DµFS mice can develop antibodies with the VH158/Vκ115 gene combi-
nation as a dominant clone in the tertiary response. 
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Table 14 
Nucleotide sequences of HCDR3 of phOx-CSA-induced tertiary anti-phOx antibodies generated from ΔD-DµFS 
FS3°  ----VHa----   ------------------------DHb--------------------  ----JHc---- RFd 
DH gene                T TTT ATT ACT ACG GTA GTT AGC TAC   1 
01 μ TGT GCA AGC         GGG GGT ACT ACG GTA GCC TTT  GAC TAC TGG 1 
02 μ TGT GCA AGA               G ACT ACG GCA AAA GAG GT  GGC TAC TGG 2 
05 μ TGT ATT ACT                     ACG GTA GTT AGC TAC TGG TAC TTC  GAT GTC TGG 1 
06 μ TGT GCA AGA         GGC AGG GCT ACG GTA GTT AGC TAC GCC TGG TTT GCT TAC TGG 1 
07 μ TGT GCA AGA               G ACT ACG GT  GAC TAC TGG 2 
08 μ TGT GCA AGA               G ACT ACG GT  GAC TAC TGG 2 
03 μ TGT GCA AGA   AGA GAT GGG GCT TAT TGG nf 
04 μ TGT GCC AGA   GAT TCG GGG GAC TAC TGG nf 
09 μ TGT ACG GGG   GGT CCC TGG TTT  GCT TAC TGG nf 
10 μ TGT GCA AGA   GGG GCC GGT AGT GGA GCC TGG TTT  GCT TAC TGG nf 
13 γ TGT GCA AGG           T TTT ACT ACG GTA GGG GGG GGC TCG TCTACTTT  GAC TAC TGG 2 
14 γ TGT GCA AGG           T TTT ACT ACG GTA GGG GGG GGC TCG TCTACTTT  GAC TAC TGG 2 
16 γ TGT GCA AGA GGA GGC TTT ATT AGG ACG ACG GTA GCC GGG GAC TAC TGG 1 
17 γ TGT ACA ACA       G GGG ATT ACT ACG GT  AGT TAC TGG 2 
20 γ TGT GCA AGA             TTT ACT ACG GTA GTT AGC TAC TGG TACTTC GAT GTC TGG 1 
21 γ TGT GCA AGA               G ACT ACG GG GCT TAC TGG 2 
25 γ TGT GCA AGA       G GTT ATT ACT ACG GTA GTT GGT TT  GCT TAC TGG 2 
26 γ TGT GCA AGA       G GGC ATT ACT ACG GTG CCT GGT TT  GCT TAC TGG 2 
27 γ TGT GCA AGA       G GTC ATT ACT ACG GTA CTT GGT TT  GCT TAC TGG 2 
28 γ TGT GCA AGA       G GTC ATT ACT ACG GTA CTT GGT TT  GCT TAC TGG 2 
29 γ TGT GCA AGA       G GTC ATT ACT ACG GTA CTT GGT TT  GCT TAC TGG 2 
30 γ TGT GCA AGA       G GGG ATT ACT ACG GTG CCT GGT TT  GCT TAC TGG 2 
31 γ TGT GCT AGT           G ACT ACG GC  CTC TAC TGG 2 
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32 γ TGT GCT AGT        G ACT ACG GC  CTC TAC TGG 2 
33 γ TGT GCT AGA  TAT GAG ATT ACT ACG GTA GTT ACC  TCT ATC TGG 1 
36 γ TGT GCA AGA    G GGG ATT ACT ACG GTG CCT GGT TT  GCT TAC TGG 2 
15 γ TGT GCC AGA    GAT TGG GGG GAT TAC TGG nf 
18 γ TGT GCC AGA    GAT GGG GGG ACT TAT TGG nf 
19 γ TGT GCC AGA    GAT GAG GGT GTG AAC TGG nf 
22 γ TGT ACA ACT    AGA GGG GAC TAT TGG nf 
23 γ TGT ACA ACT    AGA GGG GAC TAT TGG nf 
24 γ TGT GCA AGA            G GGG ACG GTC GTG GAG CCT GGT TT  GCT TAC TGG nf 
 
Legend 
a  –  VH-encoded base of HCDR3. 
b  –  DH nucleotides of the HCDR3-loop. 
c  –  JH-encoded base of HCDR3. 
d  –  Reading frame of DH gene. 
inv  –  inverted. 
nf  –  not found. 
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline sequence in ΔD-DµFS mice. 
Nucleotides marked in red are generated by N and P region insertions. 
Nucleotides marked in blue (4 or 5 successive nucleotides) correspond probably to DH germline sequence in ΔD-DµFS mice. 
DH germ line coding sequence of ΔD-DµFS is outlined in first line in green colour. 
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HCDR3 nucleotide sequences of tertiary antibodies 
60 % of the IgM antibodies contain germ line-related HCDR3 sequences of variable length 
(Tab. 14). Among IgG antibodies this value is even higher with 72 %. As in all previous 
antibodies of this investigation, antibodies with RF1 (~ 19 %) usage in HCDR3 are clearly 
counter selected. RF2 dominates with 50 % and in 31 % of the antibodies the reading frame 
could not be ascribed. The HCDR3 loop of antibody FS3°-16 seems to interesting since to 
separated germ line-related sequences occur which are separated from each other by non-
ascribable nucleotides. It may be speculated that this D region may be generated by D-D du-
plication. 
Conclusion: 
• Reading frame used in these tertiary anti-phOx antibodies from ΔD-DµFS mice thus 
confirm findings from the earlier stages of this response. 
 
HCDR3 amino acids in tertiary antibodies in ΔD-DμFS mice 
The deduced amino acid HCDR3 sequences in the tertiary anti-phOx antibodies are shown in 
Tab. 15. Only 3 IgM and 3 IgG contained hydrophobic amino acids encoded by DH RF1, 
while 3 IgM and 13 IgG antibodies had RF2-encoded hydrophilic amino acids. In 4 IgM and 6 
IgG, the reading frame could not be assigned and the newly generated HCDR3 nucleotide se-
quences encoded mostly hydrophilic amino acids. Interestingly, only the germ line-related 
HCDR3 sequences coded for tyrosines, which was missing in germ line-non-related HCDR3. 
The negative selection of hydrophobic amino acid encoded by DH RF1 is also reflected in the 
hydropathicity scores of the HCDR3 loops, i.e. negative values prevail while positive scores 
are very rare. Thus, the majority of the HCDR3-loops resembled those seen in BALB/c WT 
mice with hydrophilic amino acids like tyrosine and glycine (Tab. 15). 
 
The lengths of HCDR3-loops of these tertiary ΔD-DµFS anti-phOx antibodies showed the 
same characteristics as before, namely that germ line-related coding caused longer loops than 
non-related coding. In IgG antibodies, the length of HCDR3-loops ranged from 2 to 11, while 
those of IgM antibodies varied between 3 and 11 amino acids. Interestingly, the middle IdOx1 
related motive DXG was present in four clones of IgM class (FS3°-3, -7, -8 and -41) and in 5 
IgG antibodies (FS3°-15, -18, -19, -21, -31 and -32). The HCDR3-loops of these clones were 
encoded by N nucleotides generated during the recombination processes and did not show any 
homology with the germ line DH segment. 
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Conclusions: 
• Also in the tertiary response, ΔD-DµFS mice `try to avoid´ coding of HCDR3 in RF1. 
Instead, RF2 usage and generation of newly form nucleotide sequences during recombi-
nation favor HCDR3 loops which are rich in glycine and tyrosine. 
 
Table 15 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced tertiary anti-phOx 
Abs generated from ΔD-DµFS mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FS3° Basea CDRH3-loopb Basec RFd He
01 μ CAS GGTTVAF DYW 1 0.48
02 μ CAR DYGKRG GYW 2 -0.6
05 μ CIT TVVSYWYF DVW 1 0.43 
06 μ CAR GRATVVSYAWF AYW 1 0.36
07 μ CAR DYG DYW 2 -0.64
08 μ CAR DYG DYW 2 -0.64 
03 μ CAR RDG AYW nf -0.76
04 μ CAR DSG DYW nf -0.36
09 μ CTG GPWF AYW nf 0.16
10 μ CAR GAGSGAWF AYW nf 0.31
13 γ CAR FYYGRGGLVYF DYW 2 0.29
14 γ CAR FYYGRGGLVYF DYW 2 0.29
16 γ CAR   GGFIRTTVAG DYW 1 0.38
17 γ CTT  GDYYG SYW 2 -0.3
20 γ CAR FTTVVSYWYF DVW 1 0.45 
21 γ CAR DYG AYW 2 -0.41
25 γ CAR GYYYGSWF AYW 2 0.01
26 γ CAR GHYYGAWF AYW 2 0.04
27 γ CAR GHYYGTWF AYW 2 -0.06
28 γ CAR GHYYGTWF AYW 2 -0.06
29 γ CAR GHYYGTWF AYW 2 -0.06
30 γ CAR GDYYGAWF AYW 2 0.03
31 γ CAS DYG LYW 2 -0.41 
32 γ CAS DYG LYW 2 -0.41
33 γ CAR     YEITTVVT SIW 1 0.43
36 γ CAR GDYYGAWF AYW 2 0.03
15 γ CAR DWG DYW nf -0.37
18 γ CAR DGG TYW nf -0.31
19 γ CAR DEG VNW nf -0.66
22 γ CTT RG DYW nf -0.64
23 γ CTT RG DYW nf -0.64
24 γ CAR GDGRGAWF AYW nf -0.06
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Legend 
a – VH-encoded base of HCDR3.      
b – Predicted amino acid sequence of the HCDR3 loop.   
c – JH-encoded base of HCDR3.     
d – Reading frame of DH gene.  
e – The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop  
[72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-DµFS mice. 
Amino acids marked in red are generated by N and P region insertions. nf – Not found 
 
As general conclusions from the analysis of the thymus-dependent anti-phOx response in ΔD-
DµFS mice it can be stated: 
1.) The restriction of the number of DH gene segments to one artificial DH gene demonstrates 
the extraordinary variability at the third hypervariable region which is enzymatically cre-
ated during VDJ-recombination by exonucleases and the insertion of non-templated (N) 
and palindromic (P) nucleotides. 
2.) The restriction of the number of DH gene segments to one artificial DH gene, coding for 
hydrophobic amino acids, causes a substantial reduction of the antibody repertoire of the 
mice. 
3.) The canonical VH/VL gene combination VH171/Vκ072 together with IdOx1-typical amino 
acid sequence DRG in HCDR3 is extremely rarely verified and, if so, only in particular 
animals. 
 
3.5.2 Genetic analysis of the phOx-reactive repertoire of ΔD-iD mice 
Next, ΔD-iD mice were immunized with the TD antigen phOx-CSA. These mice can only 
make use of a single DH gene coding for charged amino acids in HCDR3. Anti-phOx anti-
body-secreting hybridomas were generated by cell fusion from the primary, secondary and 
tertiary of immune response. Here, the V region-coding sequences of these antibodies will be 
described.  
 
3.5.2.1  Analysis of early primary anti-phOx antibodies 
Primary repertoire 
From the early primary response of ΔD-iD mice, i.e. 7 days after immunization, 18 hybridom-
as could be established. Eleven of them (61 %) were of the IgM and 39 % belonged to the IgG 
class (Tab. 16). The nomenclature of these antibodies is analogous to that of ΔD-DµFS mice. 
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This mutant strain is abbreviated by iD and early primary antibodies are marked with 1° fol-
lowed by the day 7 of the fusion. IgM anti-phOx antibodies iD1°7-05, -06 and -07 and IgG 
antibodies iD1°7-13 and -14 expressed a VHOx1 heavy chain (VH171) in association with al-
ternative light chains. Only IgG antibody iD1°7-12 used the VκOx1 light chain (Vκ072) in 
combination with VH183. Hence, the IdOx1 VH/VL gene combination VH171/Vκ072, domi-
nating the primary TD response of BALB/c WT mice, is not expressed among early primary 
antibodies of ΔD-iD mice. Moreover, the normally dominant IdOx1 is not replaced by another 
dominant VH/VL gene combination. Most of the variable genes in this primary response in 
the ΔD-iD mice have been observed in the WT mice, but in different combinations. 
Conclusions: 
• Hence, the restriction to a single DH gene segment coding for charged amino acids 
changes the pattern of VH/VL combinations in ΔD-iD mice, but not the V gene usage of 
heavy and light chains. 
• There is no dominant idiotype in the early primary anti-phOx antibodies. 
 
Affinity of primary antibodies 
The relative affinity of the majority of IgM antibodies was 10-20 lower than that of the IgM 
IdOx1 antibody H11.5 (μ, κ). In contrast, the affinities of the 2 IgG antibodies iD1°7-16 and -
17 were in the range of the IdOx1 control antibody NQ2/16.2, and antibodies iD1°7-13, -14 
and -15 exhibited clearly higher affinities (Tab. 16). 
Conclusion: 
• Even a restricted pre-immune repertoire generated from the single D gene segment of 
ΔD-iD mice may contain antibodies with VH/VL gene combinations which confer high-
er affinities than that of IdOx1 antibodies. 
 
Mutations in early primary antibodies 
Most of the early primary anti-phOx antibodies from ΔD-iD mice showed no or low mutation 
numbers, with some exceptions. The 2 IgM antibodies iD1°7-03 and -04 had enhanced muta-
tions in the VH1 family gene VH286. However, since this is a class 2 gene, these mutations 
are doubtful. Three other IgM antibodies, iD1°7-01, -05 and -10, contain some productive as 
well as silent mutations in their light chain which can not be explained at this early stage of 
the primary response. 
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Conclusion:  
• We conclude that the mutation rates of early primary phOx-CSA-induced antibodies in 
ΔD-iD mice did not differ significantly from those of BALB/c WT mice. Thus, the alte-
ration in the DH locus did not influence the mutation rate at this stage of immune re-
sponse.  
 
Table 16 
VH/VL gene combinations of phOx-CSA-induced primary day 7 anti-phOx antibodies 
in ΔD-iD mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a – The annotation of antibodies indicates their generation from ΔD-iD mice (iD), after 
primary immunization (1°) on day 7 (7) and is followed by a sequential number. All 
clones are generated from the same fusion. 
b – Isotype of the monoclonal antibody. 
c – Indication of VH or VL gene family in the VBASE2 integrative database. 
d – In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
genomic and rearranged evidence, for class 2 genes only genomic evidence and for class 
3 genes only rearranged evidence. 
e – VH and VL gene numbers according to the integrative database VBASE2. 
f – Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
g – The relative affinities were measured in a hapten inhibition test in comparison to IdOx1 
   IgM and IgG anti-phOx antibodies, respectively.  
k – IdOx1 genes VH171 and Vκ072 are marked in bold.  
- – Sequence not determined. 
MAba VH chain genes VL chain genes      rel.
iD1°7 Isb Famc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J Aff.g
01 µ 1 1 532 0/0 1 2 1 097 7/1 1 -
02 µ 1 1 532 1/0 3 23 1 171 0/0 2 0,05
03 µ 1 2 286 5/1 2 9A 1 108 1/0 2 -
04 µ 1 2 286 3/0 2 1 1 122 1/0 2 0,07
05 µ 2 1 171k 1/0 4 4/5 1 078 2/3 2 0,2
06 µ 2 1 171k 3/0 2 10 1 137 1/1 1 0,1
07 µ 2 1 171k 2/0 3 21 1 210 0/1 2 0,1
08 µ 5 1 131 0/1 1 1 1 122 1/0 2 0,05
09 µ 6 1 114 1/0 3 9A 1 108 0/0 2 0,06
10 µ - - - -/- - 8 1 195 6/3 5 0,07
11 µ - - - -/- - 21 1 064 2/0 4 -
12 γ 2 1 183 1/0 4 4/5 1 072k 1/0 5 -
13 γ 2 1 171k 0/1 4 1 1 115 0/0 2 4,1
14 γ 2 1 171k 1/1 3 4/5 1 154 0/0 5 5,7
15 γ 5 1 176 1/0 3 8 1 195 0/1 1 9,2
16 γ 5 1 139 0/0 4 4/5 1 050 0/0 2 0,8
17 γ 6 1 114 0/0 3 8 1 188 0/0 4 0,9
18 γ - - - -/- - 19/281 186 0/0 2 -
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Table 17 
Nucleotide sequences of HCDR3 of phOx-CSA-induced primary day 7 anti-phOx antibodies generated from ΔD-iD mice 
iD1°7   ----VHa----     -----------------------------DHb-----------------------  ----JHc----  RFd  
DH gene  TT TAT CGT AAT CAT AGT AGA AGC TAC  1 
01 μ TGT GCA AGA AGG GGT CGT AAT CAT AGT AGA AGC TAC GTA GGC GGG TAC TTC GAT GTC TGG 1 
02 μ  TGT GCA AGG ATT TAT CTG ATC   CCT TAC TGG  1 
08 μ  TGT GCA AGA CAG GGG CGT AAT CAT AGT AGA AGC TAC CCC TCA CTG GTA CTT CGA TGT CTG 1 
03 μ  TGT GCA AGT ATT AGT ACG GTA   GTC ATC TGG  nf 
04 μ  TGT GCA AGA TGG GGC AAC   GAC TAC TGG  nf 
05 μ  TGT GCC AGA GAT CGG GGG   GAC TAC TGG  nf 
06 μ  TGT TCC AGA GAT CGG GGG   GAC TAC TGG  nf 
07 μ TGT GCC AGA GAT CGG GGG   GCT TAC TGG  nf 
09 μ  TGT TCC AGG CGA GGG   ACT CAC TGG  nf 
14 γ  TGT GCC AGG TCT TAT CGT AAT CAT AGT AGA ACC   GCT TAC TGG  1 
15 γ  TGT GCA AGT AGC TTC TAC TAT GAT TAC GAT AAA TCG TTT   GCT TAC TGG  inv 
16 γ TGT GCA AGA      CC CGT AAT CAG ATA TTA CTA TGC TAT G   GAC TAC TGG  2 
17 γ  TGT ACC AGG  CC TCT TAT CGT AAG GGT TCA CTT T   GCT TAC TGG  2 
12 γ  TGT GCC AGA AAT TGG GGG   GAC TAC TGG  nf 
13 γ  TGT GCC AGA GAT CGA GGG   GAC TAC TGG  nf 
 
Legend 
a     –  VH-encoded base of HCDR3.    b   – DH nucleotides of the HCDR3-loop.    
c     –  JH-encoded base of HCDR3.    d   – Reading frame of DH gene.     
inv  – inverted.      nf – not found. 
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline sequence in ΔD-iD mice. 
Nucleotides marked in red are generated by N and P region insertions. 
Nucleotides marked in blue (4 or 5 successive nucleotides) correspond probably to DH germline sequence in ΔD-iD mice. 
DH germ line coding sequence of ΔD-iD is outlined in first line in green colour. 
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HCDR3 nucleotide sequences of early primary antibodies 
From 15 antibodies we obtained full sequences of VH regions (Tab. 17). In 3/9 of IgM and in 
1/6 IgG of the 15 VH sequences, HCDR3 were translated in RF1. In another IgG antibody 
(iD1°7-15), HCDR3 was in an inverted RF1. Only the 2 IgG antibodies iD1°7-16 and -17 
used RF2 in HCDR3. In the majority of the antibodies, i.e. 6 IgM and 2 IgG, the D regions the 
reading frames could not be assigned. 
Conclusions: 
• The bias against RF1 usage is not as pronounced as in ΔD-DμFS mice. RF2 is not really 
dominant and in most of the antibodies the reading frame could not be assigned.  
• Invariably, non-assignable reading frames code for shorter D-regions lengths. 
• B cells seem to escape the usage of charged HCDR3-loop in two mechanisms:  
- First, by shifting the RF, so that 2 antibodies (iD1°7-16 and 17) contain RF2-encoded 
DH segments and 1 antibody (iD1°7-15) contained DH sequence encoded by an in-
verted RF1 (i-RF1). 
- Second, by an enhanced loss of nucleotides at the termini of DH gene, so that 53 % of 
the HCDR3 intervals contained no germ line-encoded DH nucleotides.  
 
HCDR3 amino acids in early primary antibodies in ΔD-iD mice 
Three IgM antibodies (iD1°7-5, -06 and -07) and 1 IgG antibody (iD1°7-13), exhibiting germ 
line non-related readings frames in HCDR3, contained the DRG motive of wildtype IdOx1 
antibodies, but only one of them (iD1°7-13) reacted with our IdOx1–specific prototypic mono-
clonal anti-idiotype 8-21/W18. This is astonishing, since only antibody iD1°7-07 showed the 
complete IdOx1-typical sequence CAR-DRG-AYW (Tab. 18). However, the 3 IgM antibodies 
iD1°7-05, -06 and -07 contained the DRG motive and used the VHOx1 in combination with 
alternative light chain genes as the other VH171-encoded IgG antibodies. 
Conclusions: 
• This shows that the IdOx1 specificity relies not only on the DRG motive in the HCDR3 
loop, but is also influenced in its 3-dimensional structure by other parts of the complete 
molecule, i.e. including the L chain. 
• With the only exception of antibody iD1°7-02, short HCDR3-loops are only seen in 
antibodies in which the reading frame could not assigned.  
3 Results  80
Table 18 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced primary day 7 anti-
phOx antibodies generated from ΔD-iD mice 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a – VH-encoded base of HCDR3. 
b – Predicted amino acid sequence of the HCDR3 loop. 
c – JH-encoded base of HCDR3. 
d – Reading frame of DH gene.  
e – The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop  
[72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-iD mice. 
Amino acids marked in red are generated by N and P region insertions. 
nf – not found 
 
3.5.2.2  Analysis of late primary anti-phOx antibodies 
Clonal development in the late primary response 
After primary immunization of ΔD-iD mice with phOx-CSA, 20 anti-phOx antibody-secreting 
hybridomas could be established from the late primary response in 2 separate fusions on day 
14 (Tab. 19). As the most remarkable finding, the absolute majority of 19 antibodies were of 
the IgM and only 2 antibodies of the IgG class. This is in sharp contrast to BALB/c WT mice 
in which only IgG-secreting hybridomas can be generated at this late time point of the pri-
mary immune response. It is also striking that the IdOx1 variable genes were almost absent. 
The VHOx1 gene VH171 is found not at all in antibodies of both fusions, and VκOx1 is only 
found once in the IgM antibody iD1°14-11. Hence, as among the early primary antibodies, the 
iD1°7 Basea CDRH3-loopb Basec RFd He
01 μ CAR RGRNHSRSYVGGYF DVW 1 -0,27
02 μ CAR IYLI PYW 1 1,13
08 μ CAR QGRNHSRSYPSLVLRC LGR 1 -0,4
03 μ CAS ISSV VIW nf 0,78
04 μ CAR WGN DYW nf -0,37
05 μ CAR DRG DYW nf -0,76
06 μ CSR DRG DYW nf -0,76
07 μ CAR DRG AYW nf -0,76
09 μ CSR RG THW nf -0,64
14 γ CAR SYRNHSRT AYW 1 -0,63
15 γ CAS SFYYDYDKSF AYW 1inv -0,19
16 γ CAR PVIRYYYAM DYW 2 0,27
17 γ CTR PLIVRVHF AYW 2 0,6 
12 γ CAR NWG DYW nf -0,37
13 γ CAR DRG DYW nf -0,76
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IdOx1 is not expressed (Tab. 17). In addition, there is no other dominant VH/VL combination. 
The repertoire of these 20 late primary antibodies is with 15 VH and 14 VL genes extremely 
heterogeneous and every gene combination is unique. 
Conclusions: 
• As already observed in ΔD-DμFS mice, antibodies of the late primary response of ΔD-
iD mice revealed an impaired class switch recombination. 
• The genetic repertoire is quite heterogeneous. 
• There is no dominant VH/VL gene combination 
 
Mutations in late primary antibodies 
It is also surprising that the majority of H and L chains were not mutated. In fact, except the 3 
antibodies iD1°14-06, -09and -20, none of the VL genes showed any mutation. In addition, 5 
VH genes did not present any deviation from the germ line configuration. These data indicate 
that the late primary IgM-secreting activated B cells neither undergo class switch recombina-
tion nor do they show somatic mutation. 
Conclusion:  
• Hence, the restriction in ΔD-iD mice to a single DH gene coding for charged amino 
acids in HCDR3 drastically inhibits the early immune maturation through somatic 
mutation. 
 
HCDR3 nucleotide sequences of late primary antibodies 
The nucleotide sequences of the late primary anti-phOx antibodies from ΔD-iD mice are de-
picted in Tab. 20. In 11/18 IgM antibodies (61 %), the HCDR3 nucleotide sequences derived 
from the germ line DH gene and in another antibody (iD1°14-05), the germ line relation of 
the HCDR3 sequence was doubtful since only 5 successive nucleotides were identical with 
the germ line DH gene. A germ line related HCDR3 sequence is also observed in 1 IgG anti-
body, but not the other. 
As already observed in the early primary antibodies of ΔD-iD mice, RF1 was not decreased to 
such an extent as in ΔD-DμFS mice. In fact, 8/18 antibodies (~44 %) used RF1 in HCDR3, 2 
antibodies used RF2 and RF3, respectively, and in 6 antibodies (~33 %) the reading frame 
could not be assigned (Tab. 20). 
Conclusions: 
• The bias against RF1 usage is not as pronounced as in ΔD-DμFS mice. RF2 and RF3  
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are least frequently used and antibodies with germ line non-related HCDR3 sequences 
are rather common. 
• Non-assignable reading frames code for shorter D-regions lengths. 
 
Table 19 
VH/VL gene combinations of phOx-CSA-induced primary day 14 anti-phOx antibodies 
in ΔD-iD mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a  – The annotation of antibodies indicates their generation from ΔD-iD mice (iD), after 
    primary immunization (1°) on day 14 (14) and is followed by a sequential number. 
b  – Isotype of the monoclonal antibody. 
c  – Indication of VH or VL gene family in the VBASE2 integrative database. 
d  – In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
    genomic and rearranged evidence, for class 2 genes only genomic evidence and for class 
    3 genes only rearranged evidence. 
e  – VH and VL gene numbers according to the integrative database VBASE2. 
f  – Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
g  – The relative affinities were measured in a hapten inhibition test in comparison to IdOx1 
     IgM and IgG anti-phOx antibodies, respectively.  
h, i  – Indication of different fusions. 
k  – IdOx1 genes VH171 and Vκ072 are marked in bold. -  – Sequence not determined. 
 
MAba VH chain genes VL chain genes rel.
iD1°14 Isb Famc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J Aff.g
05h μ 1 1 706 0/0 2 4/5 1 142 0/0 2 -
02h μ 1 2 654 1/2 3 2 1 097 0/0 2 -
03h μ 1 2 499 0/0 3 19/28 1 198 0/0 1 -
04h μ 1 2 286 1/1 1 19/28 1 201 0/0 1 -
01h μ 1 3 014 0/0 1 10 1 137 0/0 1 -
06i μ 3 1 128 4/1 2 4/5 1 050 3/1 4 -
07h μ 3 1 128 1/0 1 10 1 137 0/0 4 -
08i μ 5 1 192 1/1 2 23 1 168 0/0 1 -
13h μ 5 1 185 1/1 2 4/5 1 082 0/0 5 -
12h μ 5 1 178 2/0 2 8 1 069 0/0 5 -
09i μ 5 1 147 0/0 2 38C 1 140 1/0 5 -
10i μ 5 1 135 0/0 1 23 1 168 0/0 4 -
11h μ 5 1 135 1/0 1 4/5 1 072k 0/0 5 -
14h μ 5 1 135 1/1 2 23 1 179 0/0 5 -
15i μ 6 1 114 2/2 3 1 1 115 0/0 1 -
16h μ 10 1 028 1/0 2 12/13 1 170 0/0 5 -
17i μ - - - -/- - 12/13 1 170 0/0 1 -
18h μ - - - -/- - 2 1 097 0/0 1 -
19h μ - - - -/- - 4/5 1 078 0/0 5 -
21h γ 1 1 528 8/0 3 - - - -/- - -
20i γ 1 2 455 3/1 3 1 1 115 1/1 1 -
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Table 20 
Nucleotide sequences of HCDR3 of phOx-CSA-induced primary day 14 anti-phOx antibodies generated from ΔD-iD mice 
 
iD1°14   ----VHa----     -----------------------------DHb----------------------- ----JHc----   RFd  
DH gene      TT TAT CGT AAT CAT AGT AGA AGC TAC  1 
01 μ TGT GCA AGA     CGA GAT CGT AAT CAT AGT AGA AGC TTC CTC TAC TGG TAC TTC  GAT GTC TGG 1 
03 μ TGT GCA AGA       T TAT CGT ACT CAT ATT TTA AGC TCC TGG TT  TGC TTA TGG 3 
04 μ TGT GCA AGA                 CAT CAT AGT AGA AGC TAC TGG TAC TTC  GAT GTC TGG 1 
06 μ TGT GCA AGG          GG CGT AAT CAT ACT ACT AGC TAG ATA CTT T GAC TAC TGG 2  
07 μ TGT GCA AGA     AAG GAT CGT AAT CAT AGT AGA AGG GAC TGG TAC TTC  GAT GTC TGG 1 
08 μ TGT GCA AGA CCT TTT TAT CGT AAT CAT AGG GGA TAC TTT GAC TAC TGG 1 
10 μ TGT GCA AGA     CAT CGG CGT AAT CAT AGT AGA AGA GAG ACT GAC TGG TAC TTC GAT GTC TGG 1 
11 μ TGT GCA AAT             CGT AAT CAT AGT AGA AGC TAC TGG TAC TTC  GAT GTC TGG 1 
12 μ TGT ACA AGA     GTA GCT TCT ACT ATG ATT ACG GTA AAG AGG GTC CTT  GAC TAC TGG   3inv 
13 μ TGT GCA AGG      TC AAT CGT AAT CAT AGT AGA AGC T  AAA CTA TGG 2  
14 μ TGT GCA AGA     CCA GGA CGT AAT CAT AGT AGA AGC TAC CCC TAC TTT  GAC TAC TGG 1 
02 μ TGT GCA AGA GGG GGG ATT CAT CGT AAA AAC CTG GTT  TGC TTA TGG nf 
05 μ TGT GCA AGA AGA GAT  GCC TAC TGG nf 
09 μ TGT GCA AGA CAC CCG CTA CGA CGC TAC TTT GAC TAC TGG nf 
15 μ TGT ACC AGG CCC GTC ATC CCA GAG GCC TGG TTT GCT TAC TGG nf 
16 μ TGT GTG AGA CAT GGG ACG TAC TCA TGG AGA  GGA CTA TGG nf 
20 γ TGT ACA AGA     TCA TGG GGG GAT CAT AGT AAA ACC TAC GGT TCC TGG TTT GCT TAC TGG 1 
21 γ TGT GCA AGA CGC TTT  GCT TAC TGG nf 
 
 
Legend 
a  – VH-encoded base of HCDR3. 
b  – DH nucleotides of the HCDR3-loop. 
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c  – JH-encoded base of HCDR3. 
d  – Reading frame of DH gene. 
inv  – inverted. 
nf  – not found. 
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline 
sequence in ΔD-iD mice. 
Nucleotides marked in red are generated by N and P region insertions. 
Nucleotides marked in blue (4 or 5 successive nucleotides) correspond probably to DH 
germline sequence in ΔD-iD mice. 
DH germ line coding sequence of ΔD-iD is outlined in first line in green colour. 
 
Table 21 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced primary day 14 anti-
phOx antibodies generated from ΔD-iD mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a – VH-encoded base of HCDR3. 
b – Predicted amino acid sequence of the HCDR3 loop. 
c – JH-encoded base of HCDR3. 
d – Reading frame of DH gene.  
e – The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop  
[72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-iD mice. 
Amino acids marked in red are generated by N and P region insertions. 
nf – not found 
iD1°14 Basea CDRH3-loopb Basec RFd He
01 μ CAR RDRNHSRSFLYWYF DVW 1 -0.29
03 μ CAR LSYSYFKLLV CLW 3 0.51 
04 μ CAR HHSRSYWYF DVW 1 -0.32
06 μ CAR GVIILLARYF DYW 2 0.81
07 μ CAR KDRNHSRRDWYF DVW 1 -0.69 
08 μ CAR    PFYRNHRGYF DYW 1 -0.32
10 μ CAR HRRNHSRRETDWYF DVW 1 -0.68
11 μ CAN RNHSRSYWYF DVW 1 -0.43
12 μ CTR VASTMITVKRVL DYW 3inv 0.57 
13 μ CAR SIVIIVEA KLW 2 1
14 μ CAR PGRNHSRSYPYF DYW 1 -0.41
02 μ CAR GGIHRKNLV CLW nf 0.05
05 μ CAR RD AYW nf -1.15
09 μ CAR HPLRRYF DYW nf -0.24
15 μ CTR PVIPEAWF AYW nf 0.41
16 μ CVR HGTYSWR GLW nf -0.39
20 γ CTR SWGDHSKTYGSWF AYW nf -0.21
21 γ CAR RF AYW nf -0.1
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HCDR3 amino acids in late primary antibodies in ΔD-iD mice 
As expected, the majority of these antibodies expressed mainly hydrophilic amino acids in 
HCDR3 so that the average hydrophatic score of the D loops became negative (hydropathy in-
dex lower than - 0.1; Tab. 21). In fact, all RF1 translated HCDR3 had the lowest hydropathic 
values and antibodies with positive scores were translated in RF2 and RF3 or the reading 
frame could not be assigned. In contrast to the early primary antibodies, HCDR3 sequences of 
all these antibodies showed no similarities to the typical D-loops of IdOx1 antibodies and also 
the middle DRG motive was not verified. This finding supports again the conclusion that the 
selection of phOx-repertoires at the different stages of the immune response is individually 
specific for every mouse.  
Conclusions: 
• In the late primary anti-phOx antibodies of ΔD-iD mice, hydrophilic amino acids are 
selectively expressed in HCDR3. 
• The divergence of the HCDR3 sequences from those of IdOx1 antibodies confirm find-
ings from the early response in this mouse strain. 
 
3.5.2.3 Analysis of secondary anti-phOx antibodies 
Although 4 fusions were performed after secondary immunization which all exhibited normal 
cell growth, we obtained only 2 anti-phOx antibody-secreting hybridomas from one fusion, 1 
IgM and the other an IgG antibody (Tab. 22). The IgM antibody iD2°-01 exhibited 1 silent 
and 3 productive mutations in VH as well as in VL. The IgG antibody iD2°-02 showed a high 
number of mutations in VH and half as many mutations in VL. Hence, it can be concluded 
that especially this IgG antibody had undergone immune maturation. This is also indicated by 
its substantially enhanced relative affinity in comparison to the IdOx1 IgG antibody NQ2/16.2 
(Tab. 22).  
While the HCDR3 nucleotide sequence of the IgG antibody was germ line-related, the reading 
frame of the IgM antibody could not be assigned (Tab. 23) and the deduced HCDR3 amino 
acid sequences were not related to those of IdOx1 antibodies (Tab. 24). 
Conclusions: 
• Although it is not possible to draw firm conclusion from only 2 secondary antibodies, it 
is again astonishing that an IgM antibody could be isolated 3 days after secondary 
immunization with the TD antigen phOx-CSA. 
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• Enhanced mutations and an increased affinity of the IgG antibody indicated that sec-
ondary antibodies in ΔD-iD mice are derived from an immune maturated repertoire.  
 
Table 22 
VH/VL gene combinations of phOx-CSA-induced secondary anti-phOx antibodies in 
ΔD-iD mice 
 
 
 
 
 
Legend 
a  – The annotation of antibodies indicates their generation from ΔD-iD mice (iD), after sec- 
    ondary immunization (2°) and is followed by a sequential number. All clones are generat- 
    ed from the same fusion. 
b  – Isotype of the monoclonal antibody. 
c  – Indication of VH or VL gene family in the VBASE2 integrative database. 
d  – In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
    genomic and rearranged evidence, for class 2 genes only genomic evidence and for class 
    3 genes only rearranged evidence. 
e  – VH and VL gene numbers according to the integrative database VBASE2. 
f  – Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
g  – The relative affinities were measured in a hapten inhibition test in comparison to IdOx1 
     IgM and IgG anti-phOx antibodies, respectively.  
 
Table 23 
Nucleotide sequences of HCDR3 of phOx-CSA-induced secondary anti-phOx antibodies  
 
iD2°  ----VHa--- --------------DHb------------------ ----JHc--- RFd  
DH gene           TT TAT CGT AAT CAT AGT AGA AGC TAC 
01 μ  TGT ACC AGG CGG GGC                            GAC TAC TGG nf 
02 γ  TGT GCA AGA    CTA CGT AAT CAT GGA             GAC TCT TGG 1 
 
Legend 
a  – VH-encoded base of HCDR3. 
b  – DH nucleotides of the HCDR3-loop. 
c  – JH-encoded base of HCDR3. 
d  – Reading frame of DH gene. 
inv  – inverted. 
nf  – not found. 
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline 
sequence in ΔD-iD mice. 
Nucleotides marked in red are generated by N and P region insertions. 
DH germ line coding sequence of ΔD-iD is outlined in first line in green colour. 
MAba VH chain genes VL chain genes rel.
iD2° Isb Famc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J Aff.g
01 μ 6 1 114 3/1 2 9A 1 108 3/1 5 0,5 
02 γ 1 3 386 13/4 2 9A 1 108 6/1 2 306,6
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Table 24 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced secondary anti-phOx 
antibodies generated from ΔD-iD mice 
 
 
 
 
 
Legend 
a  – VH-encoded base of HCDR3. 
b  – Predicted amino acid sequence of the HCDR3 loop. 
c  – JH-encoded base of HCDR3. 
d  – Reading frame of DH gene.  
e  – The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop  
  [72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-iD mice. 
Amino acids marked in red are generated by N and P region insertions. 
nf  – not found 
 
3.5.2.4 Analysis of tertiary anti-phOx antibodies 
Clonal development in the tertiary response 
Two months after the secondary immunization, mice were immunized once more with phOx-
CSA and hybridomas secreting anti-phOx antibodies were prepared by cell fusion 3 days lat-
er. From 2 fusions, we obtained 16 monoclonal antibodies (Tab. 25). In one fusion, we estab-
lished 9 phOx-specific hybridomas; seven of them were of the IgG class and two were IgM 
antibodies. From the other animal seven hybridomas were derived all of which produced IgM 
antibodies. The 3 IgM antibodies iD3°-02, -4 and -04 and IgG antibody iD3°-12 were encod-
ed by the VHOx1 gene VH171. While IgM antibody iD3°-3 and IgG antibody iD3°-12 show-
ed the canonical VHOx1/VκOx1 gene combination, characteristic for phOx-specific antibody, 
the 2 IgM antibodies iD3°-02 and -04 were encoded by alternative VL genes. Antibody iD3°-
09 was encoded by the VκOx1 gene Vκ072 in combination with an unknown VH gene. 
Conclusions: 
• In contrast to anti-phOx antibodies from earlier stages of TD immune responses, tertiary 
antibodies contained again VH171/Vκ072-encoded IdOx1 antibodies. 
• However, the IdOx1 clonotype was not dominant and there was no other dominant clone. 
iD2° Basea CDRH3-loopb Basec RFd He
01   μ CTR   RG DYW nf -0,64
02   γ CAR   LRNHG DSW 1     -0,36
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Table 25 
VH/VL gene combinations of phOx-CSA-induced tertiary anti-phOx Abs in ΔD-iD mice 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a  – The annotation of antibodies indicates their generation from ΔD-iD mice (iD), after 
     tertiary immunization (3°) and is followed by a sequential number. 
b  – Isotype of the monoclonal antibody. 
c  – Indication of VH or VL gene family in the VBASE2 integrative database. 
d  – In the integrative database VBASE2, the genes are classified: for class 1 genes there is 
     genomic and rearranged evidence, for class 2 genes only genomic evidence and for class 
     3 genes only rearranged evidence. 
e  – VH and VL gene numbers according to the integrative database VBASE2. 
f  – Productive (p) and silent (s) mutations of corresponding VH and VL chains. 
g  – The relative affinities were measured in a hapten inhibition test in comparison to IdOx1 
     IgM and IgG anti-phOx antibodies, respectively.  
h, i  – Indication of different fusions. 
k  – IdOx1 genes VH171 and Vκ072 are marked in bold.  
-  – Sequence not determined. 
Grey background shows the IdOx1 gene combination VH171/Vκ072. 
 
MAba VH chain genes VL chain genes rel.
iD3° Isb Famc Cld IGHVe p/sf J Famc Cld IGKVe p/sf J Aff.g
01h μ 2 1 201 0/0 2 4/5 1 050 0/0 5 -
02h μ 2 1 171k 1/0 2 9/10 1 137 0/0 2 0,3
03h μ 2 1 171k 0/0 3 4/5 1 072k 0/0 5 1,0
04h μ 2 1 171k 0/0 1 4/5 1 079 0/0 2 -
05i μ 5 1 192 1/0 4 4/5 1 157 0/0 5 0,03 
06i μ 5 1 148 -/- 4 38C 1 140 1/0 1 0,01
07h μ 5 1 147 0/1 4 10 1 137 0/0 1 -
08h μ 5 1 135 2/1 1 21 1 210 0/0 1 0,01
09h μ - - - -/- - 4/5 1 072k 0/0 2 -
10i γ 1 3 386 7/1 2 9A 1 108 0/1 2 3,8
11i γ 1 3 386 12/3 2 9A 1 108 -/- 2 2,8
12i γ 2 1 171k 5/3 3 4/5 1 072k 4/1 5 143,7
13i γ 3 1 120 -/- 2 23 1 168 8/2 1 13,9
14i γ 7 1 158 14/8 3 1 1 115 2/1 2 4,6
15i γ - - - -/- - 23 1 168 0/1 2 2,5
16i γ - - - -/- - VRF 1 128 4/3 1 4,6
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Table 26 
Nucleotide sequences of HCDR3 of phOx-CSA-induced tertiary anti-phOx Abs generated from ΔD-iD mice 
iD3° ----VHa---- -----------------------------DHb-----------------------  ----JHc----  RFd  
DH gene     TT TAT CGT AAT CAT AGT AGA AGC TAC   1 
01  μ TGT GCC AAA ATG GGT CGT AAT CAT AGT AGA AGC TAC TTT   GAC TAC TGG 1 
04  μ TGT GCC AGA                 GCG GGT AGA AGC TAC GGG TGG TAC TTC GAT GTC TGG  1 
07  μ TGT GCA AGA ATC AAT CGT AAT CAT AGT AGA AGC TAC CCG GGG TAC TTT   GAC TAC TGG  1 
08  μ TGT GCA AGT ATT TAT CGT AAT CAT AGT AGA AGT CAC TGG TAC TTC   GAT GTC TGG  1 
02  μ TGT GCC AGA GAT GGG GGG   GAC TAC TGG  nf 
03  μ TGT GCC AGA GAT GGA GGG   ATT TCC TGG  nf 
05  μ TGT GCA AGA TCC CGT TAC GAT TAC TAT GCT ATG   GAC TAC TGG  nf 
06  μ TGT GCA AGA CAT GGA GCT CCT TAT TAC TAC GGT AGT AGC TAC TAT GCT ATG  GAC TAC TGG  nf 
10  γ TGT GTA AGA AAG TTC CGA GGG GGT  GAC TAC TGG  nf 
11  γ TGT GTA AGA AAG TTC CGA GGG GGT   GAC TAC TGG  nf 
12  γ TGT GCC AGA GAT GGA GGT   GCT TTC TGG  nf 
13  γ TGT GTA AGA GGA GGG ACG GTA GTA GCT TTT   GAC TAC TGG  nf 
14  γ TGT GCA AGA GGG TTG TAC GAG GGA GCC TGG TTT   TCT TAT TGG  nf 
 
Legend 
a   – VH-encoded base of HCDR3.   b   – DH nucleotides of the HCDR3-loop.   
c   – JH-encoded base of HCDR3.   d   – Reading frame of DH gene.    
inv  – inverted.     nf – not found. 
Nucleotides marked in green (≥ 6 successive nucleotides) correspond to DH germline sequence in ΔD-iD mice. 
Nucleotides marked in red are generated by N and P region insertions. 
Nucleotides marked in blue (4 or 5 successive nucleotides) correspond probably to DH germline sequence in ΔD-iD mice. 
DH germ line coding sequence of ΔD-iD is outlined in first line in green colour. 
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Mutations in tertiary antibodies 
The tertiary IgM antibodies were either non- or almost non-mutated. In fact, VH genes of an-
tibodies iD3°-01, -03 and -04 and all VL genes, except antibody iD°3-6, did not present any 
deviation from the respective germ line genes. In contrast, the IgG antibodies showed high 
numbers of productive and few silent mutations (Tab. 25). The relative affinity of the IdOx1 
antibody iD3°-03 was identical to the control IdOx1 antibody H11.5 (μ, κ), while affinities of 
the non-IdOx1 antibodies was 10-100-times lower. In contrast, although IgG antibodies dis-
played many mutations the affinity of most of them remained comparably low. The relative 
affinities of antibodies iD3°-10, -11, -14, -15 and -16 were only slightly higher than that of 
the primary IgG IdOx1 antibody NQ2/16.2 (γ, κ). The affinity of antibody iD3°-13 was ~14-
times higher than that of NQ2/16.2 and only the IdOx1 antibody iD3°-12 exhibited an affinity 
comparable to those of BALB/c WT mice, i.e. about 150-times higher than primary IdOx1 anti-
body NQ2/16.2 (Tab. 25). The affinity maturation of antibody iD3°-12 can also be deduced 
from the fact that the VL-coding gene Vκ072 shows the well known classical affinity-enhanc-
ing early mutations H>N in position 33 and Y>F in position 35 (Fig. 2 in the appendix). 
However, the known mutation S>T in position 31 in VH171 gene of antibody iD3°-12 was 
not seen. 
Conclusions: 
• In the tertiary response of ΔD-iD mice, a high percentage of naïve, non-mutated and 
non-maturated IgM antibodies are obtained by cell fusion. 
• These IgM antibodies resemble antibodies from the primary response. 
• In individual ΔD-iD mice, the tertiary response may contain somatically mutated and 
affinity-maturated IdOx1 antibodies. 
 
HCDR3 nucleotide sequences of tertiary antibodies 
The HCDR3-coding nucleotide sequences of the tertiary anti-phOx antibodies are depicted in 
Tab. 26. As observed before, RF1-encoded sequences are not totally avoided, but verified in 4 
IgM antibodies. In the other 4 IgM and 5 IgG antibodies, the HCDR3 reading frames could 
not be assigned. RF2 and RF3 were not observed. Except in antibodies iD3°-02, -03 and -12, 
the lengths of the germ line non-related HCDR3 sequences were surprisingly long, especially 
in antibodies iD3°-13, -14 and -06. 
Conclusions: 
• Since the germ line DH gene segment of ΔD-iD mice codes for charged, i.e. hydrophilic 
amino acids, RF1 usage is suppressed, but not avoided.  
3 Results  91
• In a rather high proportion of antibodies, the HCDR3 reading frames could not be as-
signed. 
 
Table 27 
Predicted amino acid sequences of HCDR3 of phOx-CSA-induced tertiary anti-phOx 
antibodies generated from ΔD-iD mice 
 
 
 
 
 
 
 
 
 
 
 
 
Legend 
a  – VH-encoded base of HCDR3. 
b  – Predicted amino acid sequence of the HCDR3 loop. 
c  – JH-encoded base of HCDR3. 
d  – Reading frame of DH gene.  
e  – The average, normalized Kyte-Doolittle hydrophobicity of the HCDR3 loop  
  [72, 73]. 
Amino acids marked in green correspond to DH germline sequence in ΔD-iD mice. 
Amino acids marked in red are generated by N and P region insertions. 
nf  – not found 
 
HCDR3 amino acids in tertiary antibodies in ΔD-iD mice 
The deduced amino acids for HCDR3 of the tertiary antibodies are hydrophilic to such an ex-
tent that the average hydrophatic score for the D-loops are mostly negative (Tab. 27). Only in 
antibodies iD3°-13 and – 14 they are slightly positive. Hence, this result presents further 
evidence for a positive selection of hydrophilic HCDR3-loops. 
Three of the 4 antibodies encoded by the VHOx1 gene VH171 showed the IdOx1-related DH 
motive DGG, while in the fourth antibody (iD3°-04) the HCDR3 sequence show no such 
relation. Interestingly, in antibody iD3°-12 which show highest affinity, the entire CDR3-
loop, i.e. the VH-encoded base plus the HCDR3-loop plus the second base = CAR-DGG-
iD3° Basea CDRH3-loopb Basec RFd He
01 μ CAK   MGRNHSRSYF DYW 1 -0,31 
04 μ CAR       AGRSYGWYF DVW 1 -0,02
07 μ CAR   INRNHSRSYPGYF DYW 1 -0,29
08 μ CAS   IYRNHSRSHWYF DVW 1 -0,29
02 μ CAR   DGG DYW nf -0,31
03 μ CAR   DGG ISW nf -0,31
05  μ CAR   SRYDYYAM DYW nf -0,21
06  μ CAR   HGAPYYYGSSYYAM DYW nf -0,03 
10  γ CVR   KFRGG DYW nf -0,25
11  γ CVR   KFRGG DYW nf -0,25
12  γ CAR   DGG AFW nf -0,31
13  γ CVR   GGTVVAF DYW nf 0,72
14  γ CAR   GLYEGAWF SYW nf 0,24
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AFW, is most similar to the respective prototypic sequence of true IdOx1 antibodies (CAR-
DRG-AYW).  
Conclusions: 
• The expression of the original IdOx1 motive DRG or its modified forms DXG is rather 
independent of the available germ line DH segments. 
• Moreover, these findings confirm that this motive is completely associated with the 
VHOx1gene VH171. 
 
As general conclusions from the analysis of the thymus-dependent anti-phOx response in ΔD-
iD mice it can be stated: 
1.) As in ΔD-DµFS mice, the restriction of the number of DH gene segments to a non-natural 
D gene segment which encodes for charged amino acids in HCDR3, demonstrates the 
extraordinary variability at the third hypervariable region which is enzymatically created 
during VDJ-recombination by exonucleases and the insertion of non-templated (N) and 
palindromic (P) nucleotides. 
2.) The restriction of the number of DH gene segments to one artificial D gene, coding for 
charged amino acids, causes a substantial reduction of the antibody repertoire of these 
mice. 
3.) The canonical VH/VL gene combination VH171/Vκ072 together with IdOx1-typical amino 
acid sequence DRG in HCDR3 is extremely rarely verified and, if so, only in particular 
animals. 
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4 Discussion 
Adaptive immune responses are generated by B and T lymphocytes. Their ability to recognize 
a huge multitude of different molecular structures on antigens relies on a similarly huge reper-
toire of clonally distributed antigen receptors, BCR on B and TCR on T cells. The variable 
portions of antigen receptors of both lymphocyte populations are created by V(D)J recombi-
nation, pairing of immunoglobulin H and L chains in B cells and α and β or γ plus δ chains in 
T cells as well as imprecisions during the recombination process. These imprecisions are 
based on a) the action of exonucleases which delete variable numbers of nucleotides from the 
coding ends of the involved genes, b) addition of palindromic (P) nucleotides and c) random 
addition of non-template (N) nucleotides by the enzyme terminal deoxynucleotidyl transfer-
ase (TdT). Due to the fact that the diversity-enhancing DH genes are rather short mini-genes, 
the recombinatorial imprecisions create a huge non-genetic repertoire at the third hypervari-
able regions of the BCR (HCDR3) as well as the TCR (VβCDR3). In addition, the size of this 
repertoire depends on the possibility that the modified D genes can be translated in all 6 
reading frames. Together, these mechanisms enable the immune repertoire to recognize a 
seemingly unlimited universe of antigens. Imprecisions during V(D)J recombination can mo-
dify a particular DH gene to such an extent that it can not be deduced from the final nucleo-
tide sequence. Hence, since the HCDR3 is the most diverse component of antibodies and lies 
at the centre of antigen-binding site, it plays a significant role in the development of cellular 
and humoral immune responses. 
 
The relative contributions to the entire antibody pre-immune repertoire of the genomic reper-
toire of V(D)J genes on the one hand and the non-genetic generation of DH gene-associated 
variability on the other have only incompletely been studied. In a previous study [28], it has 
been demonstrated that mice with a single VH gene but complete DH and JH gene clusters are 
able to respond to a variety of quite different protein antigens like keyhole limpet hemocyanin 
(KLH), ovalbumin (OVA), hen egg-white lysozyme (HEL), cholera toxin B subunit (CTB) 
and haptens like 2,4-dinitrophenyl (DNP, coupled to KLH), phOx-conjugated CSA and 
phosphorylcholine (PC, coupled to KLH). It was observed that antibodies specific for these 
antigens differed only in HCDR3. Therefore, the authors concluded that the diversity at 
HCDR3 is decisive for determining the fine specificity of the antigen binding site while the 
genome-encoded CDR1 and 2 are much more cross-reactive. Thus, this model would argue 
that the high number of variable genes only supplies this underlying background reactivity 
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whereas the precise specificity for the epitope is provided by HCDR3. In the study by Xu and 
Davis [28], it was also observed that memory antibodies developed surprisingly high affinities 
through somatic mutations. 
 
The contribution of recombinatorial non-genetic imprecisions to the pre-immune repertoire of 
specific immune responses has so far only been investigated in TdT knock-out mice which, 
because of this genetic defect, lack N-region diversity [29, 85]. Therefore, HCDR3 loops of 
TdT- mice are shorter and less diverse than in WT mice. These mice harbor an immature rep-
ertoire [86] resembling that of fetal mice [85]. Nevertheless, with regard to efficiency as well 
as specificity, TdT- mice develop quasi normal immune responses [38]. Hence, it seems nec-
essary to reassess the general assumption that N-region diversity is required for an effective T 
and B cell repertoire. However, other results give better insights into the significance of TdT-
mediated junctional diversification. Since HCDR3 is of central importance for expression of 
idiotypic determinants [52] it is not surprising that particular idiotypes are lost in TdT- mice 
[87]. Moreover, HCDR3 sequences are important for binding of self antigens by autoantibod-
ies and autoreactive T cells. Accordingly, compared to wildtype control mice, TdT- mice 
showed lower serum concentrations of DNA-reactive autoantibodies and rheumatoid factor 
activity and had shorter HCDR3 with fewer arginines [88]. These lower autoantibody concen-
trations seem to be due to a lower incidence of polyreactivity and lower affinity of anti-DNA 
autoantibodies [89]. A physiological significance of this finding is indicated by the fact that, 
in an animal model, TdT deficiency reduces autoimmune nephritis and prolongs survival al-
though the concentrations of anti-DNA and anti-histone autoantibodies were similar as in WT 
control mice [90]. Hence, either the autoantibodies under consideration are not the indicative 
parameter or the protective effect of TdT deficiency seems to be mediated indirectly. In rela-
tion to the above mentioned findings by Mi and co-workers [87], idiotypic regulation and reg-
ulatory T cells may be considered as possible mechanistic pathways. 
 
The influence of DH gene restriction on the immune system has been investigated in different 
mutant strains (Tab. 28). The restriction to the single natural DH gene DFL16.1 in ΔD-DFL 
mice had no severe impact on several parameters of B cell development. Although the num-
ber of IgM+/IgD- pre-B cell in the bone marrow was decreased, numbers of mature IgM+/IgD+ 
B cells in bone marrow and spleen as well as of B1a, B1b and B2 in the peritoneum were as 
in WT mice [66]. In addition, the HCDR3 repertoire deduced from DFL16.1 was similar as in 
WT mice, but differed in HCDR3 sequences not related to DFL16.1. The total serum 
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immunoglobulin concentrations were slightly enhanced for IgM, IgG1 and 2a, but slightly 
decreased for IgG2b and similar for IgG3 and IgA (Tab. 28). Humoral IgG immune response 
to the two TD antigens NP-CGG and Tetanus toxoid (TT) were almost identical to wildtype 
control mice [66]. 
In contrast, DH mutant mice harbouring one of two artificial DH genes exhibited more severe 
alterations of B cell development. In one of these strains, ΔD-iD mice, the replacement of the 
central portion of DFL16.1 by the complete inverted coding sequence of DSP2.2. resulted in 
coding for charged amino acids in HCDR3 [67, 68]. In ΔD-DµFS mice, the reading frame of 
DFL16 was shifted by insertion of two thymidine nucleotides. In this way, the preferentially 
used RF1 leads to a predominant usage of hydrophobic amino acids in HCDR3 [74]. ΔD-iD 
and ΔD-DµFS mice showed an altered B cell development and reduced B cell numbers in 
bone marrow as well as in the spleen (Tab. 28). However, numbers of natural B cells in the 
peritoneum of ΔD-DµFS mice were identical to those of wildtype mice. Under specific patho-
gen-free (SPF) conditions, concentrations of total IgM and IgA in ΔD-iD and ΔD-DµFS were 
as in wildtype mice; however, all IgG subclasses were decreased in ΔD-iD, but alike in ΔD-
DµFS mice (Tab. 28) [68, 74]. In part, these findings contrast our own results. While the IgM 
concentration in sera of ΔD-DµFS mice was identical to wildtype mice, they were slightly 
lower in ΔD-iD mice (Fig. 13). Total IgG concentrations were reduced in both strains and not 
only in ΔD-iD as observed by Ippolito, Schelonka and co-workers [68, 74]. In their exper-
iments, the immune response to the TI-2 antigen dextran was impaired in both DH mutant 
strains, while the IgM response to the TD antigen tetanus toxin (TT) in ΔD-iD mice equalled 
that of WT mice and was even enhanced in ΔD-DµFS mice [74]. Compared to WT mice, IgG 
responses to NP-chicken serum gamma-globulin (CGG) was decreased in ΔD-iD, but un-
changed in ΔD-DµFS mice, while the anti-TT IgG response was impaired in both strains. The 
general overview, given in Tab. 28, reveals that ΔD-DFL mice with a single natural DH gene 
showed the least while ΔD-iD mice with an artificial DH gene the most severe deviations 
from BALB/c WT mice. 
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Table 28 
Comparison of the immune responses of 3 mutant mouse strains carrying different 
single DH gene segments relative to BALB/c wildtype mice 
 
    ΔD-DFL [66]  ΔD-iD [68]  ΔD-DµFS [74] 
  Total nucleated cells 
  Bone marrow           
  Spleen           
  Peritoneal cavity          
 
  B cells total 
  Bone marrow          
  Spleen           
  Peritoneal cavity         
  
  B cells mature 
  Bone marrow           
  Spleen                 n.d. 
 
  Total Ig 
  IgM           
  IgG1           
  IgG2a           
  IgG2b           
  IgG3           
  IgA           
 
  Anti-NP-CGG 
  IgG           
 
  Anti-TT 
  IgM           
  IgG           
  IgA          n.d. 
 
  Anti-Dex 
  IgM            
  IgG                  n.d. 
 
Legend 
The different indicated parameters were compared with those of BALB/c wildtype mice. 
Double arrows (       ) indicate no difference while green and red (    /    ) arrows symbolize  
 an increase and decrease, respectively. 
Total (CD19+) as well as mature (CD19+CD21loCD23hi) B cells were determined by FACS 
analysis. 
The humoral immune responses were measured by ELISA.  
Dex  -   dextran 
NP-CGG -   4-hydroxy-3-nitrophenylacety-chicken gamma globulin 
TT  -   Tetanus Toxin 
n.d  -   not determined 
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However, the quality of a particular immune response in the latter 2 mutant mouse strains has 
so far not been investigated at the level of single B cell clones. Therefore, the data presented 
herein describe for the first time the connection between clonal development during the TD 
immune response and a particular DH gene. 
 
4.1 B cell development in DH mutant mice 
How do these data relate to our observations? In both of our DH mutant strains, the total 
lymphocyte and B cell counts in the bone marrow were rather enhanced than decreased (Tab. 
3). In spleen, however, B cell numbers were clearly decreased as observed in the investiga-
tions by Schroeder and colleagues [66, 68, 74]. Hence, our data would indicate that simplify-
ing the genomic DH segments to a single gene, coding for hydrophobic HCDR3 amino acids 
in ΔD-DµFS or charged amino acids in ΔD-iD mice, does not influence the development of B 
cells in the antigen independent phase in the bone marrow and does not prevent an efficient 
V(D)J rearrangement, an assembling of H and L chain and the formation of pre-BCR in the 
bone marrow. Thus, the reduction of splenic B cells is most likely first induced in the periphe-
ry and does not reflect a lower influx of newly generated naïve B cells from the bone marrow. 
The progression from immature to mature naïve B cells is a critical phase in B cell develop-
ment. Mainly non-autoreactive immature B cells are allowed to move from the bone marrow 
towards the periphery, where they undergo a second round of selection against peripheral 
auto-antigens. Is it possible that this negative selection in the periphery which eliminates auto-
reactive and B cells with non-functional BCR is responsible for the reduced numbers of B 
cells in the periphery? 
 
As pointed out in the introduction, B and T cells mutually regulate the development of their 
repertoires [76, 77]. This finding is confirmed by the observation that spleens of B-cell defi-
cient mice show a three- to fivefold reduction in T cell numbers [78]. Other studies in B cell 
deficient mice proved that the function of B cells is not limited to antibody production, but are 
also required for efficient T cell responses [79, 80]. In line with these observations, T cell 
numbers in the spleen of ΔD-DµFS as well as ΔD-iD mice were drastically reduced (Tab. 3) 
although the genetic alteration in both strains of mice is restricted to Ig genes and does not 
affect the germ line repertoire of TCR. 
After selection in the thymus, thymic emigrants mature to naïve immunocompetent T cells in 
secondary lymphoid organs. In the spleen, T cells are located in the periarteriolar lymphoid 
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sheath (PALS), which also contains low numbers of plasma cells, macrophages, and inter-
digitating dendritic cells (DC) [91]. The PALS is surrounded by a region containing primary 
follicles, which are filled with B cells and macrophages. Naïve T cells become activated when 
they are exposed to antigen-MHC complexes presented by resident DCs or other antigen pre-
senting cells [92].  
 
On the other hand, studies in B cell-deficient mice generated by μ-chain gene disruption 
showed that B cells provide signals which promote T cell accumulation in the spleen and sup-
port the development of splenic T-zone stromal cells as well as the accumulation of DCs [80]. 
Ngo et al. [78] reported that the numbers of T cells in the spleen of B cell-deficient mice were 
reduced threefold in comparison with WT controls. Our study provides further evidence for 
the necessity of B cells in normal development of splenic T cells. Thus, it can be assumed that 
the decrease of T cell numbers in ΔD-DµFS and ΔD-iD mice results from an insufficient stim-
ulus by a reduced number of B cells, which emerged from a simplified DH gene repertoire. 
Furthermore, it has been documented that B cells can act as APC in the initiation of T cell 
maturation [93, 94]. Indeed, B cells are highly efficient for the presentation of their BCR-spe-
cific antigen in association with MHC molecules to mature TH cells, and can stimulate 
proliferation and differentiation of naïve T cells. Therefore the decrease in antigen presenta-
tion affects the T cell maturation. Together, reduced splenic T cells in ΔD-DµFS and ΔD-iD 
mice reflect insufficient chemokine-producing B cells and / or the impairment of antigen pre-
sentation by B cells or both. 
In contrast, the numbers of T and B cells in the bone marrow of mutant mice were similar to 
that of WT controls. In the bone marrow, the B cells include all stages of B cell development 
as well as memory and long lived plasma cells [95, 96]. Concerning the T cells, various stud-
ies showed that memory T cells (CD4+ and CD8+) migrate to the bone marrow of immunized 
mice and are sustained there over long periods of time [97-99]. Therefore our data suggest 
that the memory T cells are not affected by the alteration in the DH locus.  
 
4.2 Humoral immune responses in DH mutant mice 
The murine peripheral B cell pool consists of mature B cells and a small subset of three dif-
ferent cell types: long lived plasma cells, memory and B1 cells. Mature IgM+/IgD+ B cells are 
the main source of cells participating in the primary immune response. They differentiate into 
specific antibody-producing plasma cells and in case of TD antigens also into memory B cells 
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[100]. Our data show that the total population of splenic B cells, including MZ, B-1 and 
follicular B cells are reduced in ΔD-DµFS and ΔD-iD mice, but does this cause impaired 
humoral immune responses? For approaching an answer to this question, we first analyzed the 
initial situation and determined a) the total IgM and IgG serum concentrations, b) phOx-spe-
cific background antibodies and c) anti-phOx antibody-secreting cells before any immuniza-
tion, namely in non-immunized animals. 
As shown in Fig. 13, the concentrations of total IgM were rather similar in WT and ΔD-DµFS 
mice, but reduced in ΔD-iD mice. In contrast, IgG concentrations were significantly reduced 
in both DH mutant strains. Surprisingly, spleens of the DH mutant strains contained almost 
twice as many IgM-anti-phOx secreting cells than wildtype mice (Fig. 11). Also in the bone 
marrow, IgM-anti-phOx secreting cells were almost threefold higher in mutant as compared 
to wildtype control mice (Fig. 11). These natural IgM antibodies are known to be produced by 
B-1 cells without antigenic stimulation. Natural antibodies recognize antigens of many com-
mon pathogens and they are capable of self-renewal [101]. In addition to the protective func-
tion against pathogens, antibodies produced by B-1 cells play an important role in the clear-
ance of apoptotic cells. Moreover, B-1 and MZ B cells are proposed to provide protection 
during responses against bacterial TI-2 antigens [102, 103]. The B-1 cells predominantly re-
side in peritoneal and pleural cavities and only a small number is found in the spleen. Natural 
antibodies are mostly of the IgM class, they are auto- as well as poly-reactive, encoded by im-
munoglobulin V genes in germ line configuration, and they react with low affinity with a vari-
ety of endogenous and exogenous antigens [104]. Thus, B-1 cells and their natural antibodies 
represent part of the pre-immune repertoire. 
 
Own data have demonstrated that natural phOx-reactive antibodies do not participate in the 
TD phOx-CSA-induced response (Lange et al., in preparation). This view is supported by the 
observation that the enhanced amounts of background anti-phOx-secreting cells in spleen and 
bone marrow of DH mutant mice does neither correlate with the phOx-Ficoll-induced TI-2 
nor with the phOx-CSA-induced TD antibody response. The TD-induced IgM-anti-phOx 
serum concentrations measured 1 week after stimulation with phOx-CSA were slightly lower 
in both DH mutant mouse strains (Fig. 15). This is astonishing, since the number of IgM-anti-
phOx-secreting plasma cells in the spleen of DH mutant mice were much higher than in WT 
mice (Fig. 12A). This can only be explained by the assumption that the amount of Ig pro-
duced by a single antibody-forming cell (AFC), as indicated by the size of the ELI-spot, 
varies considerably especially for IgM-AFC (Fig. 10). The TD-induced IgG response was 
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strongly suppressed in correlation with reduced number of IgG-AFC (Fig. 15). Antibody 
production in both DH mutant mouse strains after stimulation with phOx-Ficoll, however, 
was almost identical for IgM and developed slightly faster IgG response in ΔD-DµFS mice, 
but was not significantly different in ΔD-iD and wildtype mice (Fig. 14).  
 
IgG antibodies are produced by short and long lived plasma cells. The short lived plasma 
cells, continuously generated from activated memory B cells after re-stimulation with the 
antigen, are responsible for an immediate increase of the IgG serum titer and have a lifespan 
of a few days. The long lived plasma cells are responsible for long-term production of serum 
antibodies. They can survive in the BM (95 %) or in the spleen (5 %) for extended periods of 
time, apparently from several months to years [105]. These long-lived plasma cells or their 
precursors are generated in germinal centres of secondary lymphoid organs like the spleen, 
and then migrate to the bone marrow, where they take up residence in a complex molecular 
microenvironment, a survival niche. Due to their antigen independent survival, they can main-
tain the humoral memory to previously encountered antigens without antigenic stimulation 
[106, 107]. However the switch from IgM to IgG occurs usually in the germinal centre and is 
driven by TH cell cytokines [108]. Thus, the low IgG concentration in our DH mutant mice 
probably reflects the reduction in the IgM>IgG switched plasma cells. A reduced number of 
phOx-specific IgG memory B cells can also be concluded from the observation that the differ-
ence in antibody production between WT on the one hand and DH mutant mice on the other 
remained after secondary renewed stimulation with phOx-CSA (Fig. 15). The data, however, 
do not give any information about the cellular components of the primary and further immune 
responses. It is important to remember that a substantial number of IgM-secreting hybridomas 
could be established at times of the TD immune response when in WT mice such IgM-pro-
ducers have never been seen, i.e. in the late primary, secondary and tertiary response (see 
below). Hence, the restriction of HCDR3 by using a single DH segment encoding for hydro-
phobic or charged amino acids severely impairs all stages of TD immune responses. In con-
trast, pre-immune sera and TI-2 responses seem to be not affected to a great extent.  
 
4.3 Comparison of anti-phOx repertoires in wildtype and DH mutant mice 
It was of interest to compare the repertoire of all anti-phOx antibodies generated in this study 
from DH mutant mice with that of BALB/c wildtype mice. Fortunately, the VH/VL gene 
combinations of almost 200 anti-phOx antibodies from WT mice were available (Lange et al., 
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in preparation). The repertoire of these antibodies represents a) natural antibodies, i.e. the 
hybridomas were obtained from non-immunized mice, b) antibodies obtained after immuniza-
tion with the TI-2 antigen phOx-Ficoll, c) anti-phOx antibodies received after primary to qua-
ternary immunizations with the TD antigen phOx-CSA and d) various combinations of initial 
TI-2 and following TD immunizations or vice versa. Altogether, this WT anti-phOx repertoire 
was encoded by 44 VH and 40 VL genes (Tab. 29). It is striking to see that IgM antibodies 
are distributed all over the table, whereas IgG antibodies are concentrated in certain areas of 
VH/VL combinations. Most of them are encoded by one of the IdOx1 genes VH171 or Vκ072. 
The highest proportion of IgG antibodies is encoded by the IdOx1 combination VH171/Vκ072. 
This demonstrates that most IgM-anti-phOx antibodies, activated during the early phases of 
primary TI-2 and TD responses, did not undergo class switch recombination. This is especial-
ly striking for IgM antibodies which are encoded by VH1 family genes. With the exception of 
four VH532/Vκ115-encoded antibodies, none of them switched to the IgG class. 
Hence, the question was as to whether the new anti-phOx antibodies obtained from DH mut-
ant mice were encoded within this panel of VH and VL genes. Therefore, we extended Tab. 
29 and included all anti-phOx antibodies from the 2 DH mutant strains (Tab. 30). In this table, 
the light colours represent antibodies from the early stages of the response whereas dark 
colours symbolized antibodies from the late stages. The darkest colours show antibodies from 
tertiary responses. To our surprise, these antibodies were encoded by 24 more VH and 12 
more VL genes. However, the new VH genes belonged to the same families already seen in 
WT mice. Most of the additional 24 VH genes (15 = 62 %) belonged to the VH1 family and 
the rest pertained to VH families 2, 3, 5, 6, 7, 9 and 14. The new VL genes belonged to fami-
lies 1, 4/5, 8, 9/10, 19/28, 21 and 23, already seen in wildtype mice, and to the new VL 
families 24/25 and 38C. In contrast to WT antibodies (Tab. 29), IgG antibodies of DH mutant 
mice were more evenly distributed over the whole table and a comparably high proportion of 
IgG antibodies were encoded by VH1 family genes (Tab. 30). From Tab. 30 it is already 
obvious that IdOx1 antibodies did not dominate any phase of the response, neither in ΔD-iD 
(Tab. 30, yellow to reddish colours) nor in ΔD-DµFS mice (Tab. 30, blue colours). 
Hence, in principle, anti-phOx antibodies from ΔD-iD and ΔD-DµFS DH mutant mice can 
make use of VH and VL genes already known from BALB/c WT mice. But in addition, a 
large fraction of them is encoded by V genes hitherto not observed in wildtype mice. Is it 
possible to explain this fact by a correlation between HCDR3 sequence and usage of VH/VL 
gene combinations? It is conceivable that antibodies encoded by `new´ VH or VL genes carry 
new sequences in HCDR3 or that these sequences exhibit new properties which require an as-
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sociation with new V genes to create a reactivity for the hapten phOx. However, the variabili-
ty at HCDR3 is so high that we so far could not find such an association 
 
4.4 D gene segments and homogeneity of immune responses 
Despite the potential to create an enormous antibody repertoire, certain mouse strains respond 
to the immunization with some haptens and simple antigens with a remarkably homogenous 
population of antibodies. For instance, such dominant clonotypes or idiotypes are observed in 
the response of BALB/c mice to phosphorylcholine (PC) [109], p-arzophenylarsonate [110], 
(4-hydroxy-3-nitrophenyl)acetyl (NP) [111] and phOx [69]. As already mentioned above, the 
early stage (day 7) of the primary TD anti-phOx response of BALB/c mice is characterized by 
the dominant Ox1 idiotype with the VHOx1/VκOx1 = VH171/Vκ072 gene combination. In 
addition, the IdOx1 specificity is correlated with the DRG sequence in the middle of HCDR3. 
The idiotypic characteristic is destroyed by somatic mutations during immune maturation and 
a repertoire shift is observed during the secondary response [112]. In clear contrast to these 
findings in WT mice, primary to tertiary anti-phOx antibodies from ΔD-DµFS and ΔD-iD 
mice did not contain the IdOx1 or any other dominant clonotype. Moreover, there was no in-
creased usage of the IdOx1 genes in combination with alternative VH or VL genes. The IdOx1-
typical DRG sequence in HCDR3 was only observed 3-times among early primary antibodies 
in ΔD-iD mice in the VH171 gene which, however, was associated with 3 different alternative 
VL genes (Fig. 18). Only in the tertiary response of a particular animal of ΔD-DµFS mice we 
obtained a major clonotype with the VH158/Vκ115 gene combination (Tab. 13).  
This combination has already been observed as major clonotype in the secondary response of 
BALB/c WT mice [46]. However, a comparison of HCDR3 sequences in Tab. 15 with those 
in [46] revealed that some antibodies showed rather similar sequences while others differed 
considerably and we could not detect a common motive. Thus, the genomic elimination of all 
but one DH gene, coding for hydrophobic or charged amino acids in HCDR3, does not allow 
the development of dominant clonotypes.  
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Table 29 
VH/VL gene combinations of natural and antigen-induced anti-phOx antibodies of BALB/c wildtype mice 
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Legend 
Sequences of variable region genes of heavy (VH) and light chains (VL) of anti-phOx hybrid-
oma antibodies from BALB/c wildtype mice were analyzed with the integrative database 
VBASE2. IgM antibodies are indicated by filled rectangles and IgG antibodies by ellipses. 
Large numbers indicate the sequential numbers of a particular group of antibodies and subscript 
numbers specify the amount of antibodies with a particular VH/VL combination. Antibodies 
were obtained in the following way 
       - natural antibodies from spleens of non-immunized mice 
       - primary antibodies after immunization with the TI-2 antigen phOx-Ficoll 
       - primary antibodies after immunization with the TD antigen phOx-CSA 
       - antibodies obtained after tertiary TD and a final TI-2 immunization 
       - antibodies obtained after quaternary TD immunization 
       - antibodies obtained after initial TI-2 immunization and a primary TD immunization 1
 month later and fusion on day 7 
       - antibodies were obtained after an initial TI-2 immunization and a primary TD 
 immunization 3 months later and fusion on day 7 
       - initial TI-2 immunization, 3 months pause, followed by a primary TD immunization and 
 fusion on day 14 
       - initial TI-2 immunization, 3 months pause, primary TD followed by a secondary TD 
 immunization 8 weeks later and fusion on day 3. 
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Tab. 30 
VH/VL gene combinations of thymus-dependent antigen-induced anti-phOx antibodies of DH mutant ΔD-DµFS and ΔD-iD mice 
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Legend 
Sequences of variable region genes of heavy (VH) and light chains (VL) of anti-phOx hybridoma antibodies from ΔD-DµFS and ΔD-iD mice were 
analyzed with the integrative database VBASE2 and compared with those of BALB/c wildtype mice. All wildtype antibodies of Tab. 29 are marked 
by a grey-dotted background. 
IgM antibodies are indicated by filled rectangles and IgG antibodies by ellipses in white rectangles. The number of antibodies encoded by a 
particular VH/VL gene combination is also indicated. All antibodies were obtained after immunization with the thymus-dependent antigen phOx-
CSA in the following way: 
ΔD-DµFS mice 
        -  primary immunization and fusion on day 7;         -  primary immunization and fusion on day 14; 
        -  secondary immunization, fusion on day 3;         -  tertiary immunization, fusion day3. 
ΔD-iD mice 
        -  primary immunization, fusion day 7;         -  primary immunization, fusion day 14; 
        -  secondary immunization, fusion day 3;         -  tertiary immunization, fusion day 3.  
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Hitherto, the dominance of particular clonotypic VH/VL gene combinations has been explain-
ed by their superior affinity. However, this argument does not seem to be really valid since we 
observed early primary clones of higher affinity than IdOx1 antibodies in BALB/c WT as well 
as in both DH mutant mice. In ΔD-DµFS mice, the affinity of 2 IgM non-IdOx1 clones was en-
hanced by factors of 5, in 2 IgG antibodies by a factor of 14 and 1 IgG even by a factor of 115 
(Tab. 4). In ΔD-iD mice, there were no early primary IgM non-IdOx1 with enhanced affinities, 
but those of 3 IgG were enhanced by factors of 4, 6 and 9, respectively (Tab. 16). Hence, if 
affinity is a decisive or the only factor for activation of reactive clones, it is difficult to under-
stand why such clones are not generally activated and become dominant clonotypes. More-
over, it has to be considered that the dominance of particular clones first becomes visible after 
class switch recombination to IgG (Lange et al., in preparation). Since this process is initiated 
and regulated by T cells and T cell-derived cytokines, it is tempting to speculate that the pre-
ferred selection of certain B cell clones over others is T cell-mediated and not only driven by 
affinity of the BCR. This view is in line with repertoire analyses after immunization with TI-2 
antigens. The primary repertoire of C57BL/6 mice induced with NP-coupled Ficoll, a TI-2 
carrier, is very heterogeneous while that of the TD response, induced with NP coupled to a 
protein as a TD carrier, is characterized by a dominant idiotype which is composed of a 
VH186.2 heavy chain in combination with a lambda-1 light chain [113]. Complementing 
investigations have demonstrated that C57BL/6 mice harbor B cells with much higher affinity 
than the dominant clonotype encoded by the VH186.2-lambda 1 gene combination [114]. 
Hence, why are those higher affinity clones not activated in the TD response and how can T 
cells perform such a clonotypic selection not depending on the BCR affinity? 
 
Physiological recognition of protein antigens (including idiotypes) by T cell antigen receptors 
requires a processing by antigen-presenting cells followed by the presentation of small pep-
tide fragments through MHC molecules on the surface of these cells. B cells are particularly 
efficient in presenting processed peptides since they can bind antigen specifically through 
their BCR. Therefore, antigen-specific B cells can stimulate T cells at antigen concentrations 
several orders of magnitude lower than those required for activation by nonspecific APC. B 
cells, however, do not only process BCR-bound antigen and present its fragments, but at the 
same time they present peptides of their intrinsic immunoglobulin H and L chains which can 
then be recognized by T cells (reviewed in [52]). Does this idiotypic MHC-restricted T-B 
interaction take place during TD antigen-induced immune responses? This is indeed the case 
as older investigations have shown. Antibody secretion by idiotype+ B memory cells requires 
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two signals: one is provided by "carrier"-specific and the other by idiotype-specific T helper 
cells. Both signals are required for optimal induction of idiotype+ B memory clones to secrete 
antibody [115]. From other studies it has also been concluded that a successful T-B coopera-
tion requires two types of T helper cells, one recognizing the antigen and the other recogniz-
ing the idiotype of the B cell [116-118]. Hence, T cell regulation is probably responsible for 
the dominance of IdOx1 antibodies and can not only be ascribed to their superior affinity. This 
allows concluding that a restricted DH gene repertoire causes a restricted T helper cell reper-
toire and in this way interferes with clonal progression during TD immune responses. The in-
volvement of idiotype-specific T cells in the clonal development during TD immune respons-
es has been proposed since a long time. It has been argued that a) idiotypic interaction / sup-
pression could be a way of dampening a dominating monoclonal response to favor the ob-
served mutation drift and repertoire shift in the maturation of the immune response [55], b) a 
very dominant negative selection may act against the idiotype of primary antibodies [119] and 
c) HCDR3-associated idiotypic suppression may function as a driving force for diversification 
and maturation of the antigen-induced immune response [120]. 
 
Our sequence analyses demonstrated that the IdOx1-specific VH/VL gene combination plus the 
HCDR3-typical middle DRG sequence is only very rarely produced in a few ΔD-DµFS and 
ΔD-iD mice. Since the T and the B cell system undergo a mutually selective expansion during 
early life, it is conceivable that our DH mutant mice with a drastically reduced HCDR3 reper-
toire fail to develop corresponding idiotype-specific T cells and that this failure reduces both 
repertoires equally. This reduced T cell repertoire causes also an impaired class switch recom-
bination, i.e. more than halve of the hybridomas of both mouse strains generated at different 
stages of immune responses (primary, secondary and tertiary) produce IgM antibodies. Iso-
type switching is promoted by cytokines in the immediate microenvironment of the activated 
B cells inside or outside the germinal centre [121]. These cytokines are usually derived from 
TH cells. Thus, the type of TH cells which secret a set of cytokines in the immediate micro-
environment of the activated B cells, determine which antibody isotype will be produced. 
Without intervention of the TH cells, the B cells `consider´ a TD as being TI antigen, and 
consequently, the majority of antibodies against this antigen will belong to the IgM isotype 
[122]. A similar scenario seems to happen in ΔD-DµFS and ΔD-iD mice. The low numbers of 
TH cells may produce too low amounts of cytokines to force isotype switching of all antigen-
specific B cells. Consequently, only part of the IgM-secreting activated B cells switch to IgG 
after primary injection of TD antigen, whereas the majority of the IgM activated B cells die 
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by apoptosis after elimination of the antigen. As a result, the primary antigen-specific IgG as 
well as the total IgG concentration is reduced in both mutant mice strains. Furthermore, since 
the memory B cells develop only from the switched IgG cells in germinal centres, a second 
injection with the same antigen activates only reduced numbers of the memory IgG and virgin 
IgM B cells. 
 
4.5 Selection of reading frames 
Despite its overwhelming variability, there are some limitations in HCDR3 which seem to be 
necessary for a proper function of the adaptive immune system [123]. In murine as well as in 
human sera, immunoglobulins with neutral or slight hydrophilic HCDR3 are dominant, while 
HCDR3 with hydrophobic as well as charged residues are infrequent in WT mice. In part, this 
bias is due to a preferred usage of DH reading frame 1 (RF1) which codes for neutral and 
hydrophilic amino acids [124]. As RF1 of all 13 BALB/c DH segments codes for neutral and 
hydrophilic amino acids, it is not astonishing that 90 % of murine rearranged antibodies use 
the DH segments in RF1 [125, 126]. Consequently certain amino acids like glycine and tyro-
sine are overutilized, whereas hydrophobic and charged residues like arginine and lysine are 
underrepresented. Hence, despite the high plasticity at HCDR3 by insertion or deletion of 
some nucleotides during VDJ recombination, usage of hydrophobic or charged amino acids is 
relatively rare. However, it has been observed that auto-antibodies reacting with double-
stranded DNA contain enhanced numbers of arginines in HCDR3 [127]. Such unusual re-
arrangements are not only observed in anti-DNA and but also in anti-nucleosome auto-anti-
bodies and include alternative DH reading frames, inverted D segments, and D-D fusions, all 
coding for hydrophobic and charged residues [128]. Hence, it could generally be concluded 
that antibodies with hydrophobic or charged HCDR3-loops show auto-reactivity [129]. In 
addition, the porcine respiratory and reproductive syndrome virus (PRRSV) causes auto-
immunity in neonatal piglets by inducing expansion of B cell clones bearing hydrophobic 
HCDR3s encoded by reading frame 3 of one particular DH segment [130]. On the other hand, 
the expression of auto-reactive BCRs can disrupt the development from immature to mature B 
cells and to promote receptor editing [131, 132]. 
 
In ΔD-DµFS mice, ½ to ²/3 of the antibodies use germline-encoded HCDR3 sequences, but 
only a minority of them is translated in RF1 and, as expected, this correlates with positive 
hydrophobicity scores (Tab. 6, 9, 12 and 15). Also in ΔD-iD mice, a significant number of B 
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cells express the germ line DH gene which, however, codes for charged HCDR3 amino acid 
sequences. Therefore, germline-encoded as well as germline non-related sequences, being 
translated in RF1 or non-RF1, are correlated with sometimes strongly negative hydrophobici-
ty scores in HCDR3 (Tab. 18, 21, 24 and 27). However, some of the anti-phOx antibodies in 
ΔD-iD mice exhibit even strong hydrophobic scores, like the early primary antibodies ID1°7-
02 (IgM) with a score of 1.13 and ID1°7-17 (IgG) with a score of 0.6 (Tab. 18), the late 
primary IgM antibody ID1°14-03 with a score of 0.51 (Tab. 21) and the tertiary IgG antibody 
ID3°-13 with a score of 0.72 (Tab. 27). Whether these B cells escaped negative selection in 
the periphery and exhibit, besides their anti-phOx reactivity, auto-reactivity remains a specu-
lation. The first step of negative selection of auto-reactive B cells is thought to occur at the 
stage of pre-B cells when they are confronted with auto-antigens present in the bone marrow. 
A second round of negative selection is initiated when mature B cells encounter peripheral 
auto-antigens not expressed in bone marrow. If a BCR binds to this auto-antigen with high 
affinity, the maturation will be abrogated and the B cell dies by apoptosis (clonal elimination). 
Hence, negative selection of hydrophobic and charged HCDR3 clones in the periphery 
explains, at least in part, the reduction of B splenocytes of ΔD-DµFS and ΔD-iD mice. 
 
It can be assumed that the germ line non-related HCDR3 nucleotide sequences of ΔD-DµFS 
and ΔD-iD antibodies result from the complete deletion of the whole germ line DH segment 
by exonucleases and a subsequent random addition of non-germ line (N) nucleotides inserted 
during VDJ joining processes. These N nucleotides are inserted by the terminal deoxynucleo-
tidyl transferase (TdT), a unique enzyme capable of adding from one to twenty nucleotides to 
rearranging V, D, and J termini of immunoglobulins as well as of TCR [133]. As TdT is not 
expressed in early ontogeny, fetal BCR and TCR repertoires lack N regions and, as a conse-
quence, perinatal HCDR3 are significantly less variable than those of adults, and the average 
length of HCDR3 increases with the development until adulthood [29, 39]. Hence, mice 
lacking TdT (TdT-) show a drastically reduced BCR and TCR repertoire. However, responses 
to TD and TI antigens are very similar in TdT- and control mice [38], suggesting that N 
regions might not be required for an effective T and B cell immune response. Our data sup-
port the assumption that N nucleotides may have a function other than a source of diversity. N 
region insertions promote, in some cases, the construction of germ line independent HCDR3, 
e.g. when the DH segment codes for unfavourable residues (hydrophobic or charged amino 
acids). However, because DH segments are evolutionary pre-selected for nucleotides coding 
for neutral amino acids, the construction of DH independent HCDR3 is rarely used and only 5 
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% of the antibodies in sera of wildtype mice contain HCDR3 motives unrelated to any DH 
segment.  
 
Table 31 
Genomic and non-genomic nucleotide sequences in HCDR3 of anti-phOx antibodies of 
DH mutant mice ΔD-DµFS and ΔD-iD 
 
            ΔD-DµFS              ΔD-iD 
  Ab Class    genomic   portion of  Class  genomic portion of 
    yes    no    non-genomic   yes no non-genomic 
  1°7 a)   IgM   7   6   46 %   IgM 3 6 66 % 
   IgG   11   7   39 %   IgG 4 2 33 % 
  1°14 b) IgM   4   4   50 %   IgM 11 5 31 % 
   IgG   5   2   29 %   IgG 1 1 50 % 
  2° c)   IgM   2   0   0 %   IgM 0 1 100 % 
   IgG   3   4   57 %   IgG 1 0 0 % 
  3° d)   IgM   6   4   40 %   IgM 4 4 50 % 
   IgG    16   6   27 %   IgG 0 5 100 % 
 
Legend 
a) Primary antibodies obtained in fusion 7 days after immunization. 
b) Primary antibodies obtained 14 days after immunization. 
c) Secondary antibodies. 
d) Tertiary antibodies. 
 
 
In both DH mutant strains, this picture is completely different. At all stages of the primary to 
the tertiary immune response in ΔD-DµFS and ΔD-iD mice, the proportion of antibodies 
exhibiting genome non-related HCDR3 sequences ranges from about 30 to 66 % (Tab. 31). 
This applies for IgM as well as IgG antibodies. In tertiary anti-phOx antibodies of ΔD-iD 
mice, even 100 % of IgG antibodies (n = 5) had HCDR3 nucleotide sequences showing no 
relationship to the genomic DH gene. As mentioned above, these sequences may be generated 
by an initial removal of the DH gene and a subsequent addition of N and P nucleotides. A 
second possibility may result from a direct V to J joining, likewise associated with insertion 
of N and P nucleotides. Such a direct joining of VH to JH genes has been observed in 
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BALB/c mice in vivo, but at low frequency [134]. In addition, the rare V-J joining event 
seems to be unlikely because of the genetic restriction during the recombination process (one 
and two-turn roll). Hence, usage of any germ line DH gene will automatically generate a 
neutral or hydrophilic HCDR3. In the case of ΔD-DµFS and ΔD-iD mice, the central nucleo-
tides of the single DH gene code for hydrophobic and charged amino acids, respectively. 
Thus, a direct V-J joining is also one way to escape unfavourable HCDR3 interval. 
 
4.6 Concluding remarks 
The data presented demonstrate that the reduction of normally 13 DH genes in BALB/c wild-
type mice to single artificial genes in ΔD- DµFS and ΔD-iD mutant mice has a severe impact 
on the humoral immune response to the hapten phOx. This is astonishing since both mutant 
strains harbor the full repertoire of hundreds of variable and all joining genes which are need-
ed for the generation of B cell antigen receptors. In addition, they have full access to create 
the vast repertoire of T cell antigen receptors. Is was striking to see that the reduction of DH 
genes impaired not only immunoglobulin-related parameters of the immune response, but also 
suppressed associated T cell functions. The overall T cell numbers were reduced, the TD re-
sponse was severely suppressed and T cell-mediated class switch recombination was impaired 
in all phases of immune maturation. As the switch- and T cell-dependent development of 
IdOx1 dominance was abrogated in both DH mutant strains and no other dominant clonotype 
developed, it can be concluded that idiotype dominance does not depend on canonical VH/VL 
gene combinations, but on certain HCDR3-related idiotopes. Moreover, this finding supports 
our earlier assumption that clonal selection during immune maturation is not only mediated 
by BCR-affinity but is also regulated by HCDR3-specific, i.e. idiotype-specific T cells. 
The analysis of HCDR3 sequences documented the extreme non-genetic variability at this re-
gion. In principle, HCDR3 sequences identical or similar to the IdOx1-specific sequence CAR-
DRG-AYW could be created in both DH mutant strains. However, this event was obviously 
so rare that it only occurred in a few individual mice. The extraordinary enzymatic activity of 
exonucleases during the V(D)J recombination process can be deduced from the finding that 
30-66 % of antibodies (in one case even 100 %) from all phases of immune maturation used 
HCDR3 sequences showing no relation to the respective germline DH genes. 
Future work is necessary to elucidate to precise mechanism of T cell-mediated regulation of 
the thymus-dependent immune response.  
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AA   Amino acid 
Ab   Antibody 
ABTS   2'-azinobis (3-ethylbenzthiazoline-6-sulfonic acid) 
AEC   3-Amino-9-Ethylcarbazol 
Ag   Antigen 
APC   Antigen presenting cell 
BCR   B-cell receptor 
bp   Base pair  
BSA   Bovine serum albumin 
cDNA    Complementary DNA 
CDR   Complementarily-determining region 
CSA   Chicken serum albumin 
DH   Diversity segment 
DNA    Deoxyribonucleic acid 
FITC    Fluoroisothiocyanate 
H   Heavy chain 
HRP   Horseradish peroxidise enzyme 
i.p    Intraperitoneal 
JH   Joining segment 
kDa    Kilo Dalton 
L   Light chain 
MHC   Major histocompatibility 
ORF    Open reading frame 
PBS    Phosphate- buffered saline 
PCR    Polymerase chain reaction 
phOx   2-phenyloxazolone  
RF   Reading frame 
TCR   T-cell receptor 
TD   Thymus-dependent 
TdT    Terminal deoxynucleotidyltransferase 
TH   T helper cells 
TI   Thymus-independent 
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UV    Ultraviolet 
V   Variable domain 
WT   Wildtype  
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Figure 1 
Amino acid sequences of VH/VL gene-encoded variable regions of TD antigen-induced anti-phOx antibodies in ΔD-DμFS mice  
(Legend see below) 
 
Amino acid sequences of TD antigen-induced primary day 7 antibodies of ΔD-DμFS mice 
 
 
IGHV673  QVQLQQSGPE LVKPGASVKI SCKASGSSFT SYYIHWVKQS PGQGLEWIGW IYPGSGNTKY NEKFKGKATL TADTSSSTAY MQLSSLTSED SAVYFCAR 
01H 673  ------P--- ---------- ---------- R---N----R -----+---- -F-----S-- ---------- +--------- -H-------E -------- 
01L 121  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV121  DIKMTQSPSS MYASLGERVT ITCKASQDIN SYLSWFQQKP GKSPKTLIYR ANRLVDGVPS RFSGSGSGQD YSLTISSLEY EDMGIYYCLQ YDEF 
 
 
 
IGHV671  EVQLQQSGTV LARPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGA IYPGNSDTSY NQKFKGKAKL TAVTSTSTAY MELSSLTNED SAVYYCTR 
02H 671  ---------- ------+--- -------S-- ---------- ----+---+- ---------- ---------- -----A---- ---------- -----+VI 
02L 139  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -----+---- -------- 
IGKV139  DIQMTQTTSS LSASLGDRVT ISCSASQGIS NYLNWYQQKP DGTVKLLIYY TSSLHSGVPS RFSGSGSGTD YSLTISNLEP EDIATYYCQQ YSKL 
 
 
 
IGHV627  QVQLQQSGPE LVKPGASVRI SCKASGYTFT SYYIHWVKQR PGQGLEWIGW IYPGNGNTKY NEKFKGKATL TADKSSSTAY MQLSSLTSED SAVYFCAR 
03H 627  ---------- +--T---LKM ---------+ G--------- ---------- ----D--S-- -------T-- -E----N--- -L-------- --I----+ 
03L 072  ---------- ---------- ---------- ----H----- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV627  QVQLQQSGPE LVKPGASVRI SCKASGYTFT SYYIHWVKQR PGQGLEWIGW IYPGNGNTKY NEKFKGKATL TADKSSSTAY MQLSSLTSED SAVYFCAR 
04H 627  ---------- ---------- ---------- ---------- ---------- -----V---- ---------- ---------- -------F-- F------- 
04L 139  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV139  DIQMTQTTSS LSASLGDRVT ISCSASQGIS NYLNWYQQKP DGTVKLLIYY TSSLHSGVPS RFSGSGSGTD YSLTISNLEP EDIATYYCQQ YSKL 
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IGHV532  QVQLQQSGAE LAKPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGY INPSTGYTEY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
05H 532  ---------- ---------- ---------- ---------- ---------- ---RI-NN-+ ---------- ---------- ---------- -------- 
05L 078  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV078  ENVLTQSPAI MSASPGEKVT MTCRASSSVS SSYLHWYQQK SGASPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSVE AEDAATYYCQ QYSGY 
 
 
 
IGHV506  EIQLQQSGPE LVKPGASVKV SCKASGYAFT SYNMYWVKQS HGKSLEWIGY IDPYNGGTSY NQKFKGKATL TIDKSSSTAY MHLNSLTSED SAVYYCAR 
06H 506  ----K-+--- -M-------I ------+S-- T-Y-H----- ---------- ---F----T- --+------- -V-------- ---S----A- -------S 
06L 121  ---------- ---------- ---------- ---------- ---------C ---------- ---------- ---------- ---------- -------- 
IGKV121  DIKMTQSPSS MYASLGERVT ITCKASQDIN SYLSWFQQKP GKSPKTLIYR ANRLVDGVPS RFSGSGSGQD YSLTISSLEY EDMGIYYCLQ YDEF 
 
 
 
IGHV396  EVQLQQSGPE LEKPGASVKI SCKASGYSFT GYNMNWVKQS NGKSLEWIGN IDPYYGGTSY NQKFKGKATL TVDKSSSTAY MQLKSLTSED SAVYYC 
07H 396  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------ 
07L 201  ---------- --I--R---- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------ 
IGKV201  DIVMTQSQKF MSTSVGDRVS VTCKASQNVG TNVAWYQQKP GQSPKALIYS ASYRYSGVPD RFTGSGSGTD FTLTISNVQS EDLAEYFCQQ YNSY 
 
 
 
IGHV386  QVQLQQSGAE LMKPGASVKI SCKATGYTFS SYWIEWVKQR PGHGLEWIGE ILPGSGSTNY NEKFKGKATF TADTSSNTAY MQLSSLTSED SAVYYC 
08H 386  -------+T- ---------- ---------N N-----I--- ---------- --------K- ---------- ---------- ---------- ------ 
08L 112  ---------- ---------- ---W------ ---------- ---------- ---------- ---------- ---------- ---------- --N--- 
IGKV112  DIQMTQSPSS LSASLGERVS LTCRASQDIG SSLNWLQQEP DGTIKRLIYA TSSLDSGVPK RFSGSRSGSD YSLTISSLES EDFVDYYCLQ YASS 
 
 
 
IGHV117  SQMQLQESGP GLVKPSQSLF LACSITGFPI TSGYYWIWIR QSPGKPLEWM GYITHSGETF YNPSLQSPIS ITRETSKNQF FLQLNSVTTE DTAMYYCAG 
10H 117  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
10L 121  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV121  DIKMTQSPSS MYASLGERVT ITCKASQDIN SYLSWFQQKP GKSPKTLIYR ANRLVDGVPS RFSGSGSGQD YSLTISSLEY EDMGIYYCLQ YDEF 
 
 
 
IGHV138  SDVQLQESGP DLVKPSQSLS LTCTVTGYSI TSGYSWHWIR QFPGNKLEWM GYIHYSGSTN YNPSLKSRIS ITRDTSKNQF FLQLNSVTTE DTATYYCAR 
11H 138  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
11L 163  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV163  ENVLTQSPAI MAASLGQKVT MTCSASSSVS SSYLHWYQQK SGASPKPLIH RTSNLASGVP ARFSGSGSGT SYSLTISSVE AEDDATYYCQ QWSGY 
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IGHV138  SDVQLQESGP DLVKPSQSLS LTCTVTGYSI TSGYSWHWIR QFPGNKLEWM GYIHYSGSTN YNPSLKSRIS ITRDTSKNQF FLQLNSVTTE DTATYYCAR 
12H 138  -------+-- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------L 
12L 175  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV175  DIVMTQSHKF MSTSVGDRVS ITCKASQDVG TAVAWYQQKP GQSPKLLIYW ASTRHTGVPD RFTGSGSGTD FTLTISNVQS EDLADYFCQQ YSSY 
 
IGHV120  SDVQLQESGP GLVKPSQSLS LTCSVTGYSI TSGYYWNWIR QFPGNKLEWM GYISYDGSNN YNPSLKNRIS ITRDTSKNQF FLKLNSVTTE DTATYYCAR 
14H 120  -------+-- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
14L 066  --M++---- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV066  DIVLTQSPAS LAVSLGQRAT ISCRASQSVS TSSYSYMHWY QQKPGQPPKL LIKYASNLES GVPARFSGSG SGTDFTLNIH PVEEEDTATY YCQHSWEI 
 
 
 
IGHV114  EVKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
15H 114  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------AG 
15L 106  ---------- ---------- ---------- ---------- ---------F ---------- ---------- ---------- ---------- ---------- 
IGKV106  DIKMTQSPSS MYASLGERVT ITCKASQDIK SYLSWYQQKP WKSPKTLIYY ATSLADGVPS RFSGSGSGQD YSLTISSLES DDTATYYCLQ HGES 
 
 
 
IGHV155  QIQLVQSGPE LKKPGETVKI SCKASGYTFT NYGMNWVKQA PGKGLKWMGW INTNTGEPTY AEEFKGRFAF SLETSASTAY LQINNLKNED TATYFCAR 
16H 155  ----E----- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
16L 122  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV122  DVVMTQTPLS LPVSLGDQAS ISCRSSQSLV HSNGNTYLHW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YFCSQSTHV 
 
 
 
IGHV690  EIQLQQTGPE LVKPGASVKI SCKASGYSFT DYIMLWVKQS HGKSLEWIGN INPYYGSTSY NQKFKGKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
19H 690  ---------- ---------- ---------- ---------- ---------- ---------- -L-------- -V--+----- ---N----D- -------S 
19L 210  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV210  DIVLTQSPAS LAVSLGQRAT ISCRASESVD NYGISFMNWF QQKPGQPPKL LIYAASNQGS GVPARFSGSG SGTDFSLNIH PMEEDDTAMY FCQQSKEV 
 
 
 
IGHV690  EIQLQQTGPE LVKPGASVKI SCKASGYSFT DYIMLWVKQS HGKSLEWIGN INPYYGSTSY NQKFKGKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
20H 690  ------S--- ---------- ---------- ---------- ---------- ---------- -L-------- -V--+----- ---N------ -------V- 
20L 123  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV123  DIVMTQAAFS NPVTLGTSAS ISCRSSKSLL HSNGITYLYW YLQKPGQSPQ LLIYQMSNLA SGVPDRFSSS GSGTDFTLRI SRVEAEDVGV YYCAQNLEL 
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IGHV643  EIQLQQSGPE LVKPGASVKI SCKASGYSFT GYIMHWMKQS HGKCLEWIGY ISCYIGATSY NQKFKGKAIF TVDKSSSTAY MQFNSLTFED SAVYYCAR 
21H 643  ------+--- +--T------ ---------- +-Y---V--- ---S------ ----N----- ----+---T- ---T------ -------S+- -------- 
21L 210  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV210  DIVLTQSPAS LAVSLGQRAT ISCRASESVD NYGISFMNWF QQKPGQPPKL LIYAASNQGS GVPARFSGSG SGTDFSLNIH PMEEDDTAMY FCQQSKEV 
 
IGHV532  QVQLQQSGAE LAKPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGY INPSTGYTEY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
22H 532  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------F-- F------N 
22L 077  ---------- ---------- ---------- ---------- -----R---- ---------- ---------- ---------- -----+---- -------- 
IGKV077  QIVLTQSPAI MSASPGEKVT ISCSASSSVS YMYWYQQKPG SSPKPWIYRT SNLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQY HSY 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
24H 171  -----Q---- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
24L 072  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV128  EVQLQESGPS LVKPSQTLSL TCSVTGDSIT SGYWNWIRKF PGNKLEYMGY ISYSGSTYYN PSLKSRISIT RDTSKNQYYL QLNSVTTEDT ATYYCAR 
26H 128  ------+--- ---------- ---------- ---------- ---------F -R---I---- ---------- ---------- ---------- ------- 
26L 143  ---------- -G-------- -S-------- --K------R -----R---- ---VF--H-+ -----C---L ---------- ---------- ------- 
IGKV143  EILLTQSPAI IAASPGEKVT ITCSASSSVS YMNWYQQKPG SSPKIWIYGI SNLASGVPAR FSGSGSGTSF SFTINSMEAE DVATYYCQQR SSY 
 
 
 
IGHV163  DVKLVESGGG LVKLGGSLKL SCAASGFTFS SYYMSWVRQT PEKRLELVAA INSNGGSTYY PDTVKGRFTI SRDNAKNTLY LQMSSLKSED TALYYCAR 
27H 163  ---------- ---+------ ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------S 
27L 072  ---------- ---------- ---------T --Q------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV163  DVKLVESGGG LVKLGGSLKL SCAASGFTFS SYYMSWVRQT PEKRLELVAA INSNGGSTYY PDTVKGRFTI SRDNAKNTLY LQMSSLKSED TALYYCAR 
28H 163  -------+-- ---------- ---------- ---------- -----+---- ---------- ---------- ---------- ---------G -------- 
28L 168  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---+------ ---------- --T----- 
IGKV168  DILLTQSPAI LSVSPGERVS FSCRASQSIG TSIHWYQQRT NGSPRLLIKY ASESISGIPS RFSGSGSGTD FTLSINSVES EDIADYYCQQ SNSW 
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IGHV139 DVQLVESGGG LVQPGGSRKL SCAASGFTFS SFGMHWVRQA PEKGLEWVAY ISSGSSTIYY ADTVKGRFTI SRDNPKNTLF LQMTSLRSED TAMYYCAR 
29H 139  ------F--- ---------- ---------- -------C-- ---------- ---------- ---------- ---------- ---------- --------- 
29L 099  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV099 DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL YSNGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCVQGTHF 
 
IGHV114 EVKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
30H 114  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------A- 
30L 115  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
 
IGHV158  EVKLVESGGG LVQPGGSLRL SCATSGFTFT DYYMSWVRQP PGKALEWLGF IRNKANGYTT EYSASVKGRF TISRDNSQSI LYLQMNTLRA EDSATYYCAR 
31H 158  ---------- ---------- ---------- ----N----- ---------- ---------- ---------- ---------- ---------- ---------- 
31 L210  ---------- ---F+----- ---------- ---------- ---------- ---------- ---------- F--------- ---------- ---------- 
IGKV210  DIVLTQSPAS LAVSLGQRAT ISCRASESVD NYGISFMNWF QQKPGQPPKL LIYAASNQGS GVPARFSGSG SGTDFSLNIH PMEEDDTAMY FCQQSKEV 
 
 
 
IGHV125  EVQLQQSGAE LVKPGASVKL SCTASGFNIK DTYMHWVKQR PEQGLEWIGR IDPANGNTKY DPKFQGKATI TADTSSNTAY LQLSSLTSED TAVYYCAR 
36H 125  ---------- ---------- ---------- ---------- ---------- ---------- ---------- -S-------- ---------- ------TS 
36L 172  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------T--- ---------- ---S---- 
 
33H 125  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------L 
33L 172  ---------- ---------- ---------- ---------- ---------- ------+--- -------++H ---+--T--- ---------- ---I---- 
IGKV172  DIQMTQSPAS LSASVGETVT ITCRASENIY SYLAWYQQKQ GKSPQLLVYN AKTLAEGVPS RFSGSGSGTQ FSLKINSLQP EDFGSYYCQH HYGT 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
09H 171  ----E----- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
 
 
 
IGHV128  EVQLQESGPS LVKPSQTLSL TCSVTGDSIT SGYWNWIRKF PGNKLEYMGY ISYSGSTYYN PSLKSRISIT RDTSKNQYYL QLNSVTTEDT ATYYCAR 
13H 128  ---+E----- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------+ 
25H 128  ------+--- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------+ 
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IGKV154  QIVLTQSPAI MSASLGERVT MTCTASSSVS SSYLHWYQQK PGSSPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSME AEDAATYYCH QYHRS 
17L 154  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----- 
 
 
 
IGKV121  DIKMTQSPSS MYASLGERVT ITCKASQDIN SYLSWFQQKP GKSPKTLIYR ANRLVDGVPS RFSGSGSGQD YSLTISSLEY EDMGIYYCLQ YDEF 
18L 121  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---- 
 
 
 
IGKV078  ENVLTQSPAI MSASPGEKVT MTCRASSSVS SSYLHWYQQK SGASPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSVE AEDAATYYCQ QYSGY 
23L 078  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----- 
 
 
 
IGHV125  EVQLQQSGAE LVKPGASVKL SCTASGFNIK DTYMHWVKQR PEQGLEWIGR IDPANGNTKY DPKFQGKATI TADTSSNTAY LQLSSLTSED TAVYYCAR 
32H 125  ---------- ---------- ---------- ---I------ ---------- ---------- ---------- ---------- --F------- ------VP 
 
 
 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
34L 072  ---------- ---------- ---------- ----H----- ---------- ---------- ---------- ---------- ---------- --- 
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IGHV569  QVQLQQSGAE LMKPGSSVKL SCKATGYTFT GYWIEWVKQR PGHGLEWIGE ILPGSGSTNY NEKFKGKATF TADTSSNTAY MQLSSLTSED SAVYYCAR 
01H 569  ---------- ---------- ---------S S--------- ---------- ---------- ---------- ---------- ---------- -------- 
01L 077  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV077  QIVLTQSPAI MSASPGEKVT ISCSASSSVS YMYWYQQKPG SSPKPWIYRT SNLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQY HSY 
 
 
 
IGHV532  QVQLQQSGAE LAKPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGY INPSTGYTEY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
02H 532  ---------- ---------- -N-------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
02L 097  ---------- ---------T ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV097  DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL DSDGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCWQGTHF 
 
 
 
IGHV495  QVQLQQSGAE LARPGASVKM SCKASGYTFT SYWMQWVKQR PGQGLEWIGA IYPGDGDTRY TQKFKGRATL TADKSSSTAY MQLSSLTSED SAVYYCAT 
03H 495  ---------- ---------- ---------- ---------- ---------- ---------- ----T-K--- --N------- ------A--- -------R 
03L 166  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV166  ENVLTQSPAI MSASLGEKVT MSCRASSSVN YMYWYQQKSD ASPKLWIYYT SNLAPGVPAR FSGSGSGNSY SLTISSMEGE DAATYYCQQF TSS 
 
 
 
IGHV286  EFQLQQSGPE LVKPGASVKM SCKASGYTFT SYVMHWVKQK PGQGLEWIGY IYPYNDGTKY NEKFKGKATL TSDKSSSTAY MELSSLTSED SAVYYCAR 
04H 286  ---------- ---------- ---------- ---------- ---------- -N-------- ---------- ---------- ---------- -------- 
04L 166  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV166  ENVLTQSPAI MSASLGEKVT MSCRASSSVN YMYWYQQKSD ASPKLWIYYT SNLAPGVPAR FSGSGSGNSY SLTISSMEGE DAATYYCQQF TSS 
 
 
 
IGHV073  QVQLQQSGAE LVKTGASVKM SCKASGYTFT SYTMHWVKQR PGQGLEWIGY INPSSGYTNY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
05H 073  ---------- ---------- ---------- ---------- ---------- ---------- ----M----M -------S-- ----I-+--- -------- 
05L 129  ---------- ---------- ---------- ---N------ -----Q---- ---------- ---------- ---S------ ---------- -------- 
IGKV129  DIQMNQSPSS LSASLGDTIT ITCHASQNIN VWLSWYQQKP GNIPKLLIYK ASNLHTGVPS RFSGSGSGTG FTLTISSLQP EDIATYYCQQ GQSY 
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IGHV147  EVMLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLRSED TAMYYCAR 
06H 147  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
06L 179  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV179  DIVMTQSPAT LSVTPGDRVS LSCRASQSIS DYLHWYQQKS HESPRLLIKY ASQSISGIPS RFSGSGSGSD FTLSINSVEP EDVGVYYCQN GHSF 
 
 
 
IGHV155  QIQLVQSGPE LKKPGETVKI SCKASGYTFT NYGMNWVKQA PGKGLKWMGW INTNTGEPTY AEEFKGRFAF SLETSASTAY LQINNLKNED TATYFCAR 
07H 155  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
07L 082  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV082  QIVLTQSPAI MSASPGEKVT ITCSASSSVS YMHWFQQKPG TSPKLWIYST SNLASGVPAR FSGSGSGTSY SLTISRMEAE DAATYYCQQR SSY 
 
 
 
IGHV118  QIQLVQSGPE LKKPGETVRI SCKASGYTFT TAGMQWVQKM PGKGLKWIGW INTHSGVPKY AEDFKGRFAF SLETSASTAY LQISNLKNED TATYFCAR 
08H 118  ---------- ---------- ---------- ---------- ---------- -----V-+-- +---M----- -------S-- ---TF-I--- +-+---+-- 
08L 097  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV097  DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL DSDGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCWQGTHF 
 
 
 
IGHV480  EVQLQQSGPE LVKPGASVKI SCKASGYSFT GYYMHWVKQS HVKSLEWIGR INPYNGATSY NQNFKDKASL TVDKSSSTAY MELHSLTSED SAVYYCAR 
10H 480  ---------- ---------- ---------- ---------- ---------- -I-----AT- ---------- ---------- ---------- --------- 
10L 115  ---------- ---------- --------+- ----Y----- ---------- ---N------ ---------- ---------- ---------- --------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
11H 171  ---------- ---------- -----+---S ------L+-- -----Q---- ---------- -----+V--- ---------- --T-+----- ------- 
11L 142  ---------- ---------- ---------- ----N-F--- ---------- ---------- L-----+--- ---------- ---------H --N---- 
IGKV142  EIVLTQSPTT MAASPGEKIT ITCSASSSIS SNYLHWYQQK PGFSPKLLIY RTSNLASGVP ARFSGSGSGT SYSLTIGTME AEDVATYYCQ QGSSI 
 
 
 
IGHV139 DVQLVESGGG LVQPGGSRKL SCAASGFTFS SFGMHWVRQA PEKGLEWVAY ISSGSSTIYY ADTVKGRFTI SRDNPKNTLF LQMTSLRSED TAMYYCAR 
13H 139  XXXXXXXXXX XXXXXXXXX- ---------- ---------- ---------+ ---------- ---------- ---------- ---------- -------K 
13L 103  ---------- ---------- ---------- ---------- --I------- ---------- ---------- ---------- ---------- -------- 
IGKV103  DIQMTQSPSS LSASLGERVS LTCRASQDIH GYLNLFQQKP GETIKHLIYE TSNLDSGVPK RFSGSRSGSD YSLIIGSLES EDFADYYCLQ YASS 
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IGHV168  VKLVESGGG LVQPGGSLRL SCATSGFTFS DFYMEWVRQP PGKRLEWIAA SRNKANDYTT EYSASVKGRF IVSRDTSQSI LYLQMNALRA EDTAIYYCAR 
14H 168  ---------- ---------- -----+---- ---IG----- ---------- -----I---- D--------- S--------- ---------- --------S- 
14L 115  -------T-- ---------- ---+T----- ---------- -----R---- ---------- ---------- ---------- ---------I ---------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
 
IGHV125  EVQLQQSGAE LVKPGASVKL SCTASGFNIK DTYMHWVKQR PEQGLEWIGR IDPANGNTKY DPKFQGKATI TADTSSNTAY LQLSSLTSED TAVYYCAR 
16H 125  ---------- ---------- --------F- ---------- ---------- -----DI--- ---------- ---------- ---------- -------- 
16L 172  ---------- ---------- ---------- ---------- ---------- ----V----- ---------- ---------- ---------- --S----- 
IGKV172  DIQMTQSPAS LSASVGETVT ITCRASENIY SYLAWYQQKQ GKSPQLLVYN AKTLAEGVPS RFSGSGSGTQ FSLKINSLQP EDFGSYYCQH HYGT 
 
 
 
IGKV166  ENVLTQSPAI MSASLGEKVT MSCRASSSVN YMYWYQQKSD ASPKLWIYYT SNLAPGVPAR FSGSGSGNSY SLTISSMEGE DAATYYCQQF TSS 
09L 166  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --- 
 
 
 
IGHV192  EVQLVESGGD LVKPGGSLKL SCAASGFTFS SYGMSWVRQT PDKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLKSED TAMYYCAR 
12H 192  ---------- ---------- ---------- ---------- ---------- ------+--- L--------- ---------- --------+- -------- 
 
 
 
IGHV158  EVKLVESGGG LVQPGGSLRL SCATSGFTFT DYYMSWVRQP PGKALEWLGF IRNKANGYTT EYSASVKGRF TISRDNSQSI LYLQMNTLRA EDSATYYCAR 
15H 158  ---------- ---------- ---------+ ---------- --E------S ------A--R ---------- ---------- --V------- ------+--- 
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IGHV623  EIQLQQSGPE LVKPGASVKM SCKASGYTFT DYYMHWVKQS HGKSLEWIRR VNPNNGGTSY NQKFKDKATL TVEKSSITAY MELRSLTSED SAVYYCAR 
01H 623  ---------- ---------- -----+-S-- G--------- --------G- ---------- -----G--I+ --D-+-S--- ---+------ -+------- 
01L 115  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
05H 171  ----E----- ---------- ---------- R--------- ---------- -----T---- ---------- ---------- ---------- ------- 
05L 072  -------T-- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------C--- ------- 
 
06H 171  ----E----- ---------- ---------- N--------- ---------- --T--I---- ---------R ---------- ------A--- ------- 
06L 072   ---------- ---------- ---------- -IN-F----- ---------- --------P- ---------- ---------- ------C--- -T----- 
 
07H 171  ---------- ---------- ---------- T-AI------ ---------- --T------- ---------- --+--+---- -----R---- ------- 
07L 072  ---------- ---------- --------+N --N-F----- ---------- ---------- --------F- -----+---- ------C--- ------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
08H 171  ---------- ---------- ---------- +--------- ---------- +--------- -+---+---- --+------- --+------- ------- 
08L 137  ---------- ---------- ---------- -----F---- -------+-- -----++--- ---------N ------D--- ---------- ------- 
IGKV137  DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV162  QVQLKESGPD LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLVV IWSDGSTTYN SALKSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
09H 162  ---------- ---------- ------L+-- T---N-G-+- --------+- -----I---S –L+---+--R R-----+--- ------S--- --------- 
09L 115  ---------- ---------- ---------- ---------- ++-----F-+ ---------- ---------- ---------- T--A------ --------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
 
IGHV158 EVKLVESGGG LVQPGGSLRL SCATSGFTFT DYYMSWVRQP PGKALEWLGF IRNKANGYTT EYSASVKGRF TISRDNSQSI LYLQMNTLRA EDSATYYCAR 
10H 158  ----E----- ---+------ ---------- ----T----- -----+--A- -K-R-YA--- D--T------ ---------- ---+----+- ---------+ 
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10L 115  ---------- -------+-- -------N-- ---------- ---------- ---------- ---------- ---------- T--------- ---------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
IGHV125  EVQLQQSGAE LVKPGASVKL SCTASGFNIK DTYMHWVKQR PEQGLEWIGR IDPANGNTKY DPKFQGKATI TADTSSNTAY LQLSSLTSED TAVYYCAR 
11H 125  ---------- ---S------ ---------- ----N--+-- ---------- ---------- ---------- ---------- ---------- ------V- 
11L 137  ---------- ---------- ---------Y ---------- ---------- --T------- ----R----N ---------- -------C-- -------- 
IGKV137  DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV591  QAYLQQSGAE LVRSGASVKM SCKASGYTFT SYNMHWVKQT PGQGLEWIGY IYPGNGGTNY NQKFKGKATL TADTSSSTAY MQISSLTSED SAVYFCAR 
02H 591  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
 
 
 
IGKV097  DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL DSDGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCWQGTHF 
03L 097  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
 
 
 
IGKV121  DIKMTQSPSS MYASLGERVT ITCKASQDIN SYLSWFQQKP GKSPKTLIYR ANRLVDGVPS RFSGSGSGQD YSLTISSLEY EDMGIYYCLQ YDEF 
04L 121  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---- 
 
 
 
IGKV202  DIVMTQSQKF MSTSVGDRVS ITCKASQNVR TAVAWYQQKP GQSPKALIYL ASNRHTGVPD RFTGSGSGTD FTLTISNVQS EDLADYFCLQ HWNY 
12L 202  -------P-- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---- 
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IGHV627  QVQLQQSGPE LVKPGASVRI SCKASGYTFT SYYIHWVKQR PGQGLEWIGW IYPGNGNTKY NEKFKGKATL TADKSSSTAY MQLSSLTSED SAVYFCAR 
01H 627  ---------- ---------- ---------- ---------- ---------- -----V---- ---------- ---------- ---------- -------S- 
01L 096  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV096  DIVMTQAAPS VPVTPGESVS ISCRSSKSLL HSNGNTYLYW FLQRPGQSPQ LLIYRMSNLA SGVPDRFSGS GSGTAFTLRI SRVEAEDVGV YYCMQHLEY 
 
 
 
IGHV286  EFQLQQSGPE LVKPGASVKM SCKASGYTFT SYVMHWVKQK PGQGLEWIGY IYPYNDGTKY NEKFKGKATL TSDKSSSTAY MELSSLTSED SAVYYCAR 
03H 286  ---------- ---------- ---------- ---------- ---------- -N-------- ---------- ---------- ---------- -------- 
03L 112  ---------- ---------- ---------- ---H------ ---------- ---------- ---------- ---------- ---------- -------- 
IGKV112  DIQMTQSPSS LSASLGERVS LTCRASQDIG SSLNWLQQEP DGTIKRLIYA TSSLDSGVPK RFSGSRSGSD YSLTISSLES EDFVDYYCLQ YASS 
 
 
 
IGHV171  QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
04H 171  ---------- ---------- ---------- ---------- ---------- ---------- ---------- --+------- ---------- ------- 
04L 137  ---------- ---------- ---------- -----F---- ---------- ----Q----- ---------- ---------- --A------- ------- 
IGKV137 DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV178  DVKLVESGGG LVKPGGSLKL SCAASGFTFS SYTMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLKSED TAMYYCTR 
05H 178  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------IT 
05L 210  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV210  DIVLTQSPAS LAVSLGQRAT ISCRASESVD NYGISFMNWF QQKPGQPPKL LIYAASNQGS GVPARFSGSG SGTDFSLNIH PMEEDDTAMY FCQQSKEV 
 
 
 
IGHV176  EVKLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAS ISSGGSTYYP DSVKGRFTIS RDNARNILYL QMSSLRSEDT AMYYCAR 
06H 176  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
06L 195  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV195  DIVMTQSPSS LAMSVGQKVT MSCKSSQSLL NSSNQKNYLA WYQQKPGQSP KLLVYFASTR ESGVPDRFIG SGSGTDFTLT ISSVQAEDLA DYFCQQHYS 
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IGHV139  DVQLVESGGG LVQPGGSRKL SCAASGFTFS SFGMHWVRQA PEKGLEWVAY ISSGSSTIYY ADTVKGRFTI SRDNPKNTLF LQMTSLRSED TAMYYCAR 
07H 139  ---------- ---------- ---------- ---------- ---------- ---------- V--------- ---------- ---------- -------- 
07L 072  ---------- ---------- -----R---N --N-F----- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV158  EVKLVESGGG LVQPGGSLRL SCATSGFTFT DYYMSWVRQP PGKALEWLGF IRNKANGYTT EYSASVKGRF TISRDNSQSI LYLQMNTLRA EDSATYYCAR 
10H 158  ---------- ---------- --V------- Y--------- ---------- -K-E----A- D-----R-+- -L------G- --------S- ---------- 
10L 115  ---------- ---------- ---------- ---------- ---------- -----+---- ---------- +--------- N-------+- ---------- 
 
24H 158  ---------- --------T- -----+---- ---------- ---------- VK-R------ D--------- ---------F ---------T --G------- 
24L 115  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
 
25H 158  ---------- ---------- ---+------ ---------- ---G------ -K-R----S- DS-V------ -V------G- ---------- ---------- 
25L 115 ---------- ---------- ---------- ---------- ---R-----+ ---------- ---------- ---------- ---------- ---------- 
 
26H 158  ---------- --------K- ---------- -+-------- ------C-AS ---------- ++------+- ---------- ---------V ------+--- 
26L 115  ---------- ---------- ----+T---- -RS------- ---------- ----R----- ---------- ---------- ---------- ---------- 
 
27H 158  ---------- ---------- ---------- -+-------- --------A- -+DRTS---- D-----R--- -----D---- ---------T ------F--- 
27L 115  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
 
28H 158  ---------- ---------- ---------- -+-------- --------A- -+DRTS---- D-----R--- -----D---- ---------T ------F--- 
28L 115  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
 
29H 158  ---------- --------K- ---------- -+-------- --------A- -+DRTS---- D-----R--- -----D---- ---------T ------F--- 
29L 115  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
 
30H 158  ---------- ---------- ---------- ---------- -+----S-V- --------R- ---------- --------G- ---------- ---------- 
30L 115  ---------- ---------- ---------- ---------- ---------- ---+-----V ---------- ---------- ---------- ---------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
 
IGHV139  DVQLVESGGG LVQPGGSRKL SCAASGFTFS SFGMHWVRQA PEKGLEWVAY ISSGSSTIYY ADTVKGRFTI SRDNPKNTLF LQMTSLRSED TAMYYCAR 
08H 139  ---------- ---------- ---------I ---------- ---------- ---------- V--------- ---------- ---------- --------- 
08L 231  ---------- ---------T --------T+ ---------- -+-------- ----Q----+ ---------- ----D----- ---------I --------- 
IGKV231  DVVMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRL SGVPDRFSGS GSGTXFTLKI SRVEAEDLGV YYCFQGSHV 
7 Appendix  137 
 
IGHV114  EVKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
09H 114  ---------- ---------- --------+- S---S----- ---------- -----D---- --------K- ---------R L-----S--- ---+----+G 
09L 099  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV099  DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL YSNGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCVQGTHF 
 
 
 
IGHV627  QVQLQQSGPE LVKPGASVRI SCKASGYTFT SYYIHWVKQR PGQGLEWIGW IYPGNGNTKY NEKFKGKATL TADKSSSTAY MQLSSLTSED SAVYFCAR 
13H 627  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------+ 
13L 103  ---------- ---------- ---------- ---------S -----Q---- ---------- --------T- S--------- ---------- DG------ 
IGKV103  DIQMTQSPSS LSASLGERVS LTCRASQDIH GYLNLFQQKP GETIKHLIYE TSNLDSGVPK RFSGSRSGSD YSLIIGSLES EDFADYYCLQ YASS 
 
 
 
IGHV627  QVQLQQSGPE LVKPGASVRI SCKASGYTFT SYYIHWVKQR PGQGLEWIGW IYPGNGNTKY NEKFKGKATL TADKSSSTAY MQLSSLTSED SAVYFCAR 
14H 627  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------+ 
14L 174  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV174  DIQMTQSPAS LSASVGETVT ITCRASGNIH NYLAWYQQKQ GKSPQLLVYN AKTLADGVPS RFSGSGSGTQ YSLKINSLQP EDFGSYYCQH FWST 
 
 
 
IGHV175  QVQLKESGPG LVAPSQSLSI TCTVSGFSLS RYSVHWVRQP PGKGLEWLGM IWGGGSTDYN SALKSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
15H 175  ---------- ---------- -----+---- -NN------- ---------- ---------- -------I-- ---------- ---------- ------- 
15L 072  ---------- ---------- ---------- -IQ-F----- ---------- ---------- ---------- ----G----- ---------- N-Y---- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV073  QVQLQQSGAE LVKTGASVKM SCKASGYTFT SYTMHWVKQR PGQGLEWIGY INPSSGYTNY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
16H 073  ---------- ---------- ---------- T-+------- -----+---- ---------- ----N----- I--------- ---------- -------- 
16L 078  ---------- ---------- ---------- -T-------- ---------- -+-------- T--------- ---------- ---------- -------- 
IGKV078  ENVLTQSPAI MSASPGEKVT MTCRASSSVS SSYLHWYQQK SGASPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSVE AEDAATYYCQ QYSGY 
 
 
 
IGHV171  QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
18H 171  ---------- ---------- --------VI ---+--I--- ---------+ -P--+----- -------T-T -----N---- ----+----- ------- 
18L 072  ---------- ---------- ---------- ---------- ---------- --------T- ---------- ---------- ---------- ------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
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IGHV171  QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
19H 171  ---------- ---------- ---------- +H-------- -----Q---- ---S-N---- W------R-- --------L- ---------- -V++--- 
19L 137  ---------- ---------- ---------- --+--F---- --------K- ---+------ ---------- --------+- ---------- -K----- 
IGKV137 DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV138  SDVQLQESGP DLVKPSQSLS LTCTVTGYSI TSGYSWHWIR QFPGNKLEWM GYIHYSGSTN YNPSLKSRIS ITRDTSKNQF FLQLNSVTTE DTATYYCARF 
20H 138  ---------- ---------- ---------- ----G----- ---------- ---YF---SS F--------- ---------- --------A-- --------- 
20L 123  ---------- ---------- ---------- ---------- ---------- --V------- ---------- --------K- ---------- ---------- 
IGKV123  DIVMTQAAFS NPVTLGTSAS ISCRSSKSLL HSNGITYLYW YLQKPGQSPQ LLIYQMSNLA SGVPDRFSSS GSGTDFTLRI SRVEAEDVGV YYCAQNLEL 
 
 
 
IGHV139  DVQLVESGGG LVQPGGSRKL SCAASGFTFS SFGMHWVRQA PEKGLEWVAY ISSGSSTIYY ADTVKGRFTI SRDNPKNTLF LQMTSLRSED TAMYYCAR 
21H 139  ---------- ---------- ---------- ------I--- ---------- -----N---- ---------- ---------- ---------- ---F+--- 
21L 072  ---------- ---------- ---------- --N-F----- +--------- ---S------ ---------- -------+T- ---------- -G------ 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV114  EVKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
22H 114  ---------- ---------- ---------- ---------- ---------- -----S--+- ---------- ---------- -------F-- --------+T 
22L 108  ---------- ---------- ---------- -H---F---- ---------- --+------- ---------- --+------- ----A----- ---------- 
 
23H 114  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---R------ --------+T 
23L 108  ---------- ---------- ---------- -----F---- ---------- --+------- ----G----- ---------- ---------- ---------- 
IGKV108  DIQMTQSPSS LSASLGERVS LTCRASQEIS GYLSWLQQKP DGTIKRLIYA ASTLDSGVPK RFSGSRSGSD YSLTISSLES EDFADYYCLQ YASY 
 
 
 
IGHV125  EVQLQQSGAE LVKPGASVKL SCTASGFNIK DTYMHWVKQR PEQGLEWIGR IDPANGNTKY DPKFQGKATI TADTSSNTAY LQLSSLTSED TAVYYCAR 
31H 125  ---------- ---------- ---------+ --Q---L--- ---------- -NS------- ---------- -T-I------ ---------- -S-----S 
31L 129  ---------- ---------- ---------- ---N-F---- -----+---- ---------- ---------- ---------- +--------- -------- 
 
32H 125  ---------- ---------- ---------+ --Q---L--- ---------- -NS------- ---------- -T-I------ ---------- -S-----S 
32L 129  ---------- ---------- ---------- ---N-F---- ---------- ---------- ---------- ---------- +--------- -------- 
IGKV129  DIQMNQSPSS LSASLGDTIT ITCHASQNIN VWLSWYQQKP GNIPKLLIYK ASNLHTGVPS RFSGSGSGTG FTLTISSLQP EDIATYYCQQ GQSY 
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IGHV125  EVQLQQSGAE LVKPGASVKL SCTASGFNIK DTYMHWVKQR PEQGLEWIGR IDPANGNTKY DPKFQGKATI TADTSSNTAY LQLSSLTSED TAVYYCAR 
33H 125  ---------- ---------- ---------- Y--------- ---------- ------Y--- ---------- ------S--- ---------- -------- 
33L 172  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --+----- 
IGKV172  DIQMTQSPAS LSASVGETVT ITCRASENIY SYLAWYQQKQ GKSPQLLVYN AKTLAEGVPS RFSGSGSGTQ FSLKINSLQP EDFGSYYCQH HYGT 
 
 
IGHV663  EVKLVESGGG LVQPGGSLRL SCATSEFTFT DYYMSWVRQP PGKALEWLGF IRNKANGYTT EYSASVKGRF TISRDNSQSI LYLQMNTLRA EDSATYYCAR 
36H 663  ---------- ---------- ---------- ---------- -+----S-V- --------R- ---------- --------G- ---------- ---------- 
36L 115  ---------- ---------- ---------- ---------- ---------- ---+-----V ---------- ---------- TK-------- ---------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
IGHV495  QVQLQQSGAE LARPGASVKM SCKASGYTFT SYWMQWVKQR PGQGLEWIGA IYPGDGDTRY TQKFKGRATL TADKSSSTAY MQLSSLTSED SAVYYCAT 
02H 495  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------A--- -------R 
 
 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
12L 115  ---------- ---------- ---------- ---------- ---------- -------+-- ---------- ---------- ---------- --------- 
 
 
IGKV078  ENVLTQSPAI MSASPGEKVT MTCRASSSVS SSYLHWYQQK SGASPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSVE AEDAATYYCQ QYSGY 
34L 078  ---------- ---------- ---------- ---------- --D---V--- ---------- ---------- ---------- ---------- ----- 
 
 
IGKV137 DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
11L 137 ---------- ---------- ---------- -----F---- ---------- ----Q----- ---------- ---------- --A------- ---- 
35L 137  ---------- ---------- ---------- --+--F---- --------K- ---+------ ---------- --------+- ---------- -K-- 
 
 
Legend for Figure 1 
Antibodies are specified by numbers (01, 02, etc.) and the chains are indicated by H or L followed by the coding gene, according to the integrative data 
base VBASE2. The deduced amino acid sequences of antibody V genes are compared with the respective germline VH (IGVH, full sequence shown 
above a group of Ab) and VL sequence (IGKV, full sequence shown below a group of Ab). A dash indicates identity with the respective germline-
encoded amino acid, productive mutations are indicated by the new aa in the one-letter code and silent mutations are indicated by a (+). 
Mutations correlate with affinity enhancement are showed in grey background. 
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Figure 2 
Amino acid sequences of VH/VL gene-encoded variable regions of TD antigen-induced anti-phOx antibodies in ΔD-ID mice   
(Legend see below) 
 
Amino acid sequences of TD antigen-induced primary day 7 antibodies of ΔD-ID mice 
 
IGHV532  QVQLQQSGAE LAKPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGY INPSTGYTEY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
01H 532  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
01L 097  ---------- ---------- ---------- ---------C +--------- ----PGT--- ---L-WL--- ---------- ---------- --------- 
IGKV097  DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL DSDGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCWQGTHF 
 
 
 
IGHV532  QVQLQQSGAE LAKPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGY INPSTGYTEY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
02H 532  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------+ 
02L 171  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV171  DIVLTQSPAT LSVTPGDRVS LSCRASQSIS NYLHWYQQKS HESPRLLIKY ASQSISGIPS RFSGSGSGTD FTLSINSVET EDFGMYFCQQ SNSW 
 
 
 
IGHV286  EFQLQQSGPE LVKPGASVKM SCKASGYTFT SYVMHWVKQK PGQGLEWIGY IYPYNDGTKY NEKFKGKATL TSDKSSSTAY MELSSLTSED SAVYYCAR 
03H 286  ---------- ---------- ---------- ---------- ---------- -N-----P-- ---------- S-------+- ---------- Y------S- 
03L 195  ---------- ---------- -N-------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV195  DIVMTQSPSS LAMSVGQKVT MSCKSSQSLL NSSNQKNYLA WYQQKPGQSP KLLVYFASTR ESGVPDRFIG SGSGTDFTLT ISSVQAEDLA DYFCQQHYS 
 
 
 
IGHV286  EFQLQQSGPE LVKPGASVKM SCKASGYTFT SYVMHWVKQK PGQGLEWIGY IYPYNDGTKY NEKFKGKATL TSDKSSSTAY MELSSLTSED SAVYYCAR 
04H 286  ---------- ---------- ---------- ---------- ---------- ---------S ---L------ -L-------- ---------- --------- 
04L 122  ------S--- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV122  DVVMTQTPLS LPVSLGDQAS ISCRSSQSLV HSNGNTYLHW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YFCSQSTHV 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
05H 171  ---------- ---------- ---------- -------C-- ---------- ---------- ---------- ---------- ---------- ------- 
05L 078  ---------- ---------- --------+- --F---F--- ---------- ---------- ---------- -----++--- ---------- ------- 
IGKV078  ENVLTQSPAI MSASPGEKVT MTCRASSSVS SSYLHWYQQK SGASPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSVE AEDAATYYCQ QYSGY 
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IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
06H 171  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------K--- ---------- S----S- 
06L 137  ---------- ---------- ---------+ ---------- ---------- ----Q----- ---------- ---------- ---------- ------- 
IGKV137 DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
07H 171  ---------- ---------- ---------- ---------- ---------+ ---------- ---------- -------+-- ---------- -------- 
07L 210  ---------- ---------- ---------- ---------- ---------- ---------- ----+----- ---------- ---------- -------- 
IGKV210  DIVLTQSPAS LAVSLGQRAT ISCRASESVD NYGISFMNWF QQKPGQPPKL LIYAASNQGS GVPARFSGSG SGTDFSLNIH PMEEDDTAMY FCQQSKEV 
 
 
 
IGHV131  EVKLVESGGG LVKPGGSLKL SCAASGFAFS SYDMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNARNTLY LQMSSLRSED TALYYCAR 
08H 131  -------+-- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
08L 122   ------S--- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV122  DVVMTQTPLS LPVSLGDQAS ISCRSSQSLV HSNGNTYLHW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YFCSQSTHV 
 
 
 
IGHV114  EVKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
09H 114  ---------- ---------- ---------- ---------- ---------- ---------- ---------- P--------- ---------- ---------- 
09L 108  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV108  DIQMTQSPSS LSASLGERVS LTCRASQEIS GYLSWLQQKP DGTIKRLIYA ASTLDSGVPK RFSGSRSGSD YSLTISSLES EDFADYYCLQ YASY 
 
 
 
IGHV183  QVQLKQSGPG LVQPSQSLSI TCTVSGFSLT SYGVHWVRQS PGKGLEWLGV IWSGGSTDYN AAFISRLSIS KDNSKSQVFF KMNSLQANDT AIYYCAR 
12H 183  ---------- ---------- ---------- ---------- ---------L ---------- ---------- ---------- ---------- ------- 
12L 072  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------H-- ------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
13H 171  ------+--- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
13L 115  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
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IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
14H 171  ---------- ---------- ---------- ---------- ---------- ---R------ ---------- ---------- ---------- ------+ 
14L 154  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
IGKV154  QIVLTQSPAI MSASLGERVT MTCTASSSVS SSYLHWYQQK PGSSPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSME AEDAATYYCH QYHRS 
 
 
 
IGHV176  EVKLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAS ISSGGSTYYP DSVKGRFTIS RDNARNILYL QMSSLRSEDT AMYYCAR 
15H 176  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------S-- 
15L 195  ---------- ---------- ---------- ---------- ---------- --+------- ---------- ---------- ---------- --------- 
IGKV195  DIVMTQSPSS LAMSVGQKVT MSCKSSQSLL NSSNQKNYLA WYQQKPGQSP KLLVYFASTR ESGVPDRFIG SGSGTDFTLT ISSVQAEDLA DYFCQQHYS 
 
 
 
IGHV139 DVQLVESGGG LVQPGGSRKL SCAASGFTFS SFGMHWVRQA PEKGLEWVAY ISSGSSTIYY ADTVKGRFTI SRDNPKNTLF LQMTSLRSED TAMYYCAR 
16H 139  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
16L 050  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV050  QIVLSQSPAI LSASPGEKVT MTCRASSSVS YMHWYQQKPG SSPKPWIYAT SNLASGVPAR FSGSGSGTSY SLTISRVEAE DAATYYCQQW SSN 
 
 
 
IGHV114  EVKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
17H 114  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
17L 188  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV188  DIVMTQSPSS LTVTAGEKVT MSCKSSQSLL NSGNQKNYLT WYQQKPGQPP KLLIYWASTR ESGVPDRFTG SGSGTDFTLT ISSVQAEDLA VYYCQNDYSY 
 
 
 
IGKV195  DIVMTQSPSS LAMSVGQKVT MSCKSSQSLL NSSNQKNYLA WYQQKPGQSP KLLVYFASTR ESGVPDRFIG SGSGTDFTLT ISSVQAEDLA DYFCQQHYS 
10L 195  ---------- -V-------- -N-------- ---------- --------F- --+------- -F-----+-- --F-----F- ---------- --+------ 
 
 
IGKV064  DIVLTQSPAS LAVSLGQRAT ISCRASESVD SYGNSFMHWY QQKPGQPPKL LIYRASNLES GIPARFSGSG SRTDFTLTIN PVEADDVATY YCQQSNED 
11L 064  ---------- ---------- ---------- ---------- ---------- ---------- ---------- F--------- ---G------ -------- 
 
 
IGKV186  SIVMTQTPKF LLVSAGDRVT ITCKASQSVS NDVAWYQQKP GQSPKLLIYY ASNRYTGVPD RFTGSGYGTD FTFTISTVQA EDLAVYFCQQ DYSS 
18L 186  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---- 
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Amino acid sequences of TD antigen-induced primary day 14 antibodies of ΔD-ID mice 
 
 
IGHV014  QVQLQQSGAE LVRPGTSVKI SCKASGYTFT NYWLGWVKQR PGHGLEWIGD IYPGGGYTNY NEKFKGKATL TADTSSSTAY MQLSSLTSED SAVYFC 
01H 014  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------ 
01L 137 ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------ 
IGKV137  DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV654  QVQLQQPGAE LVKPGASVKM SCKASGYTFT SYNMHWVKQT PGQGLEWIGA IYPGNGDTSY NQKFKGKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
02H 654  ---------- ---------- ---------- ---------- ---------- ---------- -P--+----- -+-------- ---------- --------- 
02L 097 ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV097  DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL DSDGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCWQGTHF 
 
 
 
IGHV499 QVQLQQSGAE LAKPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGY INPSSGYTKY NQKFKDKATL TADKSSSTAY MQLSSLTSED SAVYYCAR 
03H 499  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
03L 198 ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV198  DIVMTQSHKF MSTSVGDRVS ITCKASQDVS TAVAWYQQKP GQSPKLLIYS ASYRYTGVPD RFTGSGSGTD FTFTISSVQA EDLAVYYCQQ HYST 
 
 
 
IGHV286  EFQLQQSGPE LVKPGASVKM SCKASGYTFT SYVMHWVKQK PGQGLEWIGY IYPYNDGTKY NEKFKGKATL TSDKSSSTAY MELSSLTSED SAVYYCAR 
04H 286  ---------- ---------- ---------- ---------- ---------- -N-------- ---------- ---------- ---------- -------- 
04L 201  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV201  DIVMTQSQKF MSTSVGDRVS VTCKASQNVG TNVAWYQQKP GQSPKALIYS ASYRYSGVPD RFTGSGSGTD FTLTISNVQS EDLAEYFCQQ YNSY 
 
 
 
IGHV128  EVQLQESGPS LVKPSQTLSL TCSVTGDSIT SGYWNWIRKF PGNKLEYMGY ISYSGSTYYN PSLKSRISIT RDTSKNQYYL QLNSVTTEDT ATYYCAR 
06H 128  ---------- ---------- ---------- ---------- ---------- -RN--N-H-- ---------- ---------- ---------- ------+ 
06L 050  ---------- ---------- -----N---- --Q------- ---------- ---------- ---------+ --------T- ---------- ------- 
IGKV050  QIVLSQSPAI LSASPGEKVT MTCRASSSVS YMHWYQQKPG SSPKPWIYAT SNLASGVPAR FSGSGSGTSY SLTISRVEAE DAATYYCQQW SSN 
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IGHV706  QVQLQQSGAE LVKPGASVKL SCKTSGYTFT SYWIQWVKQR PGQGLGWIGE IFPGTGTTYY NEKFKGKATL TIDTSSSTAY MQLSSLTSED SAVYFCAR 
05H 706  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
05L 142  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV142  EIVLTQSPTT MAASPGEKIT ITCSASSSIS SNYLHWYQQK PGFSPKLLIY RTSNLASGVP ARFSGSGSGT SYSLTIGTME AEDVATYYCQ QGSSI 
 
 
 
IGHV128  EVQLQESGPS LVKPSQTLSL TCSVTGDSIT SGYWNWIRKF PGNKLEYMGY ISYSGSTYYN PSLKSRISIT RDTSKNQYYL QLNSVTTEDT ATYYCAR 
07H 128  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
07L 137  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
IGKV137 DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV192  EVQLVESGGD LVKPGGSLKL SCAASGFTFS SYGMSWVRQT PDKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLKSED TAMYYCAR 
08H 192  ----E-+--- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
08L 168  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV168  DILLTQSPAI LSVSPGERVS FSCRASQSIG TSIHWYQQRT NGSPRLLIKY ASESISGIPS RFSGSGSGTD FTLSINSVES EDIADYYCQQ SNSW 
 
 
 
IGHV147  EVMLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLRSED TAMYYCAR 
09H 147  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
09L 140  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- A--------- -------- 
IGKV140  DIQMTQSPSS LSASLGGKVT ITCKASQDIN KYIAWYQHKP GKGPRLLIHY TSTLQPGIPS RFSGSGSGRD YSFSISNLEP EDIATYYCLQ YDNL 
 
 
 
IGHV135  EVQLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLRSED TAMYYCAR 
10H 135  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
10L 168  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV168  DILLTQSPAI LSVSPGERVS FSCRASQSIG TSIHWYQQRT NGSPRLLIKY ASESISGIPS RFSGSGSGTD FTLSINSVES EDIADYYCQQ SNSW 
 
 
 
IGHV135  EVQLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLRSED TAMYYCAR 
11H 135  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------N 
11L 072  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
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IGHV178  VKLVESGGG LVKPGGSLKL SCAASGFTFS SYTMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLKSED TAMYYCTR 
12H 178  --------- ---------- ---------T ---------- ---------- -----G---- ---------- ---------- ---------- ---------- 
12L 069 --------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV069  IVMTQSPSS LSVSAGEKVT MSCKSSQSLL NSGNQKNYLA WYQQKPGQPP KLLIYGASTR ESGVPDRFTG SGSGTDFTLT ISSVQAEDLA VYYCQNDHSY 
 
 
 
IGHV185  EVQLVESGGG LVQPGESLKL SCESNEYEFP SHDMSWVRKT PEKRLELVAA INSDGGSTYY PDTMERRFII SRDNTKKTLY LQMSSLRSED TALYYCAR 
13H 185  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------+ 
13L 082 ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV082 QIVLTQSPAI MSASPGEKVT ITCSASSSVS YMHWFQQKPG TSPKLWIYST SNLASGVPAR FSGSGSGTSY SLTISRMEAE DAATYYCQQR SSY 
 
 
 
IGHV135  EVQLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLRSED TAMYYCAR 
14H 135  ----E----- ---------- ---------- ---------- ---------- ---------- -----+---- ---------- ---------- -------- 
14L 179 ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV179  DIVMTQSPAT LSVTPGDRVS LSCRASQSIS DYLHWYQQKS HESPRLLIKY ASQSISGIPS RFSGSGSGSD FTLSINSVEP EDVGVYYCQN GHSF 
 
 
 
IGHV114 VKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
15H 114 --------- ---------- ---------- I--------- ---------Q ---------- ---------- ---------- ---+------ +--------- 
15L 115  --------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV115  VLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
 
 
 
IGHV028 VQLVESGGG LVQPKGSLKL SCAASGFTFN TYAMNWVRQA PGKGLEWVAR IRSKSNNYAT YYADSVKDRF TISRDDSQSM LYLQMNNLKT EDTAMYYCVS 
16H 028 --------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------R 
16L 170 --------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV170  IQMTQSPAS LSVSVGETVT ITCRASENIY SNLAWYQQKQ GKSPQLLVYA ATNLADGVPS RFSGSGSGTQ YSLKINSLQS EDFGSYYCQH FWGT 
 
 
IGHV455  QVQLQQPGAE LVKPGASVKM SCKASGYTFT SYWMHWVKQR PGQGLEWIGM IDPSDSYTSY NQKFKGKATL TVDTSSSTAY MQLSSLTSED SAVYYCTR 
20H 455  ---------- ---------- ---------- --------+- ---------T ---+N----- ---------- ---------- ---------- --------- 
20L 115  ---------- ---------- ---------+ ----H----- ---------- ---------- ---------- ---------- ---------- --------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV 
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IGKV170  DIQMTQSPAS LSVSVGETVT ITCRASENIY SNLAWYQQKQ GKSPQLLVYA ATNLADGVPS RFSGSGSGTQ YSLKINSLQS EDFGSYYCQH FWGT 
17L 170  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---- 
 
 
 
IGKV097  DVVMTQTPLT LSVTIGQPAS ISCKSSQSLL DSDGKTYLNW LLQRPGQSPK RLIYLVSKLD SGVPDRFTGS GSGTDFTLKI SRVEAEDLGV YYCWQGTHF 
18L 097 ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --------- 
 
 
 
IGKV078  ENVLTQSPAI MSASPGEKVT MTCRASSSVS SSYLHWYQQK SGASPKLWIY STSNLASGVP ARFSGSGSGT SYSLTISSVE AEDAATYYCQ QYSGY 
19L 078 ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----- 
 
 
IGHV528  EVQLQQSGPE LVKPGASVKM SCKASGYTFT DYYMKWVKQS HGKSLEWIGD INPNNGDTFY NQKFKGKATL TVDKSSSTAY MQLNSLTSED SAVYYCAR 
21H 528  ---------- ---------- ---------- ------L+-+ ---------- ------V-I- ---------- ---R--N--- -H-SR----- -------- 
 
 
 
Amino acid sequences of TD antigen-induced secondary antibodies of ΔD-iD mice 
 
 
IGHV114  EVKLEESGGG LVQPGGSMKL SCVASGFTFS NYWMNWVRQS PEKGLEWVAE IRLKSNNYAT HYAESVKGRF TISRDDSKSS VYLQMNNLRA EDTGIYYCTR 
01H 114  ---------- --+------- ---------- -F-------- ---------- ---R-Y---- ---------- ---------- ---------- ---------- 
01L 108  -------T-- ---------- ---------- -----F---- ---------- -----P---- ---------- -----+---- ---------- ---------- 
IGKV108  DIQMTQSPSS LSASLGERVS LTCRASQEIS GYLSWLQQKP DGTIKRLIYA ASTLDSGVPK RFSGSRSGSD YSLTISSLES EDFADYYCLQ YASY 
 
 
 
IGHV386  QVQLQQSGAE LMKPGASVKI SCKATGYTFS SYWIEWVKQR PGHGLEWIGE ILPGSGSTNY NEKFKGKATF TADTSSNTAY MQLSSLTSED SAVYYCAR 
02H 386  ---------- V-R------- --------I- RF--D----- -----+---- -F--N+-YK+ --+------I ---------- ---W------ ----F--- 
02l 108  ---------- ---------- ---------- -S----+--- ----N----G ---------- --------T- ---------- G-----F--- -------- 
IGKV108  DIQMTQSPSS LSASLGERVS LTCRASQEIS GYLSWLQQKP DGTIKRLIYA ASTLDSGVPK RFSGSRSGSD YSLTISSLES EDFADYYCLQ YASY 
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Amino acid sequences of TD antigen-induced tertiary antibodies of ΔD-ID mice 
 
 
IGHV201  QVQLKQSGPG LVQPSQSLSI TCTVSGFSLT SYGVHWVRQS PGKGLEWLGV IWRGGSTDYN AAFMSRLSIT KDNSKSQVFF KMNSLQADDT AIYYCAK 
01H 201  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
01L 050  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
IGKV050 QIVLSQSPAI LSASPGEKVT MTCRASSSVS YMHWYQQKPG SSPKPWIYAT SNLASGVPAR FSGSGSGTSY SLTISRVEAE DAATYYCQQW SSN 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
02H 171  ----E----- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
02L 137  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
IGKV137  DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
03H 171  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
03L 072  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
 
12H 171  x----K---- ---------- ---------N ---I------ ---------- --V--N---- -------+-- -----++--- ---------- ------- 
12L 072  XXXXX--T-- ------+--- ---------- -IN-F----- ---------- ---------- ---------- ---------- ---------- ------- 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
 
 
 
IGHV171 QVQLKESGPG LVAPSQSLSI TCTVSGFSLT SYGVHWVRQP PGKGLEWLGV IWAGGSTNYN SALMSRLSIS KDNSKSQVFL KMNSLQTDDT AMYYCAR 
04H 171  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
04L 079  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------- 
IGKV079  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMYWYQQKPG SSPRLLIYDT SNLASGVPVR FSGSGSGTSY SLTISRMEAE DAATYYCQQW SSY 
 
 
 
IGHV192  EVQLVESGGD LVKPGGSLKL SCAASGFTFS SYGMSWVRQT PDKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLKSED TAMYYCAR 
05H 192  ----E----- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
05L 157  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV157  QIVLTQSPAL MSASPGEKVT MTCSASSSVS YMYWYQQKPR SSPKPWIYLT SNLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
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IGHV147  EVMLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLRSED TAMYYCAR 
07H 147  ---------- -------+-- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
07L 137  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV137  DIQMTQTTSS LSASLGDRVT ISCRASQDIS NYLNWYQQKP DGTVKLLIYY TSRLHSGVPS RFSGSGSGTD YSLTISNLEQ EDIATYFCQQ GNTL 
 
 
 
IGHV135  EVQLVESGGG LVKPGGSLKL SCAASGFTFS SYAMSWVRQT PEKRLEWVAT ISSGGSYTYY PDSVKGRFTI SRDNAKNTLY LQMSSLRSED TAMYYCAR 
08H 135  ----E----- ---------- ---------- ---------- ---------- ---------- -----+---- ---------- ---------- -------S 
08L 210  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- -------- 
IGKV210  DIVLTQSPAS LAVSLGQRAT ISCRASESVD NYGISFMNWF QQKPGQPPKL LIYAASNQGS GVPARFSGSG SGTDFSLNIH PMEEDDTAMY FCQQSKEV 
 
 
 
IGHV386  QVQLQQSGAE LMKPGASVKI SCKATGYTFS SYWIEWVKQR PGHGLEWIGE ILPGSGSTNY NEKFKGKATF TADTSSNTAY MQLSSLTSED SAVYYC 
10H 386  ---------- ---------- ---------- ---------- -------V-- ----FSI--- --N------- S--------- ---T------ ----+- 
10L 108  ---------- ---------- ---------- ---+------ ---------- ---------- ---------- ---------- ---------- ------ 
IGKV108  DIQMTQSPSS LSASLGERVS LTCRASQEIS GYLSWLQQKP DGTIKRLIYA ASTLDSGVPK RFSGSRSGSD YSLTISSLES EDFADYYCLQ YASY 
 
 
 
IGHV158  EVKLVESGGG LVQPGGSLRL SCATSGFTFT DYYMSWVRQP PGKALEWLGF IRNKANGYTT EYSASVKGRF TISRDNSQSI LYLQMNTLRA EDSATYYCAR 
14H 158  --Q-E----- -----D-+-- --------L- N---+----- -+---+-MA- MK--L---A- -+-+----+- -----D---- -----+---T –T-------- 
14L 115  ---------- ---------- --------T- -R------+- ---------- ---------- ---------- ---------- ---------- ---------- 
IGKV115  DVLMTQTPLS LPVSLGDQAS ISCRSSQSIV HSNGNTYLEW YLQKPGQSPK LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDLGV YYCFQGSHV- 
 
 
 
IGKV140  DIQMTQSPSS LSASLGGKVT ITCKASQDIN KYIAWYQHKP GKGPRLLIHY TSTLQPGIPS RFSGSGSGRD YSFSISNLEP EDIATYYCLQ YDNL 
06L 140  ---------- ---------- ---------- ---------- ---------- -F-------- ---------- ---------- ---------- ---- 
 
 
 
IGKV072  QIVLTQSPAI MSASPGEKVT MTCSASSSVS YMHWYQQKSG TSPKRWIYDT SKLASGVPAR FSGSGSGTSY SLTISSMEAE DAATYYCQQW SSN 
09L 072  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --- 
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IGHV386  QVQLQQSGAE LMKPGASVKI SCKATGYTFS SYWIEWVKQR PGHGLEWIGE ILPGSGSTNY NEKFKGKATF TADTSSNTAY MQLSSLTSED SAVYYC 
11H 386  ---------- ---------- ---G----I- ---------- -------V-- ----FSI--N --N------- ----+-+IV+ ---T------ ----+- 
 
 
 
IGKV168  DILLTQSPAI LSVSPGERVS FSCRASQSIG TSIHWYQQRT NGSPRLLIKY ASESISGIPS RFSGSGSGTD FTLSINSVES EDIADYYCQQ SNSW 
13L 168  ---------- ------Q--- ---------- -N----+--- H--------- G---+----- ----N----- ---------- ---------E NY-- 
15L 168  ---------- ---------- ---------- ---------- ---------- ---------- ---------- --+------- ---------- ---- 
 
 
 
IGKV128  DVQITQSPSY LAASPGETIT INCRASKSIS KYLAWYQEKP GKTNKLLIYS GSTLQSGIPS RFSGSGSGTD FTLTISSLEP EDFAMYYCQQ HNEY 
16L 128  ---------- ---------- -------T-- ---------- +-SY+---S- ---------- ---------- ------+--- ---------- ---- 
 
 
Legend for Figure 2 
Antibodies are specified by numbers (01, 02, etc.) and the chains are indicated by H or L followed by the coding gene, according to the integrative data 
base VBASE2. The deduced amino acid sequences of antibody V genes are compared with the respective germline VH (IGVH, full sequence shown 
above a group of Ab) and VL sequence (IGKV, full sequence shown below a group of Ab). A dash indicates identity with the respective germline-
encoded amino acid, productive mutations are indicated by the new aa in the one-letter code and silent mutations are indicated by a (+). 
Mutations correlate with affinity enhancement are showed in grey background. 
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